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SUMMARY
The glyoxylate bypass allows E. coli to generate precursors for biosynthesis 
during growth on acetate as the sole carbon source. During growth on acetate, there is 
competition between isocitrate dehydrogenase (ICDH) and isocitrate lyase (ICL) for the 
common substrate, isocitrate. Previous studies have shown that ICDH is regulated by 
reversible phosphorylation during growth on acetate. Although much is known about ICDH, 
comparatively little is known about the structure or catalytic mechanism and regulation of ICL.
Comparison of the restriction map of pEM9, a clone containing the ace operon 
from E. coli ML308 with the restriction/functional map of pCLlOOO, a clone encoding the ace 
operon of E. coli K12, indicated that the gene encoding ICL, aceA, was likely to be found 
within a 2.3kb BamHl-Aval fragment. This 2.3kb fragment was subcloned from pEM9 into 
the expresion vector pGLW ll to give pAR9023. E. coli KAT-1, contains a transposon TnlO 
insertion in the gene encoding aceA. After transformation of this strain with pAR9023 ICL 
activity and protein were overexpressed after addition of isopropyl-p-thiogalactoside (IPTG) to 
the growth medium.
The 2.3kb insert of pAR9023 was then subcloned into M13mp8 and a series of 
nested deletions were generated using a combination of exonuclease III and S1 nuclease. Using 
this method, the insert was sequenced using the universal primer or the -40 primer, without 
further subcloning or synthesis of other oligonucleotide primers.
During the course of this work, the sequence of aceA from E. coli K12 was 
determined by two independent groups. Comparison of the E. coli ML308 sequence with the 
K12 sequences revealed several differences which are probably due to sequencing errors or 
spontaneous mutations in the other sequences rather than strain variation. In support of my 
sequence, a third group sequenced aceA from E. coli and found it was identical to that from 
E. coli ML308, although the authors did not indicate the strain from which the aceA gene was 
cloned. Comparison of the derived amino acid sequence of ICL from E. coli ML308 with that 
of three plant ICLs and one yeast ICL revealed a very high degree of sequence identity.
Comparison of the derived amino acid sequence of ICL from E. coli ML308 with
that of ICDH, revealed a region of possible sequence and secondary structure homology. In 
addition, the three dimensional structure of ICDH is known and several residues which bind 
isocitrate in ICDH are conserved in ICL.
During the course of this project, an active site Cys residue was identified as 
Cysl95. Site directed mutagenesis was employed to replace this residue with either an Ala or a 
Ser. The mutated genes were sequenced to ensure that no other residues were replaced and then 
subcloned into pGLWl 1. The mutant ICLs, ICLSerl95 and ICLAlal95, were then 
overexpressed from transformed into KAT-1 strains and purified.
The conformation of both mutants were compared to that of the wild type enzyme 
by both near U.V. and far U.V. circular dichroism and fluorimetry. These studies indicated 
that all three ICLs had a very similar conformation and so replacment of Cys 195 with either a 
Ser or an Ala did not result in any great change in the conformation of the enzyme.
Both ICLSerl95 and ICLAlal95 showed a 3.6-fold and a 8.4-fold increase Km for 
isocitrate respectively and a 100-fold and 30-fold decrease in kcat values respectively, 
indicating that Cys 195 is an important residue. pH studies of the mutant enzymes indicated that 
Cysl95 probably has a pKa value of around 7.1, which is one pH unit below that usually 
found for sulphydryl groups. These studies also revealed that Km and kcat are dependent on 
ionisation of another group with a pKa of 7.8. The identity of this group is unknown. Based 
on these results, two possible roles for Cys 195 are postulated.
Chapter 1 
Introduction
1.1 The GIvoxvlate Bypass:
1.1.1 Introduction:
Cells contain a number of central metabolic pathways into which all carbon sources are 
directed and out of which all cell constituents are derived. The central metabolic pathways not 
only produce the precursors for biosynthesis but also generate the energy in the form of ATP 
necessary for biosynthesis and all necessary reducing power. This is achieved in aerobic 
organisms by complete combustion of the nutrients to CO2  and H2 O.
The Tricarboxylic Acid Cycle, TCA cycle or Krebs cycle serves as the central pathway 
in most organisms. This pathway condenses a C2  unit (acetyl-CoA) with an oxaloacetate 
(OAA) molecule to form citrate. This then undergoes a series of reactions in which coenzymes 
are reduced and two carbon atoms are lost as CO2  and OAA is regenerated. The reduced 
coenzymes, NADH, NADPH and FADH2 , can then be used in either reductive biosynthesis or 
to regenerate ATP by oxidative phosphorylation.
Use of intermediates for biosynthesis would prevent regeneration of OAA and thus 
cause breakdown of the cycle. Hence there is an absolute requirement for regeneration of TCA 
cycle intermediates. Thus there are anaplerotic pathways which operate to maintain the levels of 
intermediates of the central pathways (Komberg, 1966).
1.1.2 Growth Of Escherichia coli On Fattv Acids And Acetate:
E. coli, like many other organisms can grow on acetate or fatty acids as the sole carbon 
source. Both provide C2  units, in the form of acetyl-CoA, for entry into the TCA cycle.
When fatty acids enter the cell, they are either incorporated into more complex lipids or 
catabolised to acetyl-CoA.The pathway by which E. coli degrades fatty acids is very similar to 
the p-oxidative pathways of mammals and other eukaryotic organisms. The first step in the 
degradation of fatty acids is their activation to fatty-acyl-CoA, catalysed by an acyl-CoA 
synthetase. The fatty-acyl-CoA then undergoes two oxidation steps, yielding one molecule of 
FADH2  and one molecule of NADH, followed by thiolytic cleavage to give a fatty-acyl-CoA, 
which is shorter than the original by two carbon atoms, and acetyl-CoA. The shortened fatty-
1
acyl-CoA then re-enters the cycle thus yielding several molecules of acetyl-CoA for entry into 
the TCA cycle (Overath et aL, 1969).
Acetate can be activated to acetyl-CoA by two mechanisms. One mechanism involves 
the acetylation of CoA and cleavage of ATP to AMP and inorganic pyrophosphate by acetyl- 
CoA synthetase (acetate: CoAligase [AMP-forming]; EC 6.2.1.1.) (Chou andLipmann, 1952; 
Berg, 1956). The other mechanism uses two enzymes. Acetate kinase (ATP acetate 
phosphotransferase; EC 2.7.2.1.) converts acetate to acetyl phosphate, with cleavage of ATP 
to ADP, then phosphotransacetylase (acetyl-CoA: orthophosphate acyltransferase; EC .3.1.8.) 
transfers the acetyl moiety from acetyl phosphate to CoA liberating inorganic phosphate 
(Kaplan and Lipmann, 1948; Stadtman and Barker, 1950, Levine et al., 1980). It has been 
suggested from studies with ack (acetate kinase) and pta (phosphotransacetylase) mutants that 
the acetate kinase and phosphotransacetylase are required for E. coli to grow optimally on 
acetate as the sole carbon source (Brown et al., 1977). These authors also suggest that acetyl- 
CoA synthetase is used by these mutants as an alternative route for the conversion of acetate to 
acetyl-CoA.
1.1.3 The Glvoxvlate Bypass:
Operation of the TCA cycle results in the loss of both carbon atoms of the acetyl unit as 
CO2 , and by itself would allow no net accumulation of carbon. However, E. coli is able to 
grow on acetate and fatty acids as the sole source of carbon. This is achieved by diverting flux 
from the two CO2  evolving steps of the TCA cycle through the glyoxylate bypass (figure 1.1). 
In E. coli the two unique enzymes of the glyoxylate bypass, isocitrate lyase (ICL) and malate 
synthase A (MSA) are induced during growth on acetate or fatty acids as the only source of 
carbon (Komberg, 1966; Vanderwinkel and DeVliegher, 1968). (There is a second malate 
synthase, MSB, which is induced during growth on glycolate and compounds which are 
metabolised to glyoxylate as the sole carbon source (Falmange et al., 1965; Vanderwinkel et 
al., 1963)).
The first enzyme of the glyoxylate bypass, ICL [Ds-isocitrate glyoxylate-lyase E.C.
4.1.3.1.], was first discovered in sonic extracts of Pseudomonas aeroginosa which catalysed 
the reversible formation of succinate and glyoxylate on addition of either citrate or
\  /
Pyruvate
( Acetatei
Phosphoenolpyruvate Acetyl-CoA
Oxaloacetate Citrate
Malate Glyoxylate^ Isocltrate
Fomarate 2-Oxoglutarate
Succlnyl-CoASuccinate
Figure 1.1: The Glyoxylate Bypass And The TCA Cycle
The reactions numbered 1-4 are catalysed by the enzymes isocitrate lyase, malate 
synthase-A, phosphoenolpyruvate carboxykinase, and isocitrate dehydrogenase respectively. 
The heavy arrows indicate fluxes to biosynthesis.
3
cis-aconitate (Campbell et a i , 1953). This result was quickly confirmed using fungi and 
several bacteria and it was established that Ds-(+)-isocitrate was the true substrate (Olsen,
1954; Saz, 1954; Smith and Gunsalus, 1954). (Figure 1.2a)
The second glyoxylate bypass enzyme, MSA [E.C. 4.1.3.2] catalyses the condensation 
of glyoxylate and a second molecule of acetyl CoA to form malate (Wong and Ajl, 1956) with 
the equilibrium strongly in favour of malate (Figure 1.2b).
It was later shown, using labelled acetate, that ICL and MSA act together to give the 
following overall reaction (Komberg, 1958; Komberg and Madsen, 1958; Komberg and 
Quayle, 1958; Komberg et al., 1960):
Acetyl CoA + Isocitrate + H2O = Succinate + Malate + CoA
Thus there is a net gain of one C4 -dicarboxylic acid, a TCA cycle intermediate, which 
can be converted to oxaloacetate (OAA). This can then be used to supply all the precursors 
required for biosynthesis since all the TCA cycle intermediates are mutually interconvertible 
and phosphoenolpyruvate carboxykinase can convert OAA to phophenolpyruvate (PEP) which 
can then be used to generate all the phosphorylated biosynthetic precursors.
Since flux through ICDH is essential to produce 2-oxoglutarate and succinyl-CoA, as 
well as some of the energy and reducing power necessary to utilize the precursors for growth, 
there has to be flux through ICDH. ICDH and ICL compete for the common substrate, 
isocitrate, and one might therefore expect very tight regulation of the ICL and ICDH activities 
in order to ensure efficient use of the available acetate.
1.2 Control Of The Branchpoint Between ICL and ICDH In E. coli:
1.2.1 Reversible Inactivation Of ICDH:
Since there is no subcellular compartmentation in E. coli, ICL and ICDH compete 
directly with each other for the available isocitrate during growth on acetate or fatty acids as the 
sole carbon source. This raises the question of how fluxes at this branchpoint is regulated.
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Figure 1.2: Reactions Catalysed By Isocitrate Lyase And Malate Synthase-A
(A) Isocitrate lyase catalyses the reversible aldol cleavage of isocitrate to give succinate 
and glyoxylate.
(B) Malate synthase-A catalyses the condensation of glyoxylate with acetyl-CoA to 
form malate.
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There is no evidence to suggest that ICL from E. coli is allosterically controlled. Also, 
unlike the NAD-linked ICDH of eukaryotes, ICDH from E. coli, and most other bacteria, is 
NADP-linked and does not appear to be under the control of any allosteric inhibitors or 
activators (Ragland et al., 1966). ICDH is however subject to concerted inhibition by OAA 
and glyoxylate, both of which are generated by the glyoxylate bypass. This inhibition is 
complex, partly caused by the condensation of glyoxylate and OAA to yield the unstable 
compound, oxalomalate, which is a very potent competitive inhibitor of ICDH and partly 
caused by the slow binding of OAA and glyoxylate to the isocitrate-binding site of ICDH 
(Nimmo, 1986). However, several groups have reported the condensation of OAA and 
glyoxylate is too slow to account for the inhibition of ICDH by oxalomalate (Johanson and 
Reeves, 1977; Marr and Weber, 1969; Shiio and Ozaki, 1968). Also, oxalomalate was found 
to decompose spontaneously to form 4-hydroxy-2-oxoglutarate, which is a much less potent 
inhibitor of ICDH (Nimmo, 1986). The second mechanism of inactivation of ICDH by OAA 
and glyoxylate is not thought to be physiologically significant because the intracellular 
concentrations of these metabolites are probably too low (Nimmo, 1986). Moreover, one might 
expect glyoxylate and OAA to activate ICDH and not inhibit it since these metabolites can be 
considered as end products of flux through the glyoxylate bypass during growth on acetate or 
fatty acids as the sole carbon source (see section 1.2.4).
Consideration of the kinetic properties of the two competing enzymes in isolation does 
not indicate how this branchpoint is regulated (Table 1.1). The Km of ICL for isocitrate is 
63|iM in the absence of competing anions and is probably much higher in vivo, at least 
260jiM due to the presence of competing anions and inhibitors (see section 1.4.7)
(MacKintosh and Nimmo, 1988) and the Km of ICDH for the same substrate is around 5pM 
(Nimmo et al., 1987). The intracellular concentration of isocitrate is approximately 4jiM 
during growth on glucose (LaPorte et al., 1984). Since the specific activities of both ICDH 
and ICL from cells grown on acetate are similar (0.9u.mg_1 for ICDH and 0.8u.mg_1 for ICL), 
if this were also true for acetate grown cells, flux through ICDH will be favoured, the acetate 
carbon lost as CO2 , no biosynthetic precursors will be accumulated and growth will cease. In 
order to allow flux through ICL, and hence the glyoxylate bypass, there must be a means of
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Table 1.1; Properties Of ICL And ICDH
ICDH ICL
Specific activity in acetate grown cells 0.9u/mg 0 .8 u/mg
Km for Ds-isocitrate in the absence of inhibitors L/1 1 63|iM
Significant inhibitors none 3-phosphoglycerate
(Ki=0.8mM:
intracellular
conc.=2.5mM).
Sulphate 
(Kp20mM: 
intracellular 
conc. unknown).
Estimated Km for Ds-isocitrate in vivo 5jlM 0.57mM
Taken from Nimmo et al. (1987). The Km for Ds-isocitrate was measured 
at a NADP+ concentration of 40jiM. The intracellular concentrations of isocitrate in 
cells growing on glycerol and acetate are 20|iM and 570jiM respectively.
ICDH: Isocitrate Dehydrogenase 
ICL: Isocitrate Lyase
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either or both inhibiting ICDH or activating ICL in vivo.
During studies of the activities of different TCA cycle enzymes malate dehydrogenase, 
2-oxoglutarate dehydrogenase and ICDH in E. coli growing on different carbon sources, the 
control of this branchpoint became clearer. Holms and Bennett (1971) found that after growth 
had stopped on limiting glycerol, the specific activities of all three of the above enzymes
remained constant over a four hour period. However, after growth on limiting glucose, both
/
malate dehydrogenase and 2-oxoglutarate dehydrogenase but not ICDH activity remained 
constant over the same period. The ICDH activity dropped to about 20% of its original level 
over 2 hours and then rose again to 75% at the end of the 4 hour period. This is explained by 
the fact that during growth on glucose but not glycerol, E. coli excretes acetate into the medium 
(Britten, 1954). Once the glucose is exhausted, growth stops and the enzymes of the glyoxylate 
bypass are induced and acetate is metabolised. During the period of adaption to acetate and its 
use as a carbon source, the ICDH activity declined but rose again after exhaustion of the acetate. 
Addition of chloramphenicol, which inhibits protein synthesis, at the end of growth on limiting 
glucose prevented ICL activity increasing and slowed but did not stop utilization of acetate. The 
activity of ICDH did not decrease under these conditions in the 4 hour period after cessation of 
growth. The specific activity of ICDH during growth of E. coli on acetate was approximately 
30% of that during growth on glucose or glycerol (Bennett and Holms, 1975). Addition of 
ImM pyruvate to cells growing on acetate resulted in a 4-fold activation of ICDH which 
persisted until the pyruvate was exhausted when the ICDH activity dropped to the level during 
growth on acetate. Similar results were obtained after addition of a number of other metabolites 
which make the glyoxylate bypass redundant. Thus, loss of ICDH activity appears to be 
peculiar to cells growing on acetate or fatty acids as the sole carbon source.
Bennett and Holms further investigated the inactivation of ICDH by trying to determine 
the mechanism of inactivation. Addition of chloramphenicol at the same time as pyruvate to E. 
coli growing on acetate had no effect on the change in activity of ICDH, indicating that protein 
synthesis is not involved. Degradation of an inhibitor protein could also be ruled out since 
ICDH activity returns to the level during growth on acetate after the pyruvate is exhausted. 
Experiments involving dialysis and mixing extracts from acetate and glucose grown cultures
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indicated that changes in the intracellular concentration of a low molecular weight effector(s) 
was not responsible. Bennett and Holms concluded that the reversible inactivation may be the 
result of reversible covalent modification or reversible association with another macromolecule, 
and that the role of inactivation was to restrict flux through the TCA cycle and so permit 
isocitrate to be metabolised through the glyoxylate bypass (Holms and Bennett, 1971; Bennett 
and Holms, 1975).
The first evidence that ICDH from E. coli could be phosphorylated came from Gamak 
and Reeves (1979a,b). These workers added 32P and acetate (5min later) to E. coli cultures at 
the beginning of stationary phase in a low phosphate medium with limiting glucose. From 
these cells, they found a 51,000 dalton radiolabelled protein which co-purified with ICDH.
This protein was immunologically identical to ICDH and the radioactive band corresponded to 
an ICDH activity stain in native gels, suggesting that this protein was in fact 3 2P-ICDH. Ion 
exchange chromatography followed by partial acid hydrolysis identified the phosphorylated 
residue as a serine. Borthwick et al. (1984a) purified active ICDH from glycerol grown cells, 
inactive and partially active ICDH from acetate grown cells. The active ICDH bound to an 
immobilised dye column, Procion red-Sepharose, while the inactive ICDH did not bind to this 
column. All three proteins had the same mobility on SDS gels corresponding to a subunit of
45,000 daltons. The amino acid composition of all three proteins was essentially the same as 
was the chymotryptic digestion pattern on SDS gels and the tryptic digestion pattern on 2- 
dimensional gels. Non-denaturing gel electrophoresis did however reveal differences in the 
three proteins. The partially active ICDH showed two bands after protein staining, of which the 
band with higher mobility did not appear on gels stained for ICDH activity. The inactive ICDH 
appeared as one band after protein staining with the same mobility as the higher mobility band 
of the partially active ICDH. Using non-denaturing gel electrophoresis in different acrylamide 
concentrations they showed that the difference in mobility was due to a charge difference and 
not a difference in molecular weight. The alkali-labile phosphate was also measured. This 
showed that active and inactive ICDH correspond to dephosphorylated and phosphorylated 
ICDH respectively differing in one phosphate per subunit .The ICDH purified by Gamak and 
Reeves (1979a,b), which contained 32P but was active, was probably a monophosphorylated 
dimer.
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1,2,2 Phosphorylation Of ICPH-fa vivoi
When studying phosphorylation systems, it is necessary to establish the occurrence of 
the phosphorylation in vzvo.This was done for this system in E. coli ML308 by Borthwick 
et al. (1984b) When pyruvate was added to cells growing on acetate, the ICDH activity rose 
4-fold over 20-30min, then declined to its basal level by 50min. Cells were labelled with 32Pj 
during this experiment and denatured cell pellets were run on SDS gels. The 3 2P-containing 
ICDH band was easily identified. On addition of the pyruvate, there was a loss of 32P from 
this band followed by a rise after 40-60min. This effect was not due to changes in the amount 
of ICDH protein. Thus the result shows an inverse correlation between the phosphorylation 
state and the activity of ICDH in intact cells (Borthwick et al., 1984b). Cell extracts from the 
same experiment were incubated with purified ICDH kinase/phosphatase (section 1.2.3) under 
conditions in which ICDH is dephosphorylated. This caused the ICDH activity to rise to the 
value seen after addition of pyruvate. It was therefore concluded that the reversible inactivation 
of ICDH in vivo is solely due to reversible phosphorylation. Borthwick et al. (1984b) also 
isolated and sequenced phosphorylated chymotryptic peptides from ICDH labelled in vivo and 
ICDH labelled in vitro by purified ICDH kinase/phosphatase. Both labelled proteins gave 
identical digestion patterns with one peptide containing over 80% of the recovered 
radioactivity. The sequences of these peptides were identical, showing that the serine residue 
phosphorylated in vivo is the same as the one phosphorylated in vitro.
It is believed that the role of phosphorylation and inactivation of ICDH is to render this 
enzyme rate limiting in the TCA cycle and thus allow the intracellular concentration of isocitrate 
to increase to a level high enough to sustain flux through ICL. In agreement with this 
hypothesis, El-Mansi et al. (1985) found that the intracellular concentration of isocitrate was 
much higher in cells growing on acetate (570jiM) than on cells growing on glycerol or glucose 
as the sole carbon source (Tablel.l). Hence this explains how phosphorylation of ICDH 
permits flux through the glyoxylate bypass. These authors also found that addition of pyruvate 
to cells growing on acetate, known to result in reactivation and dephosphorylation of ICDH, 
caused a transient two-fold increase in intracellular isocitrate concentration.
10
1.2.3. ICDH Kinase/Phosphatase:
LaPorte and Koshland (1982) devised a purification procedure for ICDH kinase, the 
enzyme that phosphorylates ICDH. Surprisingly, they also found that ICDH phosphatase 
could be purified in the same way and that the ratios of kinase:phosphatase remained constant 
throught the purification. The kinase and phosphatase activities eluted superimposably from ion 
exchange, gel filtration and affinity chromatography columns. Fractions from the affinity 
column (immobilised ICDH) which contained both kinase and phosphatase activities gave in a 
single band of 66,000 dalton on SDS gels indicating that both activities are probably associated 
with the same polypeptide. Similar results were obtained by Nimmo et al. (1984) who 
reported the native molecular weight to be 135,000 dalton suggesting that ICDH 
kinase/phosphatase is a dimer of identical subunits, Mr 66,000. Definite proof that both kinase 
and phosphatase activities are associated with the same polypeptide came from the isolation of a 
clone which restored the ability of an aceK mutant to grow on acetate (LaPorte and Chung, 
1985). This clone expressed a 66,000 dalton protein with both ICDH kinase and ICDH 
phosphatase activities. Deletion mapping of the clone revealed a l,800bp coding region, the 
length required to encode a 66,000 dalton polypeptide. These results were confirmed by 
determination of the nucleotide sequence (Cortay et al., 1988; Klumpp et al., 1988). The 
deduced amino acid sequence revealed none of the consensus motifs characteristic of other 
protein kinases (Reed et al., 1985; Celenza and Carlson, 1986), with the exception of a 
concensus ATP binding site.
ICDH kinase transfers the y-phosphate group of ATP to a serine residue of ICDH with 
a stoichiometry of one phosphate per subunit resulting in complete inactivation of ICDH.
ICDH phosphatase catalyses the release of inorganic phosphate from phospho-ICDH, causing 
full reactivation of ICDH, in the presence of inhibitors of the kinase and either ADP or ATP. 
When 3 2P-ICDH is incubated with ICDH kinase/phosphatase in the presence of ATP, 32P is 
released from ICDH but there is only slow reactivation of ICDH. This can be explained by the 
rephosphorylation of ICDH by ICDH kinase which adds cold phosphate to the enzyme. Thus 
both the kinase and the phosphatase can be active similtaneously in vitro and so may also both 
be active in vivo (LaPorte and Koshland, 1982; Nimmo et al., 1984).
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An unusual feature of ICDH phosphatase activity is the absolute requirement for either 
ATP or ADP (LaPorte and Koshland, 1982; Nimmo et al., 1984). Since 32P released from 
[32p]_icDH appears as inorganic phosphate rather than [3 2P]-ATP, the dephosphorylation 
cannot simply be the result of the back reaction of the kinase. Although both ICDH kinase and 
ICDH phosphatase require ATP, the deduced amino acid sequence shows only one region 
which matches the consensus ATP binding site (Klumpp et al., 1988). Photoaffinity labelling 
of ICDH kinase/phosphatase using the ATP analogue 8 -azido ATP resulted in parallel losses of 
kinase and phosphatase activities and in covalent attachment of the reagent at a single site on the 
enzyme. ATP or ADP protected against this inactivation, suggesting that this occurred at the 
active site (Valera and Nimmo, 1988). Using site directed mutagenesis, Stueland et al. (1989) 
changed the "invariant" lysine, which is found in every protein kinase to date and is involved in 
ATP binding (Hanks et al., 1988), to a methionine. This mutation resulted in inhibition of 
both the kinase and phosphatase activities, indicating that they both use the same ATP binding 
site. Random mutagenesis of aceK resulted in several mutants which had retained their kinase 
activities but not their phosphatase activities (Stueland et al., 1987). It was discovered that 
these mutants suffered a drastic decrease in their affinity for phospho-ICDH. This suggests that 
both the kinase and phosphatase reactions occur in the same site (LaPorte et al., 1989). These 
mutations may be at the active site or they may cause a conformational change that inhibits the 
phosphatase and activates the kinase.
As well as a kinase and a phosphatase activity, ICDH kinase/phosphatase can also 
catalyse the hydrolysis of ATP to ADP, even in the absence of ICDH (Stueland et al., 1987).
In contrast to other kinases which can hydrolyse ATP, the ATPase of ICDH 
kinase/phosphatase has a higher Vmax than either its kinase or its phosphatase activities. The 
ATPase was found to be active even when ICDH kinase/phosphatase is complexed with ICDH 
or phospho-ICDH. This ATPase activity is thought to be involved in the reaction of the 
phosphatase. The current hypothesis is that ICDH kinase/phosphatase has a single active site 
and that the phosphatase reaction represents the reverse of the kinase reaction coupled with 
ATP hydrolysis (LaPorte et al., 1989).
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1.2.4 Control Of ICDH Phosphorylation:
Since ICDH kinase and ICDH phosphatase can be active simultaneously in vivo 
(Borthwick et al., 1984a), the phosphorylation state of ICDH is representitive of the steady 
state balance of ICDH kinase and phosphatase activities. Therefore, the activities of ICDH 
kinase and ICDH phosphatase have to be very tightly controlled.
ICDH kinase/phosphatase is controlled by a wide variety of metabolites (Figure 1.3). 
Isocitrate, 3-phosphoglycerate, pyruvate, AMP, ADP, oxaloacetate, 2-oxoglutarate and PEP 
activate ICDH phosphatase and inhibit ICDH kinase, while NADP, citrate, fructose-6 - 
phosphate and glyoxylate inhibit ICDH kinase but have little effect on ICDH phosphatase 
(LaPorte and Koshland, 1983; Nimmo and Nimmo, 1984). Considering the intracellular 
concentrations of the above metabolites (Lowry et al., 1971; Bautista et al., 1979; Morikawa 
et al., 1980; El-Mansi et al., 1985), the effectors most likely to be significant in vivo are 
isocitrate, PEP, 3-PG, AMP, ADP and NADPH (Nimmo and Nimmo, 1984).
Perhaps the most important effector of ICDH kinase/phosphatase is isocitrate since a 
low concentration of this metabolite will prevent flux through the glyoxylate bypass. The other 
effectors can be divided into three catagories. PEP, 3-PG, pyruvate, 2-oxoglutarate and 
oxoaloacetate are all precursors for biosynthesis. High levels of these metabolites would be 
expected to favour flux through the TCA cycle instead of the glyoxylate bypass. A decrease in 
the energy charge of the cell will result in increased levels of AMP and ADP and might be 
expected to favour flux through the TCA cycle. As expected, all of the above metabolites 
inhibit ICDH kinase and activate ICDH phosphatase. NADPH is a product of the TCA cycle 
and its inhibition of ICDH phosphatase can be regarded as feedback inhibition. Thus ICDH 
phosphorylation is sensitive to a number of metabolic effectors and the fact that all of these 
effectors, with the exception of NADPH, act by affecting both opposing activities amplifies 
this sensitivity.
Further amplification of the sensitivity of the ICDH phosphorylation cycle is the result 
of "zero-order ultrasensitivity" (Goldbeter and Koshland, 1981), which refers to the situation 
where one or both converter enzymes are saturated with their substrates. Also, the 
phosphorylation system can respond to variations in the ICDH concentration in vivo (LaPorte 
et al., 1985).
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Figure 1.3: Control Of ICDH Kinase/Phosphatase
Taken from Nimmo (1984). + and - represent stimulatory and inhibitory effects 
respectively.
Therefore the system responds efficiently to a number of different effectors in order to 
maintain flux through the glyoxylate bypass during growth on acetate or fatty acids as the sole 
carbon source. La Porte et al. (1985), studied the levels of ICDH activity and phosphorylation 
in different E. coli strains with multiple copies of icd, the gene encoding ICDH. It was found 
that even when icd was expressed ten-fold over the level in the wild type, the ICDH activity 
remained constant as the proportion of phosphorylated ICDH increased.
1.2.5. Mechanism Of Inactivation Of ICDH:
Evidence has been presented which suggests that ICDH is phosphorylated at a number 
of sites. Cortay et al. (1986) resolved the ICDH from E. coli grown on acetate in the presence 
of 32Pi into three distinct spots differing in charge and showed that ICDH is modified at both 
serine and threonine residues. These 3 2P-laballed bands did not appear on control cells grown 
on glucose. Digestion of phospho-ICDH with several proteases revealed the presence of a 
number of phosphorylated peptides. The authors did not however, measure the stoichiometry 
of phosphorylation and inactivation of ICDH. Most of the evidence favours the conclusion that 
phosphorylation of ICDH at a single serine residue is responsible for inactivation.
Phosphorylation of ICDH on a single serine residue completely inactivates the enzyme 
and the difference between active and inactive ICDH is that inactive ICDH contains one 
phosphoserine group per subunit (LaPorte and Koshland, 1983; Borthwick et al., 1984a,b,c; 
Nimmo et al., 1984). Borthwick et al. (1984c) isolated a 22-residue phosphopeptide of 
ICDH generated by digestion of ICDH which had been phosphorylated either in vivo or in 
vitro. The first 14 amino acids of this peptide were sequenced. Malloy et al. (1984) 
independently determined the sequence of a phosphopeptide isolated from in vivo 3 2P-labelled 
ICDH digested with trypsin. The same serine residue was phosphorylated in both cases and 
corresponds to Seri 13 from the derived amino acid sequence of ICDH (Thorsness and 
Koshland, 1987):
Thr-Thr-Pro-Val-Gly-Gly-GIy-Ile-Arg-113Ser(P)-Leu-Asn-VaI-AIa
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Since active but not inactive ICDH can bind to Procion Red Sepharose, which binds to 
the nucleotide binding site of many nucleotide binding proteins, Borthwick et al. (1984a) 
proposed that inactive ICDH was inactive because it was unable to bind NADI*. Consistent 
with this, Garland and Nimmo (1984) found that inactive ICDH was resistant to limited 
proteolysis by a variety of proteases whereas active ICDH was not, but could be protected by 
NADP+. Fluorescence titration experiments also indicated that NADP+ bound to ICDH but not 
to phospho-ICDH. Also the sequence around the phosphorylated serine residue is similar to a 
region very close to the NADP+ binding site of dihydrofolate reductase (DHFR) (Volz et al., 
1982): Arg-Ser-Leu-Asn. Nimmo (1984) proposed that phosphorylation of ICDH occurs at or 
near to the NADP+ binding site of the enzyme so that the introduction of a negatively charged 
phosphate group could prevent NADP+ binding by charge repulsion and also cause a 
conformational change similar to that caused by NADP+ binding. Consistent with this 
hypothesis was the finding that there was a difference in the near UV CD spectra between 
ICDH and ICDH bound to NADP+ (McKee et al., 1989) This would explain why both 
NADP+ and NADPH inhibit phosphorylation of ICDH and why phosphorylated ICDH cannot 
be reactivated by proteolytic removal of the phosphorylation site (Garland and Nimmo, 1984), 
unlike several eukaryotic enzymes regulated by phosphorylation (e.g. Huang and Cabib,
1974). Thorsness and Koshland (1987) introduced a negatively charged amino acid, aspartate, 
at position 113 of ICDH replacing the serine by site-directed mutagenesis. This substitution 
inactivated the enzyme suggesting that the inactivation by phosphorylation could be a result of 
the introduction of a negative charge. Replacement of Seri 13 with a variety of amino acids, 
including threonine, completely prevented phosphorylation, indicating that Seri 13 is necessary 
for recognition by ICDH kinase/phosphatase and confirming that ICDH kinase phosphorylates 
only one site in ICDH.
Contrary to this model, Dean et al. (1989), using binding studies, found that ICDH 
binds isocitrate, 2-oxoglutarate, NADP+ and NADPH at a 1:1 ratio of substrate to enzyme 
monomer but that the phospho-ICDH cannot bind isocitrate although it retains the ability to 
bind NADP+ and NADPH. This result is not compatible with the compulsory order, steady 
state kinetic mechanism of ICDH with NADP+ binding first (Nimmo, 1986). Binding studies 
were also done for the Asp 113 mutant generated by Thorsness and Koshland (1987). It was
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found that like the inactive, phosphorylated ICDH, this mutant could not bind isocitrate but the 
binding of NADPH was unaffected. Thus these results suggest that the negative charge 
introduced by either the Asp at position 113 or phosphorylation of Seri 13 causes inactivation 
by preventing binding of isocitrate. It should be noted however, that the kinetic and binding 
studies were carried out under different conditions and with enzymes from different E. coli 
strains.
The controversy over the mechanism of inactivation was not resolved until the 3- 
dimensional structure became available. Hurley et aL (1989) crystallised ICDH and 
determined the 3-dimensional structure by X-ray diffraction. Seri 13 was found to lie at the 
edge of an inter-domain pocket which is formed between the two subunits. Because of its 
position, this pocket was suggested to be the active site. The same crystals were soaked in a 
buffer containing Mg2+ and isocitrate and the 3-dimensional structure determined. The results 
of this showed that isocitrate did in fact bind in this pocket (Hurley et al., 1990a) and that the 
Seri 13 actually forms a hydrogen bond to the y-carboxyl group of isocitrate. Substitution of 
Seri 13 with Asp or Glu, both negatively charged, did not cause the conformational change in 
ICDH observed in binding of isocitrate to the enzyme or on phosphorylation (Hurley et al., 
1990b), indicating that the introduction of a negative charge at Seri 13 does not induce a 
conformational change. Instead, the conformation change observed on phosphorylation of 
ICDH is probably caused by steric effects of the phosphate group. Hurley et al. (1990a) 
calculated that the electrostatic potential change on phosphorylation could account for the 
decreased affinity of ICDH for isocitrate. Consistent with this is the finding that there is no 
significant decrease in activity of ICDH with 2R-malate as the substrate. 2R-malate is an 
anologue of isocitrate which lacks the y-carboxyl group of isocitrate that interacts with Seri 13 
and would be repelled by phospho-serine on phosphorylation (Dean and Koshland, 1990). 
ICDH crystals were also soaked in NADP+ and the structure determined (Hurley et al., 1991). 
NADP+ was found to bind to ICDH in the cleft between the a+(3 and oe/P domains. The 
pyrophosphate moiety of NADP+ binds near to the helical turn at amino acids 342-346 and 
might form hydrogen bonds with the nitrogens in the peptide bonds at amino acids 340-342. 
There is very little conformational change on binding NADP+, which is not in agreement with 
McKee et al. (1989). However, the changes in the near UV CD spectra in binding NADP+ to
ICDH may be accounted for by the electrostatic interactions between the 2' phosphate of the 
nucleotide with Tyr345 and Tyr391, by binding the adenine ring of NADP+ to the enzyme, or 
both.
For many enzymes, it is clear that phosphorylation alters their allosteric properties 
rather than kcat. The structural basis for this is known for glycogen phosphorylase (Goldsmith 
et al., 1989). It is clear that the mechanism of inactivation of ICDH by phosphorylation is 
quite different.
1.3 The Glvoxvlate Bypass (ace) Oneron:
1.3.1 Genetic Organisation Of The Glvoxvlate Bypass:
The structural genes for ICL, ace A, and MS-A, aceB, have been mapped by several 
groups independently and have been shown to be located at 90 min on the revised E.coli K12 
linkage map (Bachmann and Low, 1980). Vanderwinkel and DeVlieghere (1968) mapped 
aceA and aceB with an adjacent gene, met A, and found the gene order to be metA-aceB- 
aceA. Brice and Komberg (1968) also mapped this region and isolated mutants in an adjacent 
gene iclR,which caused constitutive expression of ICL, and showed close linkage with aceA. 
Maloy and Nunn (1982) confirmed the gene order as metA-aceB-aceA-iclR, although the exact 
distance between aceA and iclR was uncertain. Bachmann and Low placed iclR at 
approximately 0.4min from acM.Similar results were obtained by Vinopal and Fraenkel 
(1974) who suggested that the very close linkage could be due to a bias in favour of co­
inheritance of the iclR mutation and aceA since constitutive expression of the glyoxylate 
bypass enzymes enhances growth on plates containing acetate as the sole carbon source. Since 
both ICL and MS-A are coordinately expressed and because of the close genetic linkage 
between aceA and aceB, it was suggested that these genes may form an operon (Brice and 
Komberg, 1968).
Using transposon TnlO insertions, which prevent expression of genes downstream of 
the point of insertion in an operon, Maloy and Nunn (1982) found that aceA::TnlO insertions 
eliminated ICL but not MS-A activity, and aceB::TnlO insertions eliminated both ICL and
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MS-A activities, in a glc background (glc encodes a second malate synthase, MSB, which is 
induced during growth on glyoxylate, or compounds such as glycolate which are metabolised 
to glyoxylate, as the sole carbon source). This confirms that aceA and aceB do constitute an 
operon, the ace operon, with transcription from aceB to aceA.
It was also found that the regulation of expression of aceK, the structural gene for 
ICDH kinase/phosphatase, paralleled that of aceA and aceB, although aceK was expressed 
100-1000 times less than aceA or aceB.aceK was also shown to be closely linked with 
met A, suggesting that aceK may be part of the ace operon (LaPorte and Chung, 1985). This 
was confirmed by phage Mu insertion. Three phage Mu lysogens were isolated which had lost 
one or more of the activities of the glyoxylate bypass. Two of these had lost both ICL and 
ICDH kinase/phosphatase activities and had reduced MS-A activity. These were assigned as 
being aceAvMxx although they could have been aceBvMxi since this was not done in a glc 
background. Neverthless, this result confirms that aceK is part of the ace oeron. The third 
lysogen abolished only the ICDH kinase/phosphatase activity, therefore placing the aceK gene 
downstream of aceA.
The ace operon has now been cloned from E.coli by several groups. Chung et al. 
(1988) used BAL31 deletion in conjunction with enzyme assays and in vitro transcription/ 
translation using the maxicell labelling procedure to determine the 3'ends of aceB and aceA. 
aceK was mapped by comparing the restriction maps of the clone with the predicted restriction 
map from the DNA sequence of aceK (Klumpp et al., 1988). The promoter was identified by 
deletion mapping, nuclease S1 mapping and sequencing of the DNA immediately upstream of 
the startsite. These studies confirm the gene order as being aceB-aceA-aceK with transcription 
from a single promoter during growth on acetate and aceB proximal to the promoter.
1.3.2 Evidence For A Fourth ace Gene:
While sequencing the aceB gene, Byrne et al. (1988) found that DNA from the aceB 
gene hybridised to a lOkb messenger RNA. Since all three structural genes of the ace operon 
are encoded within 7kb of the promoter, it is possible that a fourth gene is encoded in the ace 
operon. An open reading frame has been found within the 1.9kb HindUl fragment 
immediately downstream of aceK (Cortay et al., 1989), which the authors first claimed to be
iclR. However, iclR has since been cloned and sequenced by the same group and another 
group from a region further downstream from the 3' end of aceK than this open reading frame 
(Sunnarborg et al., 1990; Negre et al., 1991). Garlinier et al. (1991) have sequenced the 
entire intergenic region between aceK and iclR and found an open reading frame capable of 
encoding a 69,355 dalton polypeptide. This open reading frame is in the same orientation as 
iclR but in the opposite orientation from aceK. Although the authors did not identify any 
possible promoter sequences, there are regions upstream of the translation initiation startsite 
with considerable homology to the E. coli consensus promoter and the consensus ribosome 
binding site. The sequences CATTGACGC (at position 144-152) and TACACT (at position 
171-176) are homologous to the -35 and -10 promoter consensus sequences, tcTTGACat and 
TAtAaT respectively (Rosenberg and Court, 1979; Siebenlist et al., 1980), while two 
sequences GAGG and GGAG at positions 427-430 and 447-450 respectively are similar to the 
consensus ribosome binding sequence AGGAGG (Shine and Dalgamo, 1974). Thus it appears 
that there may be a gene immediately downstream from aceK, expressed in the same direction 
as iclR. Although not part of the ace operon, the possibility that this gene may be involved in 
the regulation of the ace operon or in growth on acetate cannot be ruled out.
1.3.3 Genetic Control Of The ace Operon:
As mentioned above, the ace operon appears to be controlled by the adjacent gene, 
iclR, since mutations in this gene lead to constitutive expression of ICL (Brice and Komberg, 
1968). In addition, the fadR gene, which is also involved in the synthesis of the enzymes 
involved in fatty acid degradation (Simons et al., 1880a,b) and is required for maximal 
expression of unsaturated fatty acid biosynthesis (fab) (Nunn et al., 1983), has also been 
shown to be involved in the regulation of the ace operon (Maloy et al., 1980).ThtfadR  gene 
is thought to encode a repressor of the fad  regulon (Simons et al., 1980a).
It was shown that ICL and MS-A activities were higher in fadR and/<zdK::Tnl0 
strains grown on succinate or malate as the sole carbon source, than in fadR+ strains (Maloy 
et al., 1980). In support of this, a temperature sensitive mutant of fadR showed constitutive 
expression of tht fad  enzymes and also the ace operon at 42°C but low, inducible expression 
at 22°C. These mutants and TnlO insertions were used to map fat fadR gene at 25.5min on the
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revised E. coli K12 linkage map. Similar results were obtained with strains which could not 
grow on long chain fatty acids due to mutations in d ifferen t/^  genes. Thus the increased 
expression of the glyoxylate bypass enzymes was not due to an increase in the acetate 
concentration from (3-oxidation of fatty acids.accA::Mu d(Ap lac) showed higher P- 
galactosidase and malate synthase activities in iclR or fadR mutants grown on succinate than 
fadR+,iclR+ grown on the same substrate but similar levels when grown on acetate (Maloy 
and Nunn, 1982). This result suggests that both iclR and fadR  act at the level of 
transcription. Using F-primes which contained iclR or fadR in the host strains which were 
either iclR or fadR, it was shown that both iclR and fadR genes act in trans suggesting that 
both iclR and fadR genes encode repressors. Thus, the ace operon is regulated by two 
repressors encoded by the iclR and fadR  genes.
The iclR gene has now been cloned and sequenced from E. coli (Sunnarborg et al., 
1990; Negre et al., 1991) and Salmonella typhimurium (Garlinier et al., 1990). This clone 
complemented a mutant iclR in trans and contained a 900base pair region which was both 
necessary and sufficient for complementation. This region was sequenced and was shown to 
be capable of encoding a 29,741 dalton protein (Sunnarborg et al., 1990). Negre et al. (1991) 
also cloned and sequenced this region and obtained identical sequence except for a single 
nucleotide change in the putitive ribosome binding sequence. The deduced amino acid sequence 
data indicate a possible helix-tum-helix structure, which has been found to be present in the 
DNA-binding domains of several DNA-binding proteins. Negre et al. (1991) showed that the 
iclR gene product bound to the ace operator using extracts of E. coli which overexpress the 
iclR gene and [oc3 2P]dATP-labelled DNA containing the promoter/operator region of the ace 
operon. The same group have since purified the iclR gene product and confirmed the above 
result using this instead of the cell extracts. Interestingly, by incubating the purified iclR gene 
product with the ace promoter/operator fragment, in the presence of PEP, prevents the 
repressor from binding (Cortay et al., 1991) (see section 1.3.5).
The fadR gene has also been cloned although the nucleotide sequence is not yet 
available (DiRusso and Nunn, 1985). This fadR clone exerted transcriptional control over p- 
galactosidase synthesis in a fadR strain which had a fadE-lacZ+ operon fusion. Th tfadR
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clone also suppressed an unsaturated fatty acid auxotrophy in a. fadR  mutation, fadRfabA(Ts) 
which could not grow without unsaturated fatty acids at permissive temperatures, suggesting 
that fadR is also involvd in unsaturated fatty acid biosynthesis. This 1.3kb clone produced a
29,000 dalton protein in maxicell analysis.
/
1.3.4 Possible Advantages Of A Dual Repressor System:
When aceAvMxx d(Ap lacfadR mutants were grown on acetate as the sole carbon 
source, the p-galactosidase activity was higher than in the same strain grown on succinate. 
Also, aceA::Mu d(Ap lac)iclRfadR showed higher levels of p-galactosidase when grown on 
succinate than either aceA::Mu d(Ap lac)iclR or aceAvMn d(Ap lac)fadR strains alone 
(Maloy and Nunn, 1982). These results suggest that the iclR and fadR  repressors act 
independently causing partial repression of the ace operon, or together to cause full repression. 
Thus the operon could be activated to different levels according to different carbon sources. 
During growth on acetate as the sole source of carbon, the energy and reducing power required 
for growth can only be obtained by allowing flux through the TCA cycle. However, during 
growth on fatty acids as the sole carbon source, a substantial amount of energy and reducing 
power is generated during the p-oxidation of the fatty acid to acetyl-CoA, lmol of FADH2  and 
lmol of NADH per turn of the P-oxidation cycle, thus reducing the requirement for flux 
through the TCA cycle. In support of this, higher ICL activities were observed in cells grown 
on oleate than the same cells grown on acetate (Maloy et al., 1980).
1.3.5 Metabolic Control Of The ace Oneron:
Th efad  regulon, which is under the control of the fadR gene, has been shown to be 
induced during growth on long chain fatty acids (>Cn). It therefore seems likely that fadR 
may regulate the ace operon in the same manner (Nunn et al., 1979; Simons et al., 1980a,b).
The rapid appearance of ICL activity after addition of acetate to Achromobacter sp. 
growing on succinate suggests that either (i) acetate, or acetyl CoA, acts directly as an inducer 
of the ace operon, (ii) acetate, or acetyl CoA, reacts with another metabolite to form a product 
which then induces the ace operon, or (iii) acetate, or acetyl CoA, reacts with a repressor 
metabolite to form a product, and in doing so reduces its concentration (Rosenberger, 1962).
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Addition of acetate to E. coli growing on glucose, pyruvate or a usable intermediate of 
the TCA cycle did not induce ICL, suggesting that acetate, or acetyl-CoA, did not act directly 
as an inducer. This result also suggested that acetate did not react with another metabolite to 
produce an inducer, although during growth on glutamine, proline and y-amino butyrate, the 
addition of acetate doubled the specific activity of ICL. However, no increase in the specific 
activity of ICL occurred in mutants which lack citrate synthase (Komberg, 1963), which 
suggested that either citrate or a metabolite of citrate could be the inducer. Another possibility is 
that acetate, or acetyl CoA, reacts with oxaloacetate (OAA) to lower the concentration of an 
repressor such as oxaloacetate itself or a metabolite of it.
Supporting evidence exists for both of the above possibilities. Addition of pyruvate to 
an E. coli mutant devoid of the first enzyme of the pyruvate dehydrogenase complex (pdc-) 
growing on acetate and aspartate stopped ICL synthesis, suggesting that pyruvate acts as a 
repressor. Similar results were obtained for mutants which lacked phophoenolpyruvate 
carboxylase (PEP carboxylase), indicating that the inhibition was not due to the production of 
OAA from PEP. However, mutants devoid of both PEP carboxylase and PEP synthase 
showed inhibition of ICL synthesis on addition of glucose but not pyruvate. Therefore, 
pyruvate cannot be the repressor, instead, PEP or a metabolite close to PEP seems more likely 
(Komberg, 1966). Supporting this is the evidence from gel retardation experiments with the 
promoter/operator region of the ace operon and the purified iclR repressor. In the presence of 
PEP, there was reduced binding of the operator region by the iclR repressor while acetate, 
acetyl-CoA, pyruvate and OAA had no effect (Cortay et al., 1991). Contrary to the view that 
acetate relieves a repressor, it was shown using a series of mutants of the TCA cycle enzymes, 
that acetate had to be metabolised through the TCA cycle beyond succinate in order to induce 
ICL. Metabolism of acetate through both the TCA cycle and the glyoxylate bypass was 
necessary for full induction of ICL (Duckworth, 1981).
Thus, the mechanism of control of the ace operon is complex and the metabolites 
which regulate the expression have still to be identified. The regulation of the ace operon may 
be similar to that for the ICDH kinase/phosphatase in that it responds to a number of effectors. 
Perhaps now that iclR and fadR have been cloned and the promoter identified, the mechanism 
by which this operon is regulated can be elucidated.
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3.3,6 Downshift In Expression From  aceK i
Although aceA and aceK are part of the same operon, and as such are expressed from 
the same promoter, aceA is expressed lOO-lOOOfold more than aceK (LaPorte and Chung, 
1985).The reason for this downshift in aceK expression was unclear until the nucleotide 
sequence of the aceA-aceK intercistronic region became available (Cortay et al., 1988;
Klumpp et al., 1988). This region was shown to contain several REP (repetitive extragenic 
palindromic) elements which have been identified in the untranslated regions of a number of 
operons in E. coli.
The aceA-aceK intercistronic region contains three complete REP elements and two 
partial elements which match the left half of the complete elements. One of these partial 
elements contains the Shine-Dalgamo ribosome-binding site. A number of stem-loop structures 
are possible within this region, several of which, including the most stable, contains the Shine- 
Dalgamo site and the translation initiation codon of aceK. Therefore, it was first thought that 
this stem-loop structure may contribute to the downshift in expression from aceK by masking 
the Shine-Dalgamo site and the initiation codon so preventing translation initiation in a similar 
manner to that observed between uncE and uncF in E. coli (Klionsky et al., 1986) (figure 
1.4). However, deletion of sequences contributing to the stem-loop between aceA and aceK 
had no effect on expression from aceK but instead halved expression from aceA (Klumpp et 
al., 1988). Thus, the stem-loop does not inhibit translation initiation but instead, stabilizes the 
message upstream presumably in the same way as has been proposed for the pu f operon of 
Rhodobacter capsulatus (Belasco and Chen, 1988) i.e. by preventing 3' exonucleolytic 
digestion of the message after an initial endonucleolytic cleavage downstream. It would 
therefore appear that the downshift in expression from aceK is due to fast degradation of the 
operon-length aceBAK transcript to aceBA relative to aceB A degradation. Another factor 
which may contribute to the downshift is that that the codon usage of aceA and aceB is 
similar to that in intermediately expressed genes whereas the codon usage of aceK is similar to 
that of genes which are expressed at a low level in E.coli, thus there may also be differential 
regulation at the level of translation during chain elongation (Cortay et al., 1989).
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Figure 1.4: Possible Secondary Structures In The aceA-aceK Intercistronic Region
(A) Map of the intercistronic region between aceA and aceK, which are 
represented by the dark and light shaded boxes respectively. The heavy arrows, labelled A 
and B indicate a region of dyad symmetry, the lighter arrows, labelled 1,2 and 3 represent 
the REP elements and arrows labelled a and b represent two partial REP elements. The 
asterisk indicates the Shine-Dalgamo, ribosome binding site.
(B) The most stable of the stem loops, formed by base pairing between regions A
and B.
(C) Stem loops formed between REP elements 1 and 2 and also between the partial 
REP elements a and b.
(D) The stem loop formed REP element 2.
(E) The stem loop formed between REP elements 2 and 3.
A
aceA aceK
E
aceA aceK
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1.4 Isocitrate Lvase:
1.4.1 Physical Properties:
E. coli ICL has a subunit Mr of approximately 45,000 (MacKintosh and Nimmo,
1988) which is similar to the values obtained for ICL from other prokaryotes, Pseudomonas 
indigofera (McFadden et a l , 1968) and a thermophilic Bacillus (Chell et a l , 1978). The 
plant enzymes however generally have a higher subunit Mr of between 62,000-68,000. The 
additional 17,000-18,000 in the plant ICL is thought to contain the signal sequence for 
sequestration into glyoxysomes, although neither the mechanism nor signal sequence are as yet 
known. The value for the subunit Mr of Ricinus communis ICL has been reported to be
62.000 (Roberts and Lord, 1981) and 35,000 (Malhorta and Srivastava, 1982). This 
discrepency could be due to proteolysis during isolation when the cells are ruptured, 
processing during uptake into glyoxysomes or by proteolysis during differentiation to limit 
activity. This may also be the reason for the very low Mr values obtained for ICL from 
Helianthus annus with Mr 28,500 (Zemlyanukhin et al., 1984) and Zea mays with Mr
32.000 (Zemlyanukhin eta l., 1986).
The native Mr of the E. coli ICL is 180,000 (Robertson and Reeves, 1987;
MacKintosh and Nimmo, 1988), suggesting that like most other ICLs, the E. coli enzyme is a 
tetramer of subunits with identical Mr. Indeed,the sequence of the amino-terminus has been 
determined for the E. coli ICL indicating that the subunits are probably identical (MacKintosh,
1987). However, ICL from Glycine max (Ruchti and Windmer, 1984) and Candida tropicalis
/
(Uchida et a l , 1986) exist as dimers while the Cucumis savitus ICL has been reported to be a 
pentamer (Lamb et al., 1978) although another group reported that the enzyme from the same 
source was a tetramer. There is evidence that the N. crassa ICL is stable as a dimer (Johanson 
etal., 1974b).
The amino acid composition has been determined for ICL from several organisms;
E. coli (Hoyt et al., 1988), Pseudomonas indigofera (Shiio et al., 1965a), thermophilic 
Bacillus (Chell et al., 1978), N. crassa (Johanson et al., 1974b), Citrullus vulgaris (Jameel 
et al., 1984), Candida tropicalis (Uchida et al., 1986), Pinus pinea (Pinzauti et al., 1986)
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and Linum usitatissum (Khan and McFadden, 1982). The data is shown in table 1.2.
By comparing the amino acid composition of pairs of [proteins, Marchalonis and 
Weltman (1971) found that 98% of unrelated proteins have an SAQ value (SAQ='Z(Xij-Xjcj)2), 
where i and k indicate the proteins to be compared and Xj is the percent of residues of a given 
amino acid type j  in the monomer) of greater than 1 0 0  and no case was the value less than 50. 
Using this method of comparison, it was shown that for every ICL for which the amino acid 
composition was known, the SAQ value was less than 50 for each comparison. This indicates 
that the amino acid composition of all of ICL from various organisms is conserved.
As well as revealing the similiarity between proteins, the amino acid composition can 
also give information on the physical properties of an individual enzyme. Vanni et al. (1990) 
calculated the hydrophobicity average (Bigelow, 1967), the "non-polar side chains (Waugh, 
1954), the polar : non-polar volume ratio (Fisher, 1964), the polar : non-polar residues ratio 
(Hatch, 1965), the ratio of (Asx+Glx): (Lys+His+Arg) and the relative specific volume. When 
the values for each ICL are compared, they are similar. The only exception is that the 
(Asx+Glx): (Lys+His+Arg) ratio for ICL from E. coli, P. indigofera and Bacillus, are 
similar to each other with values of 1.84, 1.73 and 1.86 but the values for the plant enzymes 
are all in the range from 1.34 to 1.55, thus the plant ICLs are more basic. This is reflected in 
the pi values of the plant ICLs compared to the prokaryotic ICLs. The E. coli and Bacillus 
ICLs have pi values of 4.6 (Robertson and Reeves, 1987) and 4.5 (Chell et al., 1978) 
respectively, while the plant ICLs appear to have very little charge at pH7.0-7.7 (Giachetti et 
a l, 1987).
1,4,2 Requirement Of ICL for Magnesium:
ICL from E. coli requires Mg2+ for activity as does ICL from all other sources with the 
possible exception of ICL from Thiobacillus novellus, which shows greater activity with Co2+ 
(McCarthy and Charles, 1973). Hoyt et al. (1988) tested a variety of metal ions for their 
ability to activate ICL. No activity was observed in the absence of any metal ion and the highest 
activity was observed with Mg2+. With Mn2+, Co2+, Ni2+, and Sr2+, the activities were 54%, 
17%, 7% and 3% of the activity in the presence of Mg2+ respectively. The optimum Mg2+ 
concentration was found to be 5mM, concentrations above this had an inhibitory effect on ICL
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Table 1.2: Amino Acid Compositions Of ICL From Various Organisms
The amino acid compositions are expressed as the molar percentage obtained 
follows:
(1) Matsuoka and McFadden (1988)
(2) and (4) Johanson et al. (1974b)
(3) Chell et al. (1978)
(5) Jameel et al. (1984a)
(6 ) Uchida et al. (1986)
(7) Pinzauti et al. (1986)
(8 ) Khan and McFadden (1982).
The SAQ values were calculated with respect to the E. coli ICL.
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(MacKintosh, 1987). This effect is unlikely to be a result of the increased concentration of the 
chloride ion, which inhibits ICL (see section 1.4.5) as this occurs at higher Cl" concentrations.
Giatechetti et al. (1988) have shown that for the Pinus pinea ICL, the Mg2+-isocitrate 
complex is the true substrate and that Mg2+ also acts as a non-essential activator of ICL. The 
model for the action of Mg2+ in catalysis is shown in figure 1.5. In this model there are two 
Mg2+ binding sites; one high affinity site and one low affinity site, the catalytic site. Free Mg2+ 
binds to the catalytic site of the activated enzyme (Mg-E) but not the non-activated form (E). 
Neither free isocitrate nor the Mg2+-isocitrate complex can bind to the Mg-E-Mg form. This 
may be an explanation for the inhibition of ICL at high Mg2+ concentrations. Consistent with 
this was the finding that isocitrate did not protect ICL from N. crassa against 3-bromopyruvate 
inactivation unless Mg2+ was present even though Mg2+ does not itself protect (Roche et al., 
1971).
Mg2+ also protected ICL against thermal inactivation (Shiio et al, 1965b; Pinzauti et 
al., 1983; Tsukamoto et ah 1986; Galassi et al, 1988) and proteolysis (Galassi et al.,
1988). It has been suggested that there may be a third Mg2+ binding site since ICL from Pinus 
pinea when exhaustively dialysed against EDTA showed the presence of residual Mg2+ when 
submitted to atomic absorption (Vanni et al., 1990). However, the stoichiometery was not 
calculated and it is still a possibility that the residual Mg2+ is bound to the high affinity 
activation site.
1.4.3 Of ICL From E. coli For Isocitrate:
The Km of ICL from E. coli ML308 for isocitrate decreases with pH and was found to 
be 63|iM at pH7.3, 32pM at pH6 . 8  and 7}iM at pH6.3 (MacKintosh and Nimmo, 1988). 
These values compare with 18}iM and 24pM at pH6 . 8  for E. coli strains Bm and W 
respectively (Ashworth and Komberg, 1963), 8 jiM at pH7.5 in E. coli D5 H3G7 (Robertson 
and Reeves, 1987), 604|iM at pH7.5 (LaPorte et al., 1984) and 3mM (conditions not stated) 
(Bautista etal., 1979).
The values for the Km for isocitrate given by Robertson and Reeves (1987) and LaPorte 
et al. (1984) could be misleading due to the assay conditions used to obtain these values.
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LaPorte et a l  used the stopped phenylhydrazine assay in the presence of 200mM NaCl. The 
chloride ion was shown to be a competitive inhibitor of ICL (see below; MacKintosh and 
Nimmo, 1988) and ICL from E. coli ML308 assayed under these conditions gave a Km of 
600pM instead of 63pM (MacKintosh, 1987). Robertson and Reeves used a Tris buffer, 
which has been shown to give lower activities compared to Mops as the buffer for the E. coli 
enzyme (Hoyt et al., 1988). This could be the result of formation of a N-hemiacetal with 
glyoxylate and Tris (Roche et al., 1971) or the chloride ion in the Tris buffer being more 
inhibitory than the Mops anion.
Table 1.3 shows the Km values of ICL from various organisms and the conditions in 
which they were obtained. The Km value for the E. coli ML308 ICL is in the same order of 
magnitude as all the other ICLs.
1.4.4 Effect OF nH On TCL:
The optimal pH for ICL from E. coli ML308 was found to be pH7.3 (MacKintosh and 
Nimmo, 1986; MacKintosh, 1987). This value is in agreement with that obtained for ICL from 
E. coli D5 H3 G7  (Robertson and Reeves, 1987). The pH optima for ICL from various 
organisms are very diverse (Vanni et al., 1990).
Although it can be seen that the Km for isocitrate decreases with pH for the E. coli 
enzyme over the pH range 6.3-7.3, very little other work has been done on the effect of pH on 
E. coli ICL. More comprehensive studies have been done for the N. crassa (Rogers and 
McFadden, 1977) and P. indigofera (Rogers and McFadden, 1976). For the A. crassa 
enzyme, a plot of pKm against pH results in a biphasic curve with the top linear portion of the 
curve having a gradient of - 1  and the bottom non-linear portion tending to flatten, indicating 
that the Km for isocitrate depends on a single dissociating group on the enzyme-substrate 
complex. The pKa of this group was determined to be 8.5 (Rogers and McFadden, 1977). This 
dissociation involves the free enzyme since the plot of pKm against pH reflects the ionization of 
either the free substrate or the free enzyme (Fersht, 1977). With P. indigofera ICL, a plot of 
pKm against pH gives a straight line with gradient -1, indicating that, like the N. crassa 
enzyme, the Km is dependent on a single dissociating group. Similarly, in the N. crassa
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Tahle 1.3: Km Values Of ICL From Various Organisms
Organism Km for 
Isocitrate (mM)
pH And 
Buffer
Reference
Thermophilic Bacillus 0 . 0 2 0 6 .8 (Imd) Chell et al., 1978
P. indigofera 0.056 7.7 (Mops) Rogers and McFadden, 1976
N. crassa 0.050 6 . 8  (Mops) Johanson et al., 1974a
P. aerugenosa 0.450 7.6(Tris) Smith and Gunsalus, 1957
Chlorella pyrenoidosa 0.023 6 .8 (Tra) John and Syrett, 1967
S. cerevisiae 1 . 2 0 0 6.0(PO Olsen, 1959
S. lypolytica 0 . 2 2 0 7.0(Imd) Matsuoka et al., 1984
Citrullus vulgaris 0.250 7.5 (Mops) Jameel etal., 1985
Cucumis sativus 0.039 6 . 8  (Mops) Lamb et al., 1978
Cucumis sativus 0 . 1 0 0 7.4(Hepes) Frevert and Kindi, 1978
Glycine max 1.800 8.0(Pi) Ruchti and Widmer, 1986a
Helianthus annuus 0.667 7.5 (Pi) Zemlyanukhin et al., 1984
Linum usitatissimum 0.289 7.5(P0 Khan et al., 1977
Lupinus alba 0.035 7.0(Imd) Vincenzini et al., 1986
Pinus densiflora 0.330 7.6(Tris) Tsukamoto etal., 1986
Pinus pinea 0.080 7.0(Hepes) Pinzauti etal., 1982; 1986
Ricinus communis 0.290 7.0(Pi) Malhorta and Srivastava, 1982
C. elegans 0.540 7.4(Mops) Colonna and McFadden, 1975
Turbatrix aceti 0.660 7.5(Tris) Reiss and Rothstein, 1974a
Hyalomma dromedarii 2.380 7.4(P0 Kamel and Fahmy, 1982
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enzyme, the ionizing group is on the free enzyme and not on the enzyme-substrate complex and 
has a pKa of 5.8-6.0 (Rogers and McFadden, 1976).
1.4.5 Effect Of Anions On ICL:
MacKintosh and Nimmo (1988) studied the effect of anions on ICL from E. coli 
ML308 in order to try to estimate the Km for isocitrate in vivo. KC1 and NaCl were 
competitive inhibitors with respect to isocitrate, indicating that the chloride ion is probably the 
inhibitor. The slope replots were non-linear, concave upwards suggesting that the chloride ion 
interacts in more than one way at the active site. Sulphate and phosphate are linear competitive 
inhibitors of the cleavage reaction, indicating that they interact with a single site in the active 
site.
Johanson et al. (1974a) investigated the effects of phosphate, sulphate, nitrate, 
chloride and acetate on ICL from N. crassa and P. indigofera. Similar to E. coli ICL, 
phosphate and sulphate were linear competitive inhibitors with respect to isocitrate of ICL from 
both organisms, while chloride and nitrate were non-linear competitive inhibitors with the 
shape of the slope replots concave upwards.
The data from all three organisms is consistent with the masking of two adjacent sites 
by a divalent anion and multiple binding of monovalent anions to adjacent sites. Johanson et 
al. (1974a) suggested that the adjacent sites may coordinate Mg2+ which is thought to interact 
with glyoxylate in the active site. Another possibility is that monovalent anions interact 
independently with any or all of three possible binding sites for the carboxyl groups of 
isocitrate and that only one divalent anion can bind at any one time (MacKintosh, 1987).
1.4.6 Potential Metabolic Regulators Of ICL:
Since ICL is the first enzyme of the glyoxylate bypass, it might be expected to play an 
important role controlling the pathway and perhaps to be susceptible to feedback inhibition. 
Indeed, the simulations of LaPorte et al. (1984) show that changes in ICL activity can have 
significant effects on the partitioning of flux between the glyoxylate bypass and the TCA cycle. 
ICL has not been shown to be activated as yet, however, it has been shown from many
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organisms to be inhibited by various metabolites and metabolic precursors. As well as the 
products, glyoxylate and succinate, acetate, citrate, 2 -oxoglutarate, fumarate, malate and 
oxaloacetate, pyruvate, PEP, 3-PG, ATP and ADP all inhibit ICL. As mentioned in section 
1.2.4., the most important effectors of ICDH kinase/phosphatase in vivo are likely to be 
pyruvate, PEP, NADPH, adenine nucleotides and isocitrate (Nimmo and Nimmo, 1984; El- 
Mansi et al., 1985). It therefore seems likely that theses metabolites may also exert control of 
flux through the glyoxylate bypass by interacting with ICL as well as ICDH 
kinase/phosphatase.
It has been shown that PEP, or a metabolite close to it can control the synthesis of ICL 
(section 1.3.5). ICL was found to be inhibited by PEP at pH6 . 8  (Ashworth and Kornberg, 
1963) with a Ki of 0.13mM. As a result, the authors suggested that variations in the 
intracellular concentration of PEP could allosterically control ICL activity. The intracellular pH 
in E. coli is pH7.3 - 7.6 (e.g. Paden et al., 1981). At pH7.3, it was found that PEP was a 
non-competitive inhibitor and not an allosteric effector, with a Kj of 0.9 ImM, nearly one order 
of magnitude higher than at pH6 . 8  (MacKintosh and Nimmo, 1988). Since the intracellular 
concentration of PEP is thought to be 0.22mM during growth on acetate (Lowry et al., 1971) 
and does not rise after addition of glucose, it seems unlikely that PEP has any effect on flux 
through ICL in vivo.
Glutamate, aspartate, citrate, fumarate, malate, fructose 1,6-bisphosphate, fructose-6 - 
phosphate, ATP, ADP, AMP, GTP, NADP+, NAD+ and NADH inhibited ICL activity less 
than 10%, each at a concentration of 1.5mM in the presence of 0.15mM Ds-isocitrate 
(MacKintosh and Nimmo, 1988).
Better inhibitors were 2-oxoglutarate and 3-PG. 3-PG gave linear competitive inhibition 
in the cleavage reaction with a Ki of 0.8mM at pH7.3 and 2-oxoglutarate gave non-competitive
t
inhibition with a Kj of 1.35mM at pH7.3 (MacKintosh and Nimmo, 1988). The intracellular 
concentration of 2-oxoglutarate during growth on acetate is O.OlmM (Lowry et al., 1971) 
which is much lower than the Ki of 135mM for inhibition of ICL by this metabolite at pH7.3.
It is therefore unlikely that 2-oxoglutarate inhibition is significant in vivo. LaPorte and 
Koshland (1983) reported the intracellular concentration of 3-PG to be 2.5mM during growth 
on acetate, which is much higher than the Ki of 0.8mM at pH7.3 for inhibition of ICL. A 3-PG
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concentration of 2.5mM is sufficient to raise the Km of ICL for isocitrate from 63pM to 260jiM 
at pH7.3 and is therefore likely to be physiologically significant (MacKintosh and Nimmo, 
1988).
Since 3-PG also activates ICDH phosphatase and inhibits ICDH kinase (LaPorte and 
Koshland, 1983; Nimmo and Nimmo, 1984), it is also possible that 3-PG is the metabolite 
which controls expression of the aceA gene (section 1.3.5). Therefore, small changes in the 
intracellular concentration of 3-PG could have a significant effect on the partitioning of flux at 
the branchpoint of the glyoxylate bypass and TCA cycle by changing the phosphorylation state 
of ICDH, the expression of aceA, and the activity of ICL.
1.4.7 Ke  O f ICL For Isocitrate in vivo:
The intracellular pH of E. coli is thought to be in the range 7.3-7. 6  (Paden et al.,
1981). Therefore, the Km of ICL for isocitrate in intact cells is at least 63pM and probably 
higher due to the effects of metabolic inhibitors and anions. E. coli ML308 was grown in the 
presence of sulphate and phosphate anions. The intracellular anion concentration was not 
determined (MacKintosh and Nimmo, 1988), but it is known that these anions can be taken up 
into the cell. As mentioned above, the intracellular concentration of 3-PG is sufficient to 
increase the Km to 260jiM. The presence of phosphate and sulphate is likely to increase the Km 
even more.
It has been shown that the flux through ICDH during growth on acetate is close to the 
maximal catalytic capacity of the enzyme (Walsh and Koshland, 1984). In E. coli ML308, 
during growth on acetate, ICL and ICDH have similar maximal catalytic capacities (Nimmo et 
al., 1987). Flux through ICL is about half of that through ICDH (Walsh and Koshland, 1984; 
Holms, 1986). Therefore, ICL must be almost half saturated in vivo and so the Km of ICL in 
intact cells must be close to the intracellular concentration of isocitrate during growth on 
acetate, which was found to be 0.57mM (El-Mansi et al., 1985).
1.4.8 Phosphorylation O f ICL;
As well as regulation by 3-PG, it has recently been shown that ICL may also be 
regulated by phosphorylation (Hoyt and Reeves, 1988; Robertson etal., 1987; 1988).
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Robertson et al. (1987) found that after incubation of partially purified ICL with 
[y^PJ-ATP, a phosphorylated protein was found to co-migrate with purified ICL after two 
dimensional electrophoresis. The phosphorylated amino acid was acid labile, indicating that the 
amino acid was not serine, threonine or tyrosine. Pre-incubation with DEPC, a histidine 
modifying agent, prevented incorporation of 32P (Robertson et al., 1988) suggesting that the 
phosphorylated amino acid is a histidine or an adjacent residue. Alkaline hydrolysis, followed 
by anion exchange chromatography showed that the phosphorylated residue was a histidine.
The phosphorylated ICL co-migrated with catalytically active ICL after two dimensional 
electrophoresis (Robertson et <2/.,1987) suggesting that the phospho-ICL was catalytically 
active. This does not however indicate that ICL is active only when phosphorylated. Indication
that this was the case came from treatment of ICL with potato acid phosphatase (Robertson et
/
al., 1988). Incubation of ICL with acid phosphatase resulted in inactivation corresponding to 
an increase in the isoelectric point, consistent with a dephosphorylation event. In addition, acid 
phosphatase treatment of 3 2P-ICL, labelled in vitro, resulted in loss of radioactivity from the 
band corresponding to ICL. This contradicts an earlier report that phosphorylation of ICL does 
not affect enzyme activity (MacDonald and Chang, 1985).
ICL was immunoprecipitated from E. coli D5H3G7 extracts grown in the presence of 
32P inorganic phosphate. When analysed on SDS gels and Western blots, the ICL was found 
to be labelled, indicating that ICL is phosphorylated in vivo (Hoyt and Reeves, 1988).
The potato acid phosphatase experiment indicated that the active form of ICL is the 
phospho-ICL form (Robertson et al., 1988). However, partially purified ICL, as well as 
being inactivated by acid phosphatase, can be labelled by incubating with 3 2P-ATP. These 
results indicate that either, i) partially purified ICL contains a mixed population of ICL enzymes 
in different phosphorylation states, ii) proteolysis occurs duting the acid phosphatase treatment 
(which is carried out at pH5.0), which would account for the change in the isoelectric point, or 
iii) phospho-ICL is the active form but can be further phosphorylated without affecting the 
enzyme activity. Since only one band is present on isoelectric focusing gels, ICL is only 
present in only one form. Incubation of 3 2P-ICL at pH5.0 does not result in any loss of 
radioactivity from the band corresponding to ICL (Robertson et al., 1988), therefore the first
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two possibilities seem unlikely, although the possibility that there is a contaminating protease in 
the phosphatase still exists. Further investigation into ICL phosphorylation is therefore 
required. Until it has been demonstrated that a significant proportion of ICL molecules can be 
phosphorylated and that the extent of phosphorylation correlates with changes in ICL activity, 
the case that ICL is controlled by phosphorylation remains not proven.
1.4.9 Kinetic Mechanism Of ICL From E. coli ML308:
Two possible kinetic mechanisms have been proposed for ICL from various 
organisms. I will first describe results from our group, on ICL from E. coli ML308, then 
those from other groups which are sometimes contradictory. The kinetic mechanism of ICL 
from E. coli ML308 has been well characterised (MacKintosh, 1987; MacKintosh and 
Nimmo, 1988). The results are summarised in table 1.4.
For the condensation (reverse) reaction, linear double reciprocal plots were obtained 
when either glyoxylate or succinate concentrations were varied at a fixed concentration of the 
other substrate. In both cases, thelines intersected on the abcissa, indicating that neither 
substrate affected the Km of the other. PEP and glycolate were chosen as likely analogues of
succinate and glyoxylate respectively. Glycolate was a competitive inhibitor with respect to
/
glyoxylate and a non-competitive inhibitor with respect to succinate i.e. the Km for succinate 
was not affected by the presence of glycolate. PEP was a non-competitive inhibitor with 
respect to glyoxylate and a competitive inhibitor with respect to succinate. These results can be 
explained by a random order equilibrium mechanism, where both substrates bind randomly at 
equilibrium to the enzyme and binding of one substrate does not affect the binding of the other.
For the cleavage reaction, succinate and PEP gave non-competitive inhibition with 
respect to isocitrate. This is inconsistent with a random order mechanism for which both 
succinate and PEP would be expected to give competitive inhibition. It was therefore postulated 
that a ternary enzyme-isocitrate-succinate complex could exist but not the analogous enzyme- 
isocitrate-glyoxylate complex (MacKintosh and Nimmo, 1988; MacKintosh, 1987) (figure 
1.6). If this mechanism is correct then isocitrate may interact preferentially with ICL at the 
glyoxylate sub-site so that isocitrate can bind at the glyoxylate sub-site even when the succinate 
sub-site is occupied but not at the succinate sub-site when the glyoxylate sub-site is occupied.
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Tahle 1.4; Kinetic Properties Of ICL From E. coli ML308
Taken from MacKintosh and Nimmo (1988).
ft
Reaction Parameter Type Of Inhibition
Value (mMl 
pH7.3 pH 6 . 8
Cleavage Km for isocitrate 0.063 0.032
Ki for phosphoenolpyruvate Non-competitive 0.91 0 . 1 0
Ki for 3-phosphoglycerate Competitive 0.80 0.36
Ki for 2 -oxoglutarare Non-competitive 1.35
Ki for succinate Non-competitive 1.19 0.30
Condensation Km for succinate 0.59
Km for glyoxylate 0.13
Ki for phosphoenolpyruvate Non-competitive 0 . 8 6
versus glyoxylate
Ki for phosphoenolpyruvate Competitive 0.59
versus succinate
Ki for glycolate versus Competitive 0.16
glyoxylate
Ki for glycolate versus Non-competitive 0.26
succinate
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Therefore, glyoxylate should be a competitive inhibitor with respect to isocitrate. This however 
was not tested because glyoxylate interferes with both assays used and unfortunately the 
authors did not test the effect of the glyoxylate analogue, glycolate, which like glyoxylate, 
should give competitive inhibition with respect to isocitrate. Glyoxylate analogues, oxalate, 
malonate and m^so-tartrate all show competitive inhibition with respect to both glyoxylate and 
isocitrate in ICL from other sources (Jameel et al., 1985; Vincenzini et al., 1986; Hoyt etal., 
1988).
The kinetic mechanism of the E. coli ML308 ICL is different from that of ICL from 
most other sources so far, which tend to favour a compulsory order mechanism with 
glyoxylate binding first in the reverse reaction. In all cases, where studied, variation of one 
substrate at a fixed concentration of the other in the condensation reaction indicates either a 
random order rapid equilibrium mechanism or a compulsory order mechanism (e.g. Williams 
et al., 1971; Johanson et al., 1974a; Kahn and McFadden, 1982; Vincenzini et al., 1986; 
MacKintosh and Nimmo, 1988; Rua et al., 1990). The succinate analogue, itaconate showed 
linear uncompetitive inhibition with respect to both isocitrate and glyoxylate for ICL from E. 
coli D5 H3G7 (Hoyt et al., 1988), Phycomyces blakeseeanus (Rua et al., 1990), Lupinus 
(Vincenzini et al., 1986) and Pseudomonas indigofera (Williams et al., 1971), indicating that 
for itaconate to bind to ICL, glyoxylate has to bind first. PEP also showed linear uncompetitive 
inhibition with respect to isocitrate, while succinate showed either linear non-competitive or 
linear mixed inhibition with respect to isocitrate (Williams et al., 1971; Johanson et al.,
1974a; Kahn and McFadden, 1982; Jameel et al., 1985; Vincenzini et al., 1986; Rua et al., 
1990). This inhibition pattern is consistent with a compulsory order mechanism with succinate 
leaving first in the cleavage reaction.
However, at higher concentrations of succinate, PEP or itaconate, the inhibition 
patterns changed. At higher itaconate concentrations, inhibition changed from linear non­
competitive to uncompetitive with respect to isocitrate in the Citrus vulgaris enzyme (Jameel 
et al., 1985). In the Phycomyces blakeseeanus enzyme, itaconate and PEP inhibition became 
non-competitive or mixed with respect to isocitrate (Rua et al., 1990). At high PEP 
concentrations, inhibition of the N. crassa enzyme became non-competitive (Johanson et al.,
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1974a). Also, for succinate inhibition, linearity was lost at high concentrations in the Citrus 
vulgaris, N. crassa and P. indigofera enzymes (Williams et al., 1971; Johanson et al.,
1974a; Jameel etal., 1985). Therefore the compulsory order mechanism breaks down at high 
concentrations. Direct binding of 14C-succinate has been observed for the P. indigofera 
enzyme (Rittenhouse and McFadden, 1974) and there is competition between succinate and the 
reaction intermediate, 3-nitropropionate, in the absence of glyoxylate (Schloss and Cleland,
1982). Also, succinate alone affords protection of E. coli ICL against chemical modification 
by iodoacetate (Nimmo et al., 1989) These results are not consistent with a compulsory order 
mechanism. Therefore, a technically random order equilibrium with a highly preferred 
compulsory order has been proposed (Williams et al., 1971; Johanson et al., 1974a; Rua et 
al., 1990).
This preferred compulsory order mechanism predicts that PEP should show 
uncompetitive inhibition with respect to glyoxylate and that succinate should give mixed 
inhibition with respect to isocitrate where reciprocal plots against succinate should become 
non-linear in the presence of glycolate. This is clearly not the case for the E. coli ML308 
enzyme.
The kinetic results for the binding of succinate and glyoxylate with respect to isocitrate 
by the Linum usitatissimum (flax) enzyme (Khan and McFadden, 1982) are very similar to 
those for the E. coli ML308 enzyme. Also itaconate and PEP inhibition is linear non­
competitive with respect to isocitrate, implying that both dead-end inhibitors can bind to ICL in 
the absence of isocitrate which is consistent with a random order mechanism. Despite this 
evidence, the authors still favoured a compulsory order mechanism.
1.4,10 Active Site Cvsteine Residue;
Studies with 3-bromopyruvate (3-BrP) indicated that there was a cysteine residue at the 
active site of ICL. This glyoxylate analogue has been shown to inactivate ICL from P. 
indigofera (McFadden etal., 1968; Roche and McFadden, 1969; Roche etal., 1971), N. 
crassa (Johanson et al., 1974b), L. usitatissimum (Khan and McFadden, 1982) and 
Citrullis vulgaris (Jameel et al., 1985) and follows saturation kinetics. 3-BrP binds reversibly 
to a specific site prior to alkylation resulting in carboxymethylation of one cysteine residue per
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subunit and complete loss of activity. Further indication that the Cys residue modified is in the 
active site is shown by protection from 3-BrP inactivation by substrates and products. In the 
presence of Mg2+, isocitrate offers competitive protection with a Ks similar to the Km for the 
substrate (Roche et al., 1971; Jameel et al., 1985). For the P. indigofera enzyme, glyoxylate 
plus succinate but neither product on its own offers protection against 3-BrP inactivation 
(Roche et al., 1971). The authors therefore proposed that the Cys residue is part of the 
succinate sub-site since the reaction mechanism requires binding of glyoxylate prior to 
succinate. However, the data do not rule out the possibility that 3-BrP binds at a specific site 
and alkylates a residue elsewhere. For the N. crassa and L. usitatissum enzymes, glyoxylate 
and glyoxylate plus succinate protect against 3-BrP inactivation (Johanson etal., 1974b; Khan 
and McFadden, 1982) and the authors proposed that the Cys residue was in either the 
glyoxylate sub-site or both glyoxylate and succinate sub-sites.
The sequence around the active site Cys residue was identified from ICL from E. coli 
ML308 (Nimmo et al., 1989). Iodoacetate inhibited ICL in a pseudo first order process 
resulting in incorporation of one carboxymethyl group per subunit. Isocitrate, succinate and 
glyoxylate all protected against inactivation with K* values close to their respective Km values, 
suggesting that the reactive group was in the active site. After trypsin digestion, the 
carboxymethylated peptide was purified and sequenced. The sequence of this peptide was Cys- 
Gly-His-Met-Gly-Gly-Lys, which corresponds to amino acids 195-201 in the E. coli K12 
sequence (Matsuoka and McFadden, 1988; Rieul et al., 1988). The sequence around the active 
site Cys was later confirmed for the E. coli K12 enzyme (Ko and McFadden, 1990).
The rate of inactivation of ICL from E. coli ML308 by iodoacetate is greatly reduced 
below pH7.0. Assuming that the protonated form of the enzyme is unreactive, the data 
correspond to the titration of a single ionizing group with a pKa of 7.1 (Nimmo et al., 1989).
A similar result was obtained for the E. coli K12 enzyme with a group of pKa 7.4 (Ko and 
McFadden, 1990). Using circular dichroism, no conformational change in the pH range 6.5-
7.5 was detected and the pKa of 7.1 is lower than the value expected for the sulphydryl of Cys. 
It therefore seems possible that there is another group in the active site whose protonation 
affects the accessibility of the Cys to iodoacetate, 3-BrP and isocitrate.
The presence of an essential sulphydryl group would explain why addition of
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sulphydryl reagents to buffers enhanced stability of ICL during purification and storage 
(McFadden and Howes, 1963; Vanni et al., 1979; Giachetti et al., 1982; Robertson and 
Reeves, 1987; MacKintosh and Nimmo, 1988).With the exception of ICL from Pinus 
densiflora (Tsukamoto et al., 1986), which is inhibited at concentrations of l-4mM, all ICLs 
studied so far can be activated by several sulphydryl reagents such as glutathione (GSH), 
cysteine, (3-mercaptoethanol, dithiothreitol (DTT) or 1,4-dithioerythritol (DTE) (Cionni et al., 
1981; Giachetti et al., 1982).
1.4.11 Other Active Site Groups:
Diethylpyrocarbonate (DEPC) has been shown to inactivate ICL from L. usitatissum, 
Citrullis vulgaris and Zea mays with non-saturating kinetics (Khan and McFadden, 1982; 
Jameel et al., 1985; Igamberdiev and Zemlyanukin, 1987). DEPC treatment resulted in an 
increase in A2 4 0 , which was abolished by treatment with hydroxylamine concominant with 
restoration of ICL activity, indicating that the group with which DEPC reacted with was His. 
For the Citrullis vulgaris enzyme DEPC modified five His residues per subunit, but only four 
in the presence of isocitrate (Jameel et al., 1985). Similarly, there was only one essential His 
residue in the L. usitatissum enzyme (Khan and McFadden, 1982). Isocitrate, glyoxylate plus 
succinate and glyoxylate protected against inactivation by DEPC in the Citrullis vulgaris 
enzyme (Jameel et al., 1985), while both products on their own protected for the L. 
usitatissum enzyme (Khan and McFadden, 1982). Removal of the C-terminal His from the 
N. crassa and P. indigofera enzymes resulted in complete inactivation (McFadden et al.,
1968; Johanson et al., 1974b). It is not known whether or not the terminal residue is the same 
as that involved in the active site. It has been suggested that the groups with pKa 6.1 and 6.9 in 
the N. crassa and P. indigofera enzymes essential for Vmax are His residues (Rogers and 
McFadden, 1977).
A recent report indicates that two His residues, His266 and 306, are modified by DEPC 
in the E. coli ICL, following saturating kinetics, (Ko et al., 1991). These residues are not 
modified in the presence of isocitrate, indicating that they are in the active site. His 266 has 
been previously been suggested to be the residue phosphorylated resulting in activation of the
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enzyme (Matsuoka and McFadden, 1988).
Work done by our group (Rua, Robertson and Nimmo, submitted) also indicates that 
His306 can be modified by DEPC and that this modification results in inactivation of ICL from 
E, coli ML308. Unlike the E. coli K12 enzyme however, His 266 was not found to be 
modified by DEPC. Isocitrate, glyoxylate and succinate offer protection against DEPC 
inactivation, suggesting that His306 is in the active site. However, the Ks values obtained for 
the protection by isocitrate, glyoxylate and succinate are much higher than the Km values and 
the Ks values from the protection of inactivation by iodoacetate (Nimmo et al., 1989). Also 
His306 in the E. coli ICL sequence is not conserved between other ICLs although other 
residues in this region are highly conserved, and there is a greater effect of pH change on 
isocitrate binding to the active site than on protection of ICL from DEPC by this substrate.
Thus, it appears that His306 is probably not involved in the catalytic mechanism of E. coli 
ICL and it seems more likely that reaction with DEPC may cause some non-specific 
conformational change. This does not rule out the possibility that another His residue, perhaps 
one close to the active site Cys 195, may be involved in catalysis.
The Citrullis vulgaris enzyme has been shown to be inactivated by the analogue of the 
inhibitor itaconate, itaconate epoxide (Jameel etal., 1985). Itaconate and succinate offered 
protection against inactivation, suggesting that the reactive group is in the active site. This 
inhibition is reversed by hydroxylamine, indicating that an ester linkage has been formed 
between itaconate epoxide and a carboxylate of an Asp or a Glu residue in the enzyme.
1,4,12 Catalysis:
Considering the chemical reaction, the cleavage of isocitrate to succinate and 
glyoxylate, is the reverse of an aldol cleavage. The first step in the cleavage reaction is the 
deprotonation of the hydroxyl group on C2 of isocitrate by the enzyme, resulting in a carbanion 
at C3 which can then extract a proton from the enzyme, cleaving the C2-C3 bond to give 
succinate and glyoxylate. In the reverse reaction, the enzyme must first extract a proton from 
the a-C of succinate, resulting in either a succinate carbanion or the conjugate base of 
succinate. This may then form a C-C bond with the keto group of glyoxylate, concominant 
with protonation of the keto group by the enzyme (figure 1.2). However, the a-hydrogen of
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succinate is very non-acidic, with a pKa estimated to be in the region of 24 (Walsh, 1979).
In a similar reaction catalysed by citrate lyase, the enzyme cleaves citrate by forming a 
S-citryl-enzyme intermediate, which stabilises the a-carbanion, reducing the pKa of the a -  
hydrogen to around 14 (Walsh, 1979). ICL, however, does not proceed by this mechanism.
It is clear that ICL acts as an acid-base catalyst, although the amino acids involved in 
either catalysis or substrate binding have not been identified. However, chemical modification 
of ICL has shown that Cys 195 in the E. coli enzyme may be involved in some way (Nimmo 
et al., 1989; Ko and McFadden, 1990). Also, although it has been shown that neither His266 
or His306 is involved, the results do not rule out the possibility that another His residue plays 
some role in the catalytic mechanism (Ko e ta l,  1991; Rua, Robertson and Nimmo, 
submitted). Either Asp or Glu could also be involved in the catalytic mechanism (Jameel et al., 
1985), as well as an Arg (El-Gul and McFadden, unpublished). Jameel et al. (1985) 
suggested that the residues modified by itaconate epoxide, either a Glu or an Arg, could be 
involved in coordination of the Mg2+ ion of the Mg2+-isocitrate complex due to their negative 
charge.
Although chemical modification has indicated that the above residues may be involved 
in the catalytic mechanism, it is possible that modification of the above residues either causes or 
conformational change in the enzyme which prevents substrate binding or that the reagents 
used in the modification bind to the enzyme at a specific site and modify an adjacent residue. 
Therefore, more information is required before the catalytic mechanism of ICL can be 
determined.
1.5 Aims Of This Thesis:
This introduction has described how in E. coli flux through the glyoxylate bypass is 
controlled by a reversible phosphorylation of ICDH catalysed by the bifunctional ICDH 
kinase/phosphatase. The Km of ICL for isocitrate is much higher than that of ICDH and it was 
proposed that during growth on acetate as the sole carbon source, inactivation of ICDH permits 
the intracellular isocitrate concentration to rise to a level that can allow flux through the 
glyoxylate bypass. Much work has been carried out on ICDH, while comparatively little is 
known about the mechanism of ICL despite the fact that the metabolic effectors of ICDH
45
kinase/phosphatase are dependent on flux through this enzyme.
When I started my research, the sequence of ICL or the gene encoding this enzyme, 
aceA had not been determined from any source, although the ace operon had been cloned 
from E. coli ML308 in Glasgow (El-Mansi et al., 1987) and work was underway to identify 
an active site Cys residue.
The first objective was to subclone the aceA gene from the plasmid containing the ace 
operon, pEM9 to enable overexpression of ICL and determination of the nucleotide sequence 
of aceA. During the course of this work, several groups determined the nucleotide sequence of 
this gene from several organisms, including E. coli K12. This allowed comparison of the 
derived amino acid sequences which were already thought to be similar from comparison of the 
amino acid compositions.
Identification of the active site Cys residue as Cys 195 by chemical modification by 
iodoacetate, allowed site directed modification of this residue, replacing it with a Ser or an Ala. 
By this strategy, in conjunction with X-ray diffraction studies, it was hoped to determine 
whether Cys 195 was an essential residue. Using kinetic studies of the mutant enzymes and 
comparison with the wild type enzyme, it was hoped to determine the role of Cys 195 in 
catalysis and/or substrate binding.
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Chanter 2 
Materials And Methods
2.1 Materials:
General chemicals of analytical reagent grade were obtained from BDH Ltd., Poole, 
U.K.; Boehringer Mannheim, Lewes, U.K.; Formachem Ltd, Strathaven, U.K.; FSA 
Laboratory Supplies, Loughborough, U.K.; Koch-Light Ltd, Haverhill, U.K.; May and 
Baker, Dagenham, U.K..
Ampicillin, tetracyclin, dithiothreitol (DTT), ethidium bromide, Ficoll, Mops buffer, 
ribonuclease A (RNase A), benzamidine hydrochloride, bovine serum albumin (for Bradford's 
protein determination), Coomassie Brilliant Blue G250, DL-isocitrate (trisodium salt), 
lysozyme, phenylmethylsulphonyl fluoride (PMSF), Tris buffer and Triton X-100 were 
obtained from Sigma (London) Chemical Co., Poole, Dorset, U.K..
Acrylamide, alkaline phosphatase (calf intestine), ammonium sulphate (enzyme grade), 
HC1 (Aristar), 2-mercaptoethanol, N,N'-methylenebisacrylamide, N,N,N',N'- 
tetramethylenediamine, ATP, lactate dehydrogenase (pig heart) and NADH were obtained from 
Boehringer Mannheim, Lewes, U.K..
Amberlite MB3, bromophenol blue, caesium chloride, iodoacetic acid, polyethylene 
glycol 6000 and SDS were obtained from BDH Chemicals Ltd., Poole, Dorset, U.K..
Xylene cyanol was obtained from IBI Ltd., Cambridge, U.K..
Agarose, 5-bromo-4-chloro-3-indoyl-P-galactoside (X-gal), exonuclease III (Exo HI), 
isopropyl-p-thiogalactoside (IPTG), the Klenow fragment of E. coli DNA polymerase I, 
nuclease S1, phenol (ultrapure), all restriction enzymes, T4 DNA ligase, T4 polynucleotide 
kinase and urea (ultrapure) were obtained from Gibco, BRL Ltd., Paisley, U.K..
Bactotryptone, yeast extract and bactoagar (agar) were obtained from Difco, Detroit, 
USA. Oxoid No.l agar was obtained from Oxoid Ltd., London, U.K..
Oligonucleotides were synthesised on an Applied Biosystems Model 280A DNA 
synthesiser using phosphoramidate chemistry by Dr. Veer Math (Department Of 
Biochemistry).
FPLC ion-exchange (Mono Q) pre-packed columns, Sephacryl S-300 superfine and 
Phenyl Sepharose were obtained from Pharmacia, Milton Keynes, Bucks., U.K..
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[a-3 5 S]-dATP (code SJ.304), the oligonucleotide-directed in vitro mutagenesis system 
version 2 (code No. RPN.1523) and the Amersham M l3 sequencing kit (code No. N4502) 
were obtained from Amersham International pic., Amersham, U.K..
The Sequenase version 2.0 sequencing kit was obtained from United States 
Biochemical Corporation (distributed by Cambridge BioScience, Cambridge, U.K.).
All other chemicals were of analytical reagent grade and were obtained from one of the 
following suppliers: BDH Ltd., Poole, U.K.; Formachem Ltd., Strathaven, U.K.; FSA 
Laboratory Supplies, Loughborough, U.K.; Koch-Light Ltd., Haverhill, U.K..
2.2 General Biochemical Methods:
2.2.1 p H  M easurem ents!
All pH measurements were made with a Radiometer pH probe calibrated at room 
temperature using standards of pH7 and pH4 prepared from tablets obtained from the 
manufacturer.
2.2.2 Conductivity Measurements:
Conductivity measurements were made on a Radiometer conductivity meter, type 
CDM2e (Radiometer, Copenhagen, Denmark).
2.2.3 Glassware And Plastics:
Glassware was washed in Haemo-sol solutions (Alfred Cox (Surgical) Ltd., U.K.), 
rinsed with tap water and then distilled water and dried in an oven. Plastic tips for 
micropipettes and Eppendorf tubes were taken from a newly opened bag.
2.2.4 Distilled Water:
Glass distilled water stored in polythene containers was used in all experiments.
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2.2.5 P ro te in Estim ations;
Protein concentrations were determined by the method of Bradford (1976). This 
method is based on the binding of Coomassie Brilliant Blue to the protein. The reagent was 
prepared by dissolving lOOmg Coomassie Brilliant Blue G250 in 50ml of 95% (v/v) ethanol 
and 85% (w/v) orthophosphoric acid. The reagent was made up to 1 litre with distilled water 
and filtered. For each of the assays, a standard curve in the range 0-25fig protein was obtained 
using a lmg.mT1. BSA solution which was made up assuming that a lmg.ml'1. BSA solution 
has an absorbance of 0.62 at 280nm. To each sample 2.5ml of Bradford Reagent was added, 
the samples vortexed and allowed to stand for 2 minutes. The absorbances were recorded at 
595nm. The amount of protein present in the unknown samples was estimated from the 
standard curve. Protein concentrations of the fractions eluted from columns were monitored at 
280nm.
2.2.6 D ialysis;
Dialysis membranes (Scientific Instruments Centre Ltd., London), were boiled for 5 
min. in 1% (w/v) EDTA, pH7.0, stored in 20% ethanol and rinsed in distilled water prior to 
use.
2.2.7 P reparation  Of Chrom atographic Media:
Phenyl-Sepharose and Sephacryl S-300 superfine were obtained pre-swollen, 
resuspended in starting buffer and poured. Phenyl-Sepharose was regenerated, after use, by 
washing with 24% (v/v) ethanol and then distilled water.
All columns were poured at room temperature and packed at higher flow rates than 
would be used during a run, then moved to a 4°C cold room. Columns were stored in 0.02% 
(w/v) sodium azide and equilibrated with starting buffer before use.
2.2.8 Snectrophotom etric Determination O f Nucleic Acid Concentrations:
Nucleic acid concentrations were determined spectrophotometrically at 260nm (Maniatis 
et al., 1982). In a 1 cm path length quartz cuvette an absorbance of 1.0 corresponds to 50 
fig.ml'1. for double stranded DNA, 40 jig.ml'1. for single stranded DNA and approximately
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20 pg.mT1. for single stranded oligonucleotides.
2,2,9 Sterilisation:
Solutions for the preparation of growth media and solutions used in manipulation of 
nucleic acids were autoclaved in a B&T Autoclave 225E (laboratory Thermal Equipment U.K.) 
at 15 p.s.i. for 25 min., except carbon sources which were autoclaved at 5 p.s.i. for 50 min..
Because of their probable heat lability, the following compounds were sterilised by 
filtration through 0.22 pm pore-sized Millex G.V. filters (Millipore Ltd., U.K.) into sterile 
bottles: ampicillin, tetracyclin, methionine, vitamin and IPTG.
2.3 Microbiological Techniques:
2.3.1 Bacterial Strains. Plasmids And Phage:
Escherichia coli ML308 (ATCC15224) was originally obtained from the American 
Type Culture Collection (Rockville, Maryland, USA). It has been maintained in Glasgow for 
twenty years. It has the genetic configuration i‘z+y+a+ for the lac operon. In all other respects, 
the strain is regarded as wild type. Because the defective repressor is produced, synthesis of 
the operon (P-galactosidase, p-galactosidase permease and thiogalactoside transacetylase) is 
constitutive and therefore, assays of P-galactosidase represent a convenient spot test indicative 
o f£ . coli ML308.
Escherichia coli KAT-1 is a mutant derived from Escherichia coli LE392 (Murray et 
al., 1977), itself a K12 derivative, by transposon TnlO insertion in the aceA gene (Maloy and 
Nunn, 1982). The genotype of Escherichia coli KAT-1 is thus F-, hsdR.514 (Ecok rm '), 
supE44, sup¥5S, lacYl or (lacTZY)6, galKl, ga lT ll, metBl, trpR55, X-, aceB+, 
aceA::TnlO. Escherichia coli KAT-1 was obtained from W.D. Nunn (University of 
California, Irvine, USA).
Escherichia coli TG-1 was obtained from Amersham International pic. (Amersham, 
U.K.) and has the genotype A lac pro, thi, supE, [F  traD36, proAB, lacl^L M15], 
hsdA5 (Ecok rm ').
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Plasmid pGLW ll is a derivative of pKK223-3 carrying ampicillin resistance, the lac 
promoter-operator region, lacZ' and the lacl gene. This plasmid was constructed in Glasgow 
and obtained from I.S. Hunter.
Plasmid pEM9 carries a llkb  insert, containing the ace operon, ligated into the Cla I 
site of pAT153 which also carries the genes for ampicillin and tetracycline resistance (El-Mansi 
etal., 1987).
Plasmid pUC18 (Yanish-Perron et a i, 1985) carries the gene encoding ampicillin 
resistance and was obtained from BRL, Gibco Ltd., Paisley, U.K.
\c851sl DNA was obtained from BRL, Gibco Ltd., Paisley, U.K.. This DNA was 
digested with appropriate restriction enzymes and used exclusively as molecular weight 
markers. From this point onward XcS57s7 DNA is referred to simply as X DNA.
Phage M13mp8 was obtained from Amersham International pic. Amersham U.K..
2,3.2 Storage Of Bacteria:
Organisms were stored in L-broth, containing 40% (v/v) glycerol at -20°C and at -80°C 
or as a stab (L-agar) at room temperature for long term storage. Short term storage was on a 
suitably sealed plate at 4°C or as a 1 0 ml L-broth culture at 4°C. Samples were checked for 
homogeneity microscopically and periodically plated out on L-agar plates, containing 
lOjig.ml'1. 5-bromo-4-chloro-indoxy-(3-galactoside (X-gal) in the case of E. coli ML308, and 
containing 12.5jig.ml’1. tetracyclin for E. coli KAT-1 or containing the appropriate 
antibiotic(s) for strains carrying plasmids.
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2.3.3 Growth Media:
Unless otherwise stated, all media were sterilised by autoclaving at 15 p.s.i. for 25
min..
a) Rich Media:
L-Broth- (per litre) Bactotryptone lOg
Yeast extract 5g
NaCl lOg
(+5ml 20% (w/v) glucose) 
pH7.5 with NaOH
L-Agar-(per litre) As for L-broth, +15g Difco-agar.
2xTY-Medium- (per litre) Bacto-tryptone 16g
Yeast extract lOg
NaCl 5g
H-Agar- (per litre) Bacto-tryptone lOg
NaCl 8 g
Bacto-agar 12g
H-Top Agar- (per litre) Bacto-tryptone lOg
NaCl 8 g
/ Bacto-agar 8 g
20% (w/v) glucose was autoclaved separately at 5 p.s.i. for 50 min. and added where 
appropriate to prepared media.
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bi Minimal Media: The minimal medium used was based on the M9 salts medium and 
contained per litre of distilled water:
After autoclaving, vitamin Bi (thiamine hydrochloride; final concentration 2|ig.ml'1.), 
CaCl2  (final concentration O.lmM), and glucose (final concentration 2g.l'1.) was added. The 
CaCl2  and glucose were autoclaved together prior to the addition to the M9 salts while the 
vitamin Bi was filter sterilised through a 0.22jim filter (Millipore).
For solid media, the salts were autoclaved separately from the agar to avoid 
precipitation problems. Hence, the M9 salts were made up as a 10 times concentration stock 
solution and autoclaved separately before being mixed with the agar solution. Oxoid No. 1 agar 
was used at 12.5 g.l'1. final concentration. After mixing the M9 salts and the agar, the various 
supplements were added after cooling to 55°C.
cl Specific Supplements To Defined Media: E. coli KAT-l/pEM9 required addition of vitamin 
Bi to a final concentration of 2|ig.ml'1., methionine to a final concentration of SOjig.ml"1. and 
ampicillin to a final concentration of lOOjig.ml'1..
2,3.4 Antibiotics:
Ampicillin (Amp) was used at a final concentration of lOOjig.ml'1.. A stock solution of 
25mg.ini'1. was filter sterilised and stored at -20°C. Hot L-agar was cooled to 55°C before 
ampicillin was added. L-Amp plates were stable for at least 4 weeks if stored at 4°C.
Tetracycline (Tet) was used at a final concentration of 12.5jig.ml'1.. A stock solution 
of 12.5mg.ml'1. in 50% (v/v) ethanol was stored in the dark at -20°C. Hot agar was cooled to 
55°C before tetracycline was added. L-Tet plates were used on the day of preparation.
NH4 CI
M gS04 .7H20
KH2PO4
Na2HP04
lg
0.13g
3g
6 g
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2.3.5 Growth Of Bacteria:
10ml of media in a 20ml universal bottle was inoculated from a loop of a single colony 
from a plate or from 10p.l of a glycerol stock. 100ml of media in a 250ml conical flask was 
inoculated with 500JJ.1 of an overnight 10ml L-broth culture. For larger cultures, 500ml L-broth 
in a 2.5 litre conical flask was inoculated with 10ml of an overnight culture. All cultures were 
grown on an orbital shaker at 37°C.
2.3.6 Measurement Of Growth:
Bacterial cell density was measured as an apparent absorption at either 420nm or 
600nm. The measurements were carried out in 1 cm light path cuvettes using a Unicam SP500 
spectrophotometer (Pye Unicam Instruments Ltd., U.K.) equipped with a Gilford photoelectric 
detector and digital read out. If necessary, the culture samples were diluted 1:10 to give an 
absorbance of less than 0.5.
2.3.7 Harvesting Of Bacteria:
Cells were harvested by centrifugation at 8,00Qrpm for 15 min at 4°C (MSE 18 with an 
8x250ml rotor).
2«3*8-J>,isr.uptign B acts d a i
al Ultrasonic Disruption: A sample of culture (2.5ml) was added to 2.5ml of chilled BSA 
(lOmg.ml'1.) in 0.15M NaCl in a 2-dram vial within a brass holder (Holms and Bennett, 1971) 
surrounded by an ice/water slurry. The sample was ultra-sonicated (Dawe Soniprobe type 
1130A from Dawe Instruments Ltd., London) for three 30 sec. periods alternating with two 30 
sec. cooling periods.
b) French Pressure Cell Disruption: Bacterial cell pellets were gradually resuspended in 2 
volumes of lOmM potassium phosphate pH6.5,0.5M KC1,2mM MgCl2 , ImM benzamidine, 
ImM DTT, 1.2mM PMSF at 4°C and disrupted by 2 passages through a French pressure cell 
(Cat. No. 4-3398A, American Instruments Company, Maryland, U.S.A.) at a pressure of 98
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MPa (14,300 p.s.i.)- The pressure cell, capacity 40ml, was cooled on ice before use.
2.4 General Recombinant DNA Techniques:
2.4.1 Larffe Scale Plasmid Purification:
Both methods employed are based on the alkali lysis method of Bimboim and Doly 
(1979) and were routinely used to purify milligram quantities of plasmid or RF M13 DNA.
al Using CsCl Gradients: 500 ml of L-broth, containing the appropriate antibiotic, was 
inoculated with 10 ml of an overnight culture of plasmid transformed cells. This culture was 
incubated at 37°C on an orbital shaker overnight (16hrs). The bacterial cells were harvested by 
centrifugation for 10 min at 7,000 rpm, 4°C (MSE 18, 6x250ml rotor). The cell pellet was 
washed once in GTE (50mM glucose, 25mM Tris. HC1, pH8.0, lOmM EDTA). The cells 
were then resuspended in 16 ml GTE. Lyzozyme was added to a final concentration of 18 
mg.ml'1. and the suspension was incubated at room temperature for 30 min. 40 ml of 0.2N 
NaOH, 1% (w/v) SDS were added, gently mixed by swirling and incubated on ice for 5 min. 
Lysis was achieved by addition of 20 ml of ice cold 5M potassium acetate, pH4.8, followed by 
rocking to mix and incubation on ice for 15-60 min. Bacterial cell debris was removed by 
centrifugation (10,000 rpm, 10 min, 4°C, MSE 18, 8x50ml rotor). The supernatant was 
filtered through gauze to remove any floating cell debris. The nucleic acids were precipitated by 
addition of 0.7 volumes of isopropanol. After incubation at room temperature for 30 min, the 
nucleic acid was recovered by centrifugation (Sorvall H B-4,12,000 rpm, 30 min, 25°C). The 
pellet was washed with 70% (v/v) ethanol, dried briefly under vacuum and resuspended in 5 
ml 50mM Tris.HCl, pH8.0, lOmM EDTA. 5.5g of CsCl and 0.5 ml ethidium bromide, 
lOmg.ml"1., were added and the concentration of CsCl adjusted to exactly lg.mT1., using a 
refractometer with a sodium lamp to check the concentration. The gradient was then set up by 
centrifugation at 55,000 rpm for 16 hrs at 25°C in a Beckman Ti70.1 rotor in polycarbonate 
tubes. The DNA bands were usually visible, however if the bands were not visible, long 
wavelength U.V. light was used to visualise the plasmid band which migrates in front of the 
host chromosomal DNA. The plasmid band was removed by inserting a micro capillary tube,
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attached to a pump, to just below the plasmid band. Ethidium bromide was removed by 
extracting several times with TE (lOmM Tris. HC1, pH8.0, ImM EDTA) saturated 1-butanol. 
The DNA was then diluted to double the volume with distilled water and precipitated twice with 
ethanol (2.4.10) and resuspended in 0.2 ml TE. The DNA concentration and purity 
(A260/^2g0) Was then measured spectrophotometrically.
b) Using OIAGEN-Tips: 100 ml of L-broth, containing the appropriate antibiotic, was 
inoculated with 10 ml of an overnight culture of plasmid transformed cells. This culture was 
incubated at 37°C on an orbital shaker overnight (16hrs). The bacterial cells were harvested by 
centrifugation for 10 min at 7,000 rpm, 4°C (MSE 18, 8x50ml rotor). The cell pellet was then 
resuspended in 4 ml lOOjig.ml'1. RNaseA, 50mM Tris.HCl, pH8.0, lOmM EDTA. 4 ml 
200mM NaOH, 1% (w/v) SDS was added, mixed gently by rocking and incubated at room 
temperature for 5 min. Lysis was achieved by addition of 4 ml 2.55M potassium acetate, 
pH4.8. The lysate was then centrifuged at 10,000 rpm for 30 min at 4°C (MSE 18, 8x50ml 
rotor) The supernatant was removed promptly and centrifuged again at 10,000 rpm for 30 min 
at 4°C (MSE 18) to obtain a particle free lysate. The lysate was then loaded onto a QIAGEN-tip 
100 equilibrated with 3 ml 750mM NaCl, 50mM Mops, 15% (v/v) ethanol, pH7.0,0.15% 
(v/v) Triton X-100 and allowed to flow through the QIAGEN-tip 100 by gravity. The 
QIAGEN-tip 100 was then washed in 10 ml 1.0M NaCl, 50mM Mops, 15% (v/v) ethanol, 
pH7.0 and the plasmid DNA was eluted from the QIAGEN-tip 100 with 5 ml 1.25M NaCl, 
50mM Mops, 15% (v/v) ethanol, pH8.2. The QIAGEN-tip 100 was then re-equilibrated with 3 
ml 750mM NaCl, 50mM Mops, 15% (v/v) ethanol, pH7.0, 0.15% (v/v) Triton X-100 and the 
run-through from the first loading step re-applied. The QIAGEN-tip 100 was washed and the 
plasmid DNA was eluted as above. The two eluates were then combined. The plasmid DNA 
was precipitated by addition of 0.7 volumes of isopropanol, incubated at room temperature for 
15 min and centrifuged at 10,000 rpm at 25°C for 30 min (Beckman J2-21, 8x50ml rotor). The 
DNA pellet was washed in 2 ml 70% (v/v) ethanol, allowed to dry for 5-15 min and 
resuspended in 200}il TE (lOmM Tris.HCl, pH8.0, ImM EDTA). The DNA concentration and 
purity (A260/ a 2 8q) was t^ ien measured spectrophotometrically.
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2.4.2 Small Scale Plasm id Purification:
The method employed for small scale plasmid and RF M13 DNA was based on the 
method of Bimboim and Doly (1979). 1.5 ml. of an overnight culture was harvested in a 
microfuge and the cell pellet resuspended in 100 pi GTE. 10 pi lOmg.ml'1. Lyzozyme was 
added and incubated at room temperature for 5 min. 200 pi freshly made 0.2N NaOH, 1% 
(w/v) SDS was added, mixed gently and incubated at 4°C for 5 min.. Lysis was achieved by 
addition of 150 pi ice cold 5M potassium acetate, pH4.8. The lysate was incubated in ice for 5- 
15 min. and the cell debris removed by centrifugation in a microfuge. The supernatant was then 
removed into a fresh microfuge tube and the plasmid DNA was then precipitated by addition of 
0.5 volumes of 7.5M ammonium acetate and 2.5 volumes of cold (-20°C) ethanol. After 
incubation at -80°C for 30-60 min., the plasmid DNA was recovered by centrifugation in a 
microfuge at 4°C (cold room) for 30 min. The pellet was washed with 200 pi 70% (v/v) 
ethanol, air dried for 5-15 min. and resuspended in 30 pi TE. A 5 pi sample was sufficient for 
digestion by restriction enzymes. During the digestion, lp l boiled RNase A, lOmg.mT1, was 
added to the digest for the last 15 min. of the incubation at 37°C.
2.4.3 Digestion Of DNA With Restriction Enzymes:
The methods used were as described in Sambrook et al. (1989). Restriction digests 
were carried out using the BRL React buffers which were provided with each batch of enzyme. 
There are ten different React buffers with a range of salt concentrations, each one suitable for a 
range of enzymes. Analytical digests were carried out in a volume of 10 or 20 pi at 37°C. 
Preparative digests were carried out in larger volumes. When DNA was digested with two 
restriction enzymes, the endonuclease requiring the lower salt buffer was used first. After the 
recommended duration of digestion the salt concentration was adjusted and the second enzyme 
added.
2.4.5 Filling Recessed Termini Using Klenow Polymerase:
After digestion of the DNA with restriction enzymes, the DNA was ethanol precipitated 
and redissolved in 10 pi TE. 1 pi of each of the four deoxynucleoside triphosphates at 
concentrations of 5 mM, 2 pi lOOmM Tris.HCl, pH8.0, 50mM MgCl2  and 1 unit of the
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Klenow fragment of E. coli DNA polymerase I for each jig of DNA were added. Distilled 
water was added to give a final volume of 20 pi and the reaction was carried out at room 
temperature for 15-30 min.
2.4.5 Agarose Gel Electrophoresis:
DNA was separated at room temperature on horizontal submerged agarose gels as 
described by Sambrook et al., (1989). The Tris-borate (TBE) and Tris-acetate (TAE) buffer 
systems were employed. A 0.8% (w/v) agarose gel was used to size restriction fragments 
accurately in the range of 0.8 -10 kb. Samples for agarose gels were prepared by addition of
0.2 volumes of 10 mM-Tris/HCl pH 7.2, 20% (w/v) ficoll, 0.5% (w/v) bromophenol blue and
/
10 mg.ml'1. ethidium bromide. Ethidium bromide (0.5 pg.ml"1.) was added to both gel and 
buffer, and stained DNA bands visualised on a long wave U.V. transilluminator (U.V. 
Products Inc.). Restriction fragment markers of known size were run alongside the unknown 
fragments, usually X DNA digested with HindlU, or with EcoRI+Hin&TII.
2.4.6 Recovery Of DNA From  Agarose Gels:
The method employed was based on the use of the GENECLEANII kit (Bio 101 inc.). 
The agarose gel was made up and run in TAE buffer and the DNA band of interest was 
visualised by ethidum bromide staining and low energy long-wave U.V. transillumination. The 
desired band was excised, placed in a 1.5 ml microfuge tube and weighed. 3 volumes of 
saturated Nal was added and then incubated at 50°C, mixing in a vortex occasionally until the 
gel slice had melted. 5pi of glassmilk (Bio 101 Inc.) solution was added and incubated on ice 
for 5 min. The glassmilk/DNA complex was then pelleted by centrifugation in a microfuge for 
10 sec. and the supernatant was removed. The pellet was then washed three times in 500 pi 
NEW WASH (Bio 101 Inc.), resuspending the glassmilk/DNA complex and centrifuging in a 
microfuge each time. The DNA was then eluted from the glassmilk by adding 10-50 pi TE and 
incubating at 50°C for 5 min. and removing the glassmilk by centrifugation in a microfuge for 
30 sec.. For the highest recovery, the elution step was repeated and the eluates pooled.
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2.4.7 Phenol/Chloroform Extraction of Nucleic Acids:
Restriction digests and other solutions containing DNA were deproteinised by 
extracting with phenol and chloroform. The volume of the sample was measured and adjusted 
to lOOfil (usually) and an equal volume of TE-saturated phenol:chloroform:isoamyl alcohol 
(25:24:1) was added. This mixture was vortexed, allowed to stand until the two layers 
separated and then vortexed again. The two layers were then separated by centrifugation in a 
microfuge for 5 min.. The top layer was removed into a fresh tube and 100 pi TE added to the 
bottom, phenol layer. The mixture was vortexed and the two layers separated as in the first 
extraction. The two aqueous , top, layers were pooled and extracted in an identical manner with 
an equal volume of TE-saturated chloroform/isoamyl alcohol (24:1) which removes any 
residual traces of phenol. The DNA was recovered from the aqueous layer by ethanol 
precipitation (section 2.4.9).
2.4.8 Extraction Of DNA With Butanol:
When the volume of a restriction digest or other DNA solution was too large for ethanol 
precipitation in a single microfuge tube, this procedure was used to reduce the volume of the 
sample (Maniatis et al., 1982). The volume of the DNA sample was measured and an equal 
volume of butan-2-ol was added and the solution vortexed. The layers were separated by 
centrifugation in a microfuge for 30-60 secs. The top, butan-2-ol, layer was removed and 
discarded and the extraction repeated until the desired volume was achieved. Traces of butan-2- 
ol were removed by extraction with TE-saturated ether. The top layer, containing the ether was 
discarded and the tube allowed to stand to remove any remaining ether by evaporation. The 
DNA was recovered from the aqueous layer by ethanol precipitation (section 2.4.9).
2.4.9 Ethanol Precipitation:
Sodium acetate was added to the DNA solution to a final concentration of 0.3M by 
adding 0.1 volumes of a 3.0M solution. 2.5 volumes of cold ethanol (-20°C) were added and 
mixed. The mixture was then incubated at -20°C overnight or alternatively, at -80°C for 1 hour 
and the precipitated DNA recovered by centrifugation in a microfuge at 4°C for 30 min. or for
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larger volumes, centrifugation at 10,000 rpm for 30 min. at 4°C (MSE 18, 8x50ml rotor). The 
DNA pellet was washed in 70% (v/v) ethanol and resuspended in a suitable volume of TE.
An alternative to the addition of sodium acetate was to add 0.5 volumes of 7.5M 
ammonium acetate, however, when the DNA was to be treated with T4 polynucleotide kinase, 
sodium acetate was used since ammonium ions inhibit this enzyme.
2.4.10 Ligations:
The insert DNA was digested with the appropriate restriction enzymes, purified on an 
agarose gel and recovered using GENECLEAN. Plasmid vector DNA was linearised by 
digestion with the appropriate restriction enzymes and treated with bacterial alkaline 
phosphatase to yield DNA ready to use. This treatment prevented self-ligation of the vector and 
facilitated a low-background of false positive clones.
For ligation reactions where the insert size was similar to the vector size an equal 
concentration of foreign DNA to vector DNA was employed. For those reactions where the 
insert size was much greater than the vector size, at least a four-fold excess in molar 
concentration of foreign DNA to vector DNA was typical. Depending on the size of insert, 
ligation mixtures contained 25 ng vector and between 25 to 400 ng insert in a final volume 
between 5 to 10 p.l.
Vector plus insert were pre-incubated at 45°C for 5 minutes to melt any cohesive termini 
that had reannealed. The ligations were performed overnight in 6 6  mM-Tris/HCl pH 7.6, 6 . 6  
mM-MgCl2 , 0.5 mM-ATP, 10 mM-DTT at 16°C using 0.5 Units (Weiss et aL, 1968) of 
bacteriophage T4 DNA ligase.
2.4.11 Transform ation Of E. coli W ith DNA:
al Preparation Of Competent Cells: A single colony of E.coli KAT-1 from an L-agar plate 
containing tetracycline was used to inoculate 10 ml of L-broth containing tetracycline which 
was incubated overnight at 37°C on an orbital shaker. 1.0 ml of overnight culture was used to 
inoculate 100 ml of L-broth containing tetracycline which was grown at 37°C for around 2 
hours to an Agoo of 0.4 - 0 .6 . The cells were cooled on ice for 1 0  minutes and gently harvested 
(Beckman J2-21,4000 rpm, 10 minutes, 8x50ml rotor, 4°C). When being prepared by the
CaCl2  method (Cohen et aL, 1972) the cells were resuspended in one half of the original 
culture volume of ice-cold, sterile 50 mM-CaCl2 , 10 mM-Tris/HCl pH 8.0 and placed in an ice 
bath for 15 minutes. Following centrifugation (Beckman, J2-21, 4000 rpm, 10 minutes, 
8x50ml rotor, 4°C) the cells were resuspended in l/15th original culture volume 50 mM-CaCl2 , 
10 mM-Tris/HCl pH 8.0 and mixed in the ratio 3:1 culture to glycerol and cells dispensed into 
chilled microfuge tubes in 200-400 pi aliquots. These cells were stored at -80°C.
For E. coli TG-1, the competent cells were not viable if stored at -80°C and the cells 
were prepared the day before transformation, since the greatest efficiency of transformation 
was achieved 24 hours after preparation (Dagert and Ehrlich, 1979).
bl Transformation Of Competent Cells:
Transformations were carried out in sterile 1.5 ml microfuge tubes. Ligation mix also 
refers to any DNA being used in the transforming process but was usually a ligation mixture. 
An aliquot of ligation mix containing up to 25 ng plasmid DNA was added to 300 pi aliquots of 
competent cells and the mixture was incubated on ice for at least 30 minutes. The DNA/cell mix 
was then heat shocked at 42°C for 2 minutes. 1 ml of L-broth was added to the tubes and they 
were incubated without shaking at 37°C for at least 1 hour. The cells were then plated onto an 
appropriately prepared antibiotic-containing L-agar plate inverted and incubated overnight at 
37°C.
When transforming with M l3 and M l3 recombinants, 40 pi IPTG (lOOmM), 40pl X- 
gal (2% (w/v) in dimethylformamide), 200pl of fresh E. coli cells and the DNA/cell mix were 
added to 3 ml. of molten H-top agar and poured onto H-agar plates. The plates were then 
inverted and incubated at 37°C overnight.
2.5 Cloning In M13:
2.5.1 Maintenance Of Host Cells:
E. coli TG-1 was grown in 10 ml. 2xTY, glycerol was added to a final concentration 
of 50% (v/v) and cells were stored at -80°C. Before transformation with M l3 DNA, the culture 
was plated out on a glucose/minimal medium plate and grown overnight at 37°C. This ensured
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that the host cells maintained the F episome essential for infection by M13. The plate was then 
used for short term storage of the host cells.
2.5.2 Preparation Of Phage Stock:
A single TG-1 colony from the glucose/minimal plate was used to inoculate 10 ml. 
2xTY medium which was then grown on an orbital shaker at 37°C overnight. One drop of the 
overnight culture was then used to inoculate 20 ml. of fresh 2xTY medium which was then 
grown at 37°C on an orbital shaker for 3 hours. 1 ml of 2xTY medium was inoculated with 100 
jil of the 3 hour culture and with a plaque from a plate of E. coli TG-1 transformed with M l3 
or a recombinant. This culture was then grown at 37°C on an orbital shaker for 4 hours. The 
cells were removed by centrifugation in a microfuge. The supernatant was removed into a fresh 
microfuge tube and centrifuged as before. The supernatant contained the phage and was stored 
at -20°C. Before plating out the stock phage was diluted 1 in 108 and 10 |il was used for 
infection.
2.5.3 Preparation Of RF M13 DNA:
al Small Scale: A host cell lawn was prepared by inoculating 10 ml. 2xTY with a single colony 
of TG-1 from a glucose/minimal medium plate which was then grown overnight at 37°C on an 
orbital shaker. One drop of the overnight culture was used to inoculate 20 ml. of 2xTY which 
was grown for 3-4 hours.
200 Jil of this culture was infected by either 10 jj.1 of phage stock, diluted 1 in 108, or 10 |il of 
a single plaque in 1 ml. 2xTY medium, diluted 1 in 104. 40 jil IPTG (lOOmM) and 40p,l X-gal 
(2% (v/v) in dimethylformamide) were added and mixed with 3 ml. molten H-top agar and then 
poured onto H-agar plates. The plates were inverted and grown overnight at 37°C. 5 ml. 2xTY 
medium was inoculated with 50 jil of a fresh overnight culture of E. coli TG-1. A plaque was 
picked up, using a Pasteur pipette to ensure that the whole plaque was obtained, and 
transferred into the 5 ml. culture. This culture was then grown at 37°C on an orbital shaker for 
5 hours. The culture was then transferred into 5 microfuge tubes (5xlml) and centrifuged for
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5 min. The RF M13 DNA was then isolated by the alkali lysis method (section 2.4.2).
blLarge Scale: 100 ml 2xTY medium were inoculated with 1 ml. of an overnight culture of E. 
coli TG-1 and grown on an orbital shaker at 37°C until the culture had an A5 5 0  of 0.3.1 ml. of 
phage stock was added to the culture and growth was continued for a further 4 hours. The cells 
were harvested (MSE 18, 8,000 rpm, 10 min., 4°C, 8x50ml rotor) and the RF M13 DNA 
isolated using a QIAGEN-Tip 100 (section 2.4.1 b).
2.5.4 Preparation Of Single Stranded DNA:
The host cells were prepared, infected, plated out, the plaques grown and centrifuged 
as in section 2.5.3 a. The supernatants were transferred into fresh microfuge tubes and the 
centrifugation repeated. At this stage, one of the supernatants was stored at -20°C and used as a 
phage stock. To the other four supernatants, 200 pi PEG/NaCl (polyethyleneglycol 6000, 20% 
(w/v), 2.5M NaCl) was added, mixed by shaking and left to stand at room temperature for 15 
min.. The phage particles were then pelleted by centrifugation in a microfuge at room 
temperature for 15 min.. The supernatant was discarded and the phage pellet resuspended in 
100 pi TE. The single stranded DNA was then isolated by extracting with an equal volume of 
TE-saturated phenol:chloroform;isoamyl alcohol (25:24:1) and an equal volume of TE- 
saturated chloroform:isoamyl alcohol (24:1) (section 2.4.7) and recovered by ethanol 
precipitation (section 2.4.9).
2.6 Generation Of Nested Deletions Using Exonuclease III:
The method employed to generate a series of nested deletions was based on that devised 
by Henikoff (1984) and is outlined in figure 3.6.
2.6.1 Digestion With PstI And BamHI:
20 pg of pAR23 and p AR24 were digested to completion with 10 units each of PstI 
and BamHI in a total volume of 40 pi according to section 2.4.3. The DNA was then ethanol 
precipitated and the DNA pellet resuspended in 80 pi distilled water.
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2.6.2 Digestion With Exonuclease III:
20 pi of 330mM Tris.HCl, pH8.0, 3.3mM MgCl2  was added to the digested DNA and
/
equilibrated at 37°C for 10 min..5 pi Exonuclease HI (65 units. p i'1.) was added and 5pl 
samples were removed at 30 sec. intervals into 15 pi 0.2N NaCl, 5mM EDTA, pH8.0 and 
incubated at 70°C for 10 min.. The DNA in each sample was then precipitated with ethanol and 
resuspended in 38.5 pi distilled water.
2.6.3 Removal Of Single Stranded Overhangs:
10 pi of 1.25M NaCl, 150mM potassium acetate, 25% (v/v) glycerol, 5mM ZnSC>4 and 
SI nuclease to a final concentration of 67 Vogt units, ml'1, were added to each sample and then 
incubated at room temperature for 30 min. (One Vogt unit will cause 1 pg of nucleic acid to 
become perchloric acid soluble per min. at 37°C). The reaction was stopped by addition of 6  pi 
0.5M Tris.HCl, pH8.0,0.125M EDTA and the DNA extracted with phenol and with 
chloroform. The DNA was recovered by ethanol precipitation and resuspended in 10 pi 
distilled water.
2.6.4 Ligation And Transformation:
Any remaining overhangs were removed by treatment of the DNA with the Klenow 
fragment of E. coli DNA polymerase I (section 2.4.5). The DNA was precipitated with 
ethanol, resuspended in 5 pi distilled water and ligated overnight at 25°C (section 2.4.10). Half 
the sample was used to transform competent E. coli TG-1, plated on H-agar and incubated at 
37°C overnight.
2.6.5 Analysis Of Deletion Clones:
/
Each plaque was used to infect 5 ml TG-1 cultures and grown for 5 hours at 37°C.
Both RF DNA and single stranded DNA were prepared (sections 2.5.3 a and 2.5.4). Clones 
suitable for sequencing were selected by digesting the RF DNA with EcoKL and HindJR and 
running on agarose gels.
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2,7 Sequencing Bv The Chain Termination Method:
Sequencing described in chapter 3 was carried out using Amersham M13 sequencing 
kit (cat. No. N4502) and protocols described in the 'M l3 Cloning and Sequencing Handbook' 
(Amersham International) were strictly adhered to. Sequencing described in both chapters 3 
and 4 was carried out using the United States Biochemical Corporation (USB) sequencing kit 
and protocols described in 'Step-By-Step Protocols For Sequencing With Sequenase Version 
2 .0 ' were strictly adhered to.
The major difference between the two sequencing kits was the enzyme used to 
synthesise DNA complementary to the M13 template. The Amersham kit contained the Klenow 
fragment of E. coli DNA polymerase I whereas the USB kit contained Sequenase Version 2.0. 
Sequenase Version 2.0 is a site directed mutant of bacteriophage T7 DNA polymerase which 
carries no 3'-5’ exonuclease activity and gives a high rate of polymerisation of nucleotides 
(Tabor and Richardson, 1989). The USB sequencing system was found to give clearer gels 
than the Amersham system that were easier to read and as a result, more sequence could be 
read from each reaction.
2.7.1 Sequencing W ith The Klenow Fragment Of E. coli DNA Polymerase I;
al Annealing Primer To Template: 5 jil of single stranded template prepared as described as in 
section 2.5.4, was annealed for 2 hours at 55°C in a mixture also containing:
1 jil M13 sequencing primer (see below)
1.5 jil lOxKlenow Buffer (lOOmM Tris.HCl, pH8.5, lOOmM MgCl2 )
2.5 jil distilled water
The Ml 3 sequencing primer employed in this work was a 17-mer with the sequence 5'- 
GTA AAA CGA CGA CCA GT-3'. Annealings could be stored at -20°C for up to 1 month.
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bl Sequencing Reactions: The annealed primer/template mix was thawed and 1.5 pi (15 pCi) 
[a3 5 S]-dATPaS at >600Ci. mmol-1. (Amersham SJ.304) and 1 unit of Klenow fragment 
added. After thorough mixing, 2.5 pi aliquots were spotted just inside the rim of four 
microfuge tubes, labelled A, C, G and T. 2 pi of the relevent ddNTP/dNTP mix (see below) 
were added to the individual tubes and the contents mixed by a brief spin in a microfuge. The 
sequencing reactions were performed at room temperature and after 20 min., 2 pi of a 0.5mM 
uniform chase solution of all four dNTPs added in the same manner. Following the 15 min. 
chase, the sequencing reaction was stopped by addition of 4 pi of formamide dye mix (96% 
(v/v) deionised formamide, 0.03% (w/v) bromophenol blue, 0.03% (w/v) xylene cyanol, 
20mM EDTA).
cl Composition Of Reaction Mixes:
i) deoxyNTP mixes (A°, C°, G° and T°) for sequencing with [a3 5 S]-dATPaS (volumes
in pi):
A° C° G° rpo
0.5mM dCTP -  2 0 1 2 0 2 0
0.5mM dGTP 2 0 2 0 1 2 0
0.5mM dTTP 2 0 2 0 2 0 1
TE buffer 2 0 2 0 2 0 2 0
ii) dideoxyNTP solutions:
O.lmM ddATP 0.3mM ddGTP
0. ImM ddCTP 0.5mM ddTTP
iii) dNTP/ddNTP mixes: To each dNTP mix (N°), an equal volume of the 
corresponding ddNTP mix was added.
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For sequencing areas which were particularly G/C rich, 2mM dTIP was used instead of 
0.5mM dGTP in making up the deoxyNTP mixes and 0.03mM ddGTP instead of 0.3mM 
when making up the dideoxyNTP mixes.
2.7.2 Sequencing With Sequenase Version 2.0:
al Annealing Primer To Template: 7 pi of single stranded template prepared as described as in 
section 2.5.4, was annealed for 2 hours at 55°C in a mixture also containing:
1 pi M l3 sequencing primer, -40 primer (3ng. p i'1.) (see below)
2 pi 200mM Tris.HCl, pH7.5, lOOmM MgCl2 , 250mM NaCl (5xSequenase Buffer)
The primer used was the M13 -40 primer, which has the sequence 5-GTT TTC CCA 
GTC ACG AC-3’.
b) Sequencing Reactions: To the annealed primer/template mix, the following were added; 1 pi 
DTT (lOOmM), 2 pi labelling mix (1.5 pM dGTP, 1.5pM dCTP, 1.5pM dTTP), 0.5 pi 
(5pCi) [a 3 5 S]-dATPaS at >600Ci. mmol*1. (Amersham SJ.304) and 1.5 units of Sequenase 
Version 2.0. After mixing the labelling reaction was incubated at room temperature for 5 min.. 
During this incubation, 3.5 pi of the labelling reaction was spotted just inside the rim of four 
microfuge tubes labelled A, C, G, and T, in which 2.5 pi of the appropriate termination mix 
(80 pM dATP, 80pM dCTP, 80pM dGTP, 80pM dTTP, 8 pM ddNTP (appropriate analogue), 
50mM NaCl) had been spotted at the bottom of the tube. After the 5 min. incubation, the tubes 
were incubated at 37°C for 1 min. and the reagents mixed by a brief spin in a microfuge. After 
a 5 min. incubation at 37°C, 4 pi of stop mix (95% (v/v) formamide, 20mM EDTA, 0.05% 
(w/v) Bromophenol Blue, 0.05% (w/v) Xylene Cyanol FF) was added to the lip of each tube 
and mixed with the reaction by a brief spin in a microfuge. The sequencing reactions were then 
stored at-20°C.
For sequencing areas which were particularly G/C rich, the laballing mix contained (3.0 
pM dITP, 1.5pM dCTP, 1.5pM dTTP) and the termination mixes were (80 pM dATP, 80pM
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dCTP, 80}iM dITP, 80|iM dTTP, 8 |iM ddNTP (appropriate analogue), 50mM NaCl) except 
the ddGTP termination mix (80 |iM dATP, 80}iM dCTP, 160|iM dITP, 80}iM dTTP, 8 fiM 
ddNTP (appropriate analogue), 50mM NaCl).
2.7.3 Polyacrylamide Gel Electrophoresis;
The nested set of primer extended fragments produced by either of the M13/dideoxy 
DNA sequencing protocols were resolved by electrophoresis on thin polyacrylamide gels using 
the BRL S2 sequencing gel apparatus (BRL-Gibco).
Gels were composed of the following constituents:
40% Acrylamide 15ml.
(38% acrylamide, 2% bisacrylamide) 
lOxTBE 10ml
Urea 50g
Distilled Water 35ml
10% (v/v) ammonium persulphate 350}il
TEMED 50[Ll
(N, N, N', N', tetramethylethylenediamine)
Before addition of TEMED and ammonium persulphate, the gel solution was degassed. 
Gels were pre-run for at least 15 min. at 50mA constant current before electrophoresis in TBE. 
Samples were prepared by heating to 75-80°C for 2 min. before loading, during which the top 
of the gel was thoroughly cleared of any unpolymerised acrylamide or urea and the lanes 
formed using a sharkstooth comb. The heat-denatured samples were loaded immediately onto 
the gel and electrophoresis carried out at 60W (constant power), 50mA, 2,000V. The duration 
of electrophoresis depended on the length of sequence required. DNA close to the primer 
extending 250bp away from the primer was obtained from gels run for 2-5 hours, or until the 
dye front reached the anode, while sequence from 200-400bp from the primer was obtained 
from gels run for 8  hours. Routinely, 5 jil of each sample was run until the dye front reached
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the anode and 5 |il run for 8  hours in order to obtain the maximum sequence ffon each reaction.
All gels were fixed in 10% (v/v) acetic acid, 10% (v/v) methanol for 30 min. following 
electrophoresis and were then dried onto a sheet of Whatman 3MM paper using a Bio-Rad gel 
drier, model 1125. The dried gel was autoradiographed using Fuji RX film at room 
temperature.
2.8 Computer Proprams Used In The Analysis Of DNA And Amino Acid 
Sequences:
A number of programs for the manipulation and analysis of DNA sequences of the 
UWGCG (University Of Wisconsin Genetics Computer Group) package (Devereux et al., 
1984) were run on a VAX computer. This package contains programs for the comparison of 
DNA sequences with those in GenBank and EMBL (European Molecular Biology laboratory, 
Heidelberg, Germany) databases. The following UWGCG programs were used:
SeqEd is an interactive editor which allows entering and modification of sequences.
Map displays both strands of a DNA sequence with a restriction map shown above the
sequence and possible protein translations shown below.
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BestFit makes an optimal alignment of the best segment of similarity between two 
sequences and inserts gaps if necessary (Smith and Waterman, 1981).
Gap finds an optimal alignment between two sequences by inserting gaps in either 
sequence. It considers all possible alignments, and creates the alignment with the 
largest number of matched bases and fewest gaps (Needleman and Wunsch, 1970).
Wordsearch searches for sequences similar to the query sequence in any group of 
sequences, using a Wilbur and Lipman search (Wilbur and Lipman, 1983).
Segments aligns and displays the segments of similarity found by Wordsearch.
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FastA searches for sequences similar to the query sequence in any group of sequences, 
using a Pearson and Lipman search (Pearson and Lipman, 1988).
TFastA Does a Pearson and Lipman search as for FastA, but first translates the query 
sequence in all six reading frames.
Strings finds sequences by searching sequence documentation for character patterns eg 
citrate.
LineUp is a screen editor for editing multiple sequence alignments.
Profile calculates a table (profile) which quantitatively represents a group of aligned 
sequences.
ProfileSearch uses a profile, created by Profile to search databases for new sequences 
with similarity to the group.
ProfileSegments makes optimal alignments showing the segments of similarity found 
by ProfileSearch.
CodonPreference is a frame specific gene finder which tries to recognise protein coding 
sequences by comparison to a codon frequency table, or by their composition in the 
third position of each codon.
TestCode identifies protein coding sequences by plotting a measure of the non­
randomness of the composition at every third base.
Translate translates nucleotide sequence into peptide sequence.
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PeptideStincture makes secondary structure predictions for a peptide sequence using 
the methods of Chou and Fasman (1978) and Gamier et al. (1978).
PlotStructure plots the output of PeptideStructure.
2.9 Site Directed Mutagenesis:
The site directed mutagenesis was carried out using the Amersham Oligonuleotide- 
directed in vitro mutagenesis system version 2 (code No.RPN.1523) and the protocols 
described in the manual ’Oligonuleotide-directed in vitro mutagenesis system version 2' were 
strictly adhered to.
2.9.1 Preparation Of Oligonucleotides:
The oligonucleotides used for mutagenesis of aceA had the sequence GTG AAG AAA 
GCC GGT CAC ATG GGC G (Cysl95-Ala), GTG AAG AAA TCC GGT CAC ATG GGC 
G (Cysl95-Ser) and were supplied in a solution of 35% (w/w) NH4 OH. The oligonucleotides 
were precipitated with ethanol (section 2.4.9) and resuspended in TE. The oligonucleotide 
concentration was measured and adjusted to a final concentration of 20nmol.mT1..
2.9.2 Phosphorylation Of Oligonucleotides:
The oligonucleotides were phosphorylated with 2 units of T4 polynucleotide kinase at 
37°C for 15 min. in lOOmM Tris.HCl. pH8.0, lOmM MgCl2 ,7mM DTT and ImM ATP. The 
T4 polynucleotide kinase was inactivated by heating at 70°C for 10 min.
2.9.3 Annealing Oligonucleotides To Single Stranded Templates:
5|ig of single stranded template, pAR24, were mixed with 2.5pl of phosphorylated 
oligonucleotide, 3.5}il buffer 1 and 17pl of distilled water in a microfuge tube. The tube was 
heated at 70°C for 3 min, then placed in a 37°C water bath for 30 min and placed on ice.
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2.9.4 Synthesis And Ligation Of Mutant DNA Strand:
To the annealed template/oligonucleotide were added, 5jil MgCl2  solution, 19(il 
Nucleotide mix 1, 6 jil distilled water, 6  units of Klenow fragment and 6  units of T4 ligase. The 
contents of the tube were mixed by pipetting up and down and then incubated at 16°C 
overnight.
170|il of distilled water and 30(_l1 5M NaCl were added to the reaction mixture and the 
excess single stranded (non-mutant) DNA was removed by centrifugation through a 
nitrocellulose membrane at 1500 rpm for 10 min in a swing out rotor (Sorval HB-4). lOOjil of 
0.5M NaCl was then spun through the membrane in order to recover any remaining RF DNA. 
The RF DNA was then recovered by precipitation with ethanol and resuspended in 25jil 
buffer 2 .
2.9.5 Digestion Of The Non-Mutant Strand:
lOjil of the RF DNA were incubated at 37°C with 65(0.1 buffer 3 and 5 units Neil for 90 
min. 12(0.1500mM NaCl, 10(0,1 buffer 4 and 50 units of exonuclease HI were added to the 
nicked RF DNA and the reaction mixture incubated at 37°C for 30 min. The exonuclease III 
was inactivated by incubation at 70°C for 15 min.
2.9.6 Repolvmerisation And Ligation Of The Gapped DNA:
To the RF DNA with the exonuclease HI extended Neil nicks, 13(il Nucleotide mix 2, 
5(0.1 MgCl2  solution, 3 units of DNA polymerase I and T4 DNA ligase were added. The 
reaction mixture was incubated at 16°C for 3 hours. The RF DNA was then recovered by 
precipitation with ethanol, using 1 volume of 4M ammonium acetate, pH5.4 and 4 volumes of 
ethanol. In this way, unincorporated nucleotides were removed prior to transformation of 
competent E. coli TG-1.
72
2.10 Polyacrylamide Gel Electrophoresis Of Proteins:
2.10.1 Denaturing Electrophoresis:
Protein samples were analysed by discontinuous slab gel electrophoresis in the 
presence of SDS according to Laemmli (1970). Glass plates were separated by 1.5mm spacers 
and sealed with 1.0% (w/v) agarose. Gels were prepared from the volumes of stock solutions 
shown in table 2.1. The acrylamide, Tris buffer and distilled water were mixed and degassed; 
SDS, ammonium persuphate and TEMED were added and the gel was poured into the cast 
immediately. Isopropanol was layered onto the separating gel and rinsed off upon 
polymerisation. The stacking gel was then made up and poured around a well-forming 
template. The wells were rinsed with distilled water after polymerisation. The electrophoresis 
buffer consisted of 25mM Tris/192mM glycine, pH8 .8 , 0.1% (w/v) SDS. Electrophoresis was 
carried out at a constant current of 50mA.
Protein samples were mixed with at least an equal volume of sample buffer, consisting 
of 50mM Tris-HCl pH6 .8 , 1% (w/v) SDS, 10% (v/v) glycerol, 0.01% (w/v) bromophenol 
blue and 1 % (v/v) 2 -mercaptoethanol.
2.10.2 Non-denaturing Electrophoresis:
This was carried out on 7% (w/v) polyaciylamide gels at 4°C at pH8.0 (Davis, 1964). 
The following stock solutions were stored at 4°C:
A 36.3g
0.23ml
Tris
TEMED
48ml 1MHC1
Distilled Water to 100ml
B 28g
0.74g
acrylamide
N,N'-methylenebisacrylamide (bis)
Distilled Water to 100ml
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Table 2.1; Preparation Of Polyacrylamide Gels
Quantities and stock solutions used.
Stock Solution Stacking Gel (ml) Separating Gel (ml)
8 % 10% 15%
30% (w/v) acrylamide/ 
0 .8 % (w/v) bisacrylamide
1.5 8 1 0 15
1.5M Tris HC1 pH 8 . 8 - 7.5 7.5 7.5
0.5M Tris HC1 pH6 . 8 3.75 - - -
h 2o 9.45 14.05 12.05 7.05
10% (w/v) SDS 0.15 0.3 0.3 0.3
1 0 % ammonium persulphate 
(freshly prepared)
0.15 0.15 0.15 0.15
TEMED 0 . 0 1 0 . 0 1 0 . 0 1 0 . 0 1
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C 30g Tris
144g glycine
Distilled Water to 1000ml
The ’gel monomer' was prepared by mixing 1 volume A, 2 volumes B and 1 volume 
distilled water. An equal volume of freshly prepared ammonium persuphate (1.4mg.ml_1.) was 
added. Solutions were degassed separately and then mixed and poured into gel tubes 
(dimensions 0.5x10cm). 9cm gels were poured, carefully overlayed with distilled water and 
allowed to set. The electrophoresis buffer was solution C which had been diluted 25-fold with 
distilled water at 4°C containing 0.1% (v/v) 2-mercaptoethanol. The gels were pre- 
electrophoresed for 30 min at 3mA per tube at 4°C. 5|il of tracking dye (0.01% (w/v) 
bromophenol blue in 2 0 % (v/v) glycerol) was layered onto the top of each gel and 
electrophoresis was carried out until the dye had penetrated the gel. The samples (less than 
50|il in 20% (v/v) glycerol) were loaded onto the gels and electrophoresis was performed at 
3mA per tube at 4°C until the tracking dye approached the bottom of the gel. The dye front was 
marked on each gel by inserting a piece of wire through the gel.
2.10.3 Staining Gels For Protein;
Routinely, the gels were stained in 0.1% (w/v) Coomassie Brilliant Blue G250, 50% 
(v/v) methanol, 10% (v/v) acetic acid for 1 hour at 45°C and destained in several changes of 
10% (v/v) methanol, 10% (v/v) acetic acid at 45°C.
2.10.4 M£ Determination Bv SDS-PAGE:
Mr values were obtained from SDS gels, after Coomassie Blue staining by comparing 
the electrophoretic mobility (Rf) of the unknown with a standard curve produced by running a 
mixture of proteins of known Mr on the same gel. The mixture of proteins used to produce the 
standard curve was obtained from Sigma Chemical Co. and consisted of bovine albumin
(66.000), egg albumin (45,000), rabbit muscle glyceraldehyde-3-phosphate dehydrogenase
(36.000), carbonic anhydrase from bovine erythrocytes (29,000), trypsinogen from bovine
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pancreas (24,000) trypsin inhibitor from soybean (20,100) and a-lactalbumin from bovine 
milk (14,200).
2.11 Purification Of ICL From E. coli KAT-1/pAR9023, KAT-1/dAR654 And 
K A l : l / p A R 655;
Two methods were employed to purify ICL from KAT-l/pAR9023. The first method 
was based on that developed for the purification of ICL from E. coli ML308 (MacKintosh and 
Nimmo, 1988), while the second method which was also used to purify ICLSerl95 and 
ICLAlal95 from E. coli KAT-l/pAR654 And KAT-l/pAR655 respectively was based on that 
of Conder et al. (1988). All steps were carried out at 4°C except the FPLC ion-exchange on 
Mono Q, which was carried out at room temperature.
2.11,1 Purification Of Wild Type ICL From E. coli KAT-1/pAR9023;
al Purification Buffers:
Buffer A: lOmM potassium phosphate pH6.5, 0.5M KC1, 2mM MgCl2 , ImM
benzamidine, ImM DTT, 1.2mM PMSF.
Buffer Bi: 50mM Mops-NaOHpH7.3, ImM EDTA, ImM benzamidine, ImM
DTT, 1.2mM PMSF 
Buffer B2 : Buffer Bi without PMSF.
Buffer B3 : Buffer Bi with 40% (v/v) glycerol and 5mM MgCl2 .
bl Preparation Of Crude Extract: 21 (4 x 2.51 flasks, each containing 500ml medium) of L-broth 
containing ampicillin and tetracycline were inoculated with 10ml of an overnight culture of E. 
coli KAT-l/pAR9023 and grown on a shaker at 37°C for 2-3 hours. IPTG was added to a 
final concentration of ImM and growth continued overnight. After harvesting, the cells (10- 
15g) were resuspended in 2 volumes of Buffer A and passed through the French Pressure cell 
three times. The resulting material was centrifuged at 15,000 rpm for 20 min. at 4°C (MSE 18 
with an 8x50ml rotor) and the supernatant was decanted through glass wool to give the crude 
extract.
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c) Ammonium Sulphate Fractionation: Powdered (NFL^SC^ was added gradually to give 30% 
saturation (175g.l-1.), while the pH of the solution was maintained in the range pH 6.5-73 by 
the addition of 5M NH3 . The solution was stirred for 30 min and centrifuged at 18,000 rpm for 
10 min at 4°C (MSE 18, 8x50ml rotor) and the pellet was discarded. (NFL^SC^ was added to 
the supernatant to give 45% saturation (final concentration of 278g.l_1.) and the solution was 
stirred and centrifuged as before. The pellet was dissolved in a small volume of Buffer Bi.
dl Gel Filtration On Sephacrvl S-300 Superfine: The resuspended pellet from the 30-45% 
saturated (NHL^SC^ fraction was loaded onto a 2.2cm x 71cm column of Sephacryl S-300 
superfine, equilibrated in Buffer Bi. The flow rate was lOml.hour' 1 and 3ml fractions were 
collected. Fractions containing ICL activity, up to and including the fraction after the peak, 
were pooled. Later ICL-containing fractions were discarded in order to eliminate a 
contaminating band of Mr 80,000 (MacKintosh and Nimmo, 1988).
el Phenvl-Sepharose Chromotographv: Powdered (NFLt^SCU was added to the pooled 
fractions from the gel filtration on Sephacryl S-300 superfine to bring the concentration to 
0.6M. The solution was then loaded onto a 20ml column of phenyl-Sepharose equilibrated in 
0.6M (NH^SCXj. in Buffer Bi. The column was washed in this buffer, then a gradient (total 
volume 150ml) of 0.6M to 0M (N H ^SC^ in Buffer Bi was applied. The flow rate was 
30ml.hour1 and 2.5ml fractions were collected. The enzyme pool from this step was dialysed 
for 4 hours against 2 x 21 Buffer B2 .
f) FPLC Ion-exchange Chromotographv On Mono O: This was carried out at room 
temperature. One quarter of the enzyme pool from the phenyl-Sepharose chromotography was 
applied to a Mono Q column equilibrated with Buffer B2 . The enzyme was washed in this 
buffer and eluted with a gradient of 0M to 0.5M NaCl in Buffer B2 . The flow rate was
3.0ml.min_1 and 0.5ml fractions were collected. After 3 more runs, the purity was assessed
/
with SDS-PAGE and homogeneous material was pooled.
g) Storage: Pooled enzyme was dialysed overnight into Buffer B3 and stored at -20°C.
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2.11.2 Purification Of ICL. ICLSerl95 And ICLAIal95 From E. coli KAT- 
1/PAR9023. KAT-1/PAR654 And KAT-1/pAR655 Respectively;
a) Purification Buffers:
Buffer C: 50mM triethanolamine pH7.3, 5mM MgCl2 , ImM EDTA.
Buffer D: lOmM triethanolamine pH7.3, 5mM MgCl2 , ImM EDTA, 50mM
NaCl, ImM 2-mercaptoethanol.
Buffer E: 25mM triethanolamine pH7.3, 5mM MgCl2 , ImM EDTA, 450mM
NaCl, ImM 2-mercaptoethanol.
b) Preparation Of Crude Extract: Crude extracts of E. coli KAT-l/pAR9023, KAT-l/pAR654 
and KAT-l/pAR655 were prepared as in section 2.11.1b) except that the cells were 
resuspended in 2 volumes of Buffer C.
cl Ammonium Sulphate Fractionation: This was carried out as described in section 2.11.1c) 
except that the 30-45% pellet was resuspended in a small volume of Buffer D and dialysed 
against this buffer until the conductivity was equal to that of Buffer D.
dl FPLC Ion-exchange Chromotographv On Mono O: This was carried out at room 
temperature. One quarter of the dialysed enzyme pool from step c) was applied to a Mono Q 
column equilibrated with Buffer D. The enzyme was washed in this buffer and eluted with a 
gradient of 100-0% Buffer D and 0-100% Buffer E. The flow rate was 3.0ml.min_1. and 0.5ml 
fractions were collected. After 3 more runs, the purity was assessed with SDS-PAGE and 
homogeneous material was pooled.
e) Storage: Pooled enzyme was dialysed overnight into Buffer B3 (section 2.10.1a) and stored 
at -20°C.
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2.12 Isocitrate Lvase Assavsi
a) Method 1: In steady-state kinetic experiments ICL was assayed, at 340nm and 37°C, by 
coupling the formation of glyoxylate to the oxidation of NADH with lactate dehydrogenase (El- 
Mansi et al., 1987). Each cuvette contained in a final volume of 1ml, 50mM Mops-NaOH 
pH7.3, 5mM MgCl2 , ImM EDTA, 5mM DL-isocitrate, 0.2mM NADH, O.lmg.ml' 1 pig heart 
lactate dehydrogenase and ICL extract. The reaction was initiated by the addition of enzyme.
b! Method 2: In crude extracts and sonicated extracts, ICL was assayed using a modification of 
the procedure of Dixon and Komberg (1959). Each cuvette contained in a final volume of 1ml, 
50mM Mops-NaOH pH7.3, 5mM MgCl2 , ImM EDTA, 5mM DL-isocitrate, 4mM 
phenylhydrazine-HCl. The reaction was started by the addition of enzyme and the change in 
A3 3 4  was monitored. The phenylhydrazine-HCl was stored at -20°C in the dark.
Each of the above assay methods are standard methods, the linearity of rate dependent 
on enzyme concentration was checked and the maximum amount of enzyme used in the assays 
was set so that the change in absorbance was not greater than 0.2/min for a 1ml assay. In some 
steady state kinetic experiments, the DL-isocitrate concentration was varied (in the range 
0.025-lOmM) and also the pH of the assay buffer 50mM Mops-NaOH (pH6.8-7.8), 5mM 
MgCl2, ImM EDTA or 50mM Taps-NaOH (pH7.8-9.0), 5mM MgCl2, ImM EDTA.
2.13 Reaction Of ICL, ICLSerl95 and ICLAlal95 With Iodoacetate;
In the standard conditions, wild type ICL, ICLSerl95 or ICLAlal95 at a concentration 
of lmg.ml"1. was incubated in 50mM Mops-NaOH pH7.3, ImM EDTA at 25°C with 2.0mM 
iodoacetate and other additions as indicated in individual experiments. Samples were assayed 
for ICL activity at various times after addition of iodoacetate.
In substrate protection experiments, 0.5mM DL-isocitrate, 5mM MgCl2 , or both were 
included in the incubation mixture.
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The analysis was carried out at the Department of Biological and Molecular Sciences, 
University Of Stirling by N. Price and H.G. Nimmo. ICL at a concentration of 0.3mg.ini*1. in 
50mM Mops-NaOH pH7.3,5mM MgCl2 , ImM EDTA was excited at 290nm and the intrinsic 
emission spectra measured at 20°C on a Perkin-Elmer fluorescence spectrophotometer, model 
L5 50 with slit widths of 2.5nm.
2.15 Circular Dichroism:
Circular dichroism analysis of wild type ICL, ICLSerl95 and ICLAlal95 was carried 
out in lOmM Mops-NaOH pH7.3 at a protein concentration of 0.3mg.ml4 . with slit width 
0.02cm and 0.5cm for the far U.V. (190-150nm) and near U.V. (260-320nm) respectively. 
The analysis was carried out at the Department of Biological and Molecular Sciences, 
University Of Stirling by N. Price, S. Kelly and H.G. Nimmo on a Jobin-Yvon dichrograph 
LH equipped with a temperature controlled cell holder. Ellipticity values (0) (mean residue 
molar ellipticity in deg.cm2 .decimole_1) were calculated using the following equation:
q _ m.r.w. x sensitivity x displacement x 3300 
concentration x pathlength
where m.r.w. is the mean residue weight.
displacement is the difference between sample and reference at any 
given wavelength, 
concentration = 0.3mg.ini"1. 
pathlength = 1 cm.
Chapter 3 
Cloning And 
Sequencing Of aceA
3.1 Introduction:
Recombinant DNA technology is playing an increasing role in the study of enzyme 
structure, function and regulation of metabolic pathways. For example, using an adjustable 
expression vector, it is possible to evaluate the contribution of an individual enzyme to the 
control of flux through a metabolic pathway. This was done for citrate synthase in E. coli 
growing on different carbon sources (Walsh and Koshland, 1985). Cloning and 
overexpression of the appropriate genes also facilitates the purification of a desired protein in 
large amounts. It is now much quicker and easier to obtain sequence information at the 
nucleotide level than at the protein level. Recombinant DNA technology has also been of value 
in the identification of multi-gene families. Site-directed mutagenesis and protein engineering 
has been used in the identification of specific residues and domains important for the activity or 
regulation of an enzyme.
At the outset of this project, the kinetic properties of ICL from E. coli had been studied 
in great detail (e.g. MacKintosh and Nimmo, 1988; Hoyt et al., 1988), see section 1.4. The 
ace-operon had been cloned from E. coli ML308 (El-Mansi et al., 1987) and ICL had been 
overexpressed. During the early stages of the project work on determination of the three- 
dimensional structure of this enzyme was intitiated (Abeysinghe et al., 1991) and chemical 
modification experiments, using iodoacetate, allowed identification of a cysteine residue at the 
active site (Nimmo et al., 1989). Another group identified the same residue using 3-BrP to 
modify ICL (Ko and McFadden, 1990). This created the opportunity for site directed 
mutagenesis of ICL. Our objectives were therefore to sequence aceA in order to facilitate the 
resolution of the three dimensional structure and to use site directed mutagenesis to investigate 
the role of this cysteine residue in enzyme activity.
During the course of this work, both Cozzone's group (Rieul et al., 1988) and 
MacFadden's group (Matsuoka and MacFadden, 1988) determined the sequence of the aceA 
gene from E. coli K12. There were however, differences in the two sequences and it was 
hoped that by sequencing the aceA gene from E. coli ML308, these differences could be 
resolved.
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3.2 Cloning Of The aceA Gene From E. coli M L308:
3.2.1 Subcloning aceA  From pEM9:
In order to facilitate the isolation of large amounts of the enzymes of the glyoxylate 
bypass and ICDH kinase/phosphatase and to study the control of expression of the ace 
operon, this operon was cloned from E. coli ML308 (El-Mansi et al., 1987). Plasmid pCTS, 
which contained the ace operon of E. coli K12, was used as a probe in conjunction with 
complementation, to clone the ace operon into pAT153. The resulting clone, pEM9 
(figure 3.1), was shown to contain all three genes of the ace operon. E. coli KAT-l/pEM901, 
a Clal-Hin&m subclone of pEM9 (figure 3.1), could not grow on acetate. When grown on 
glycerol and challenged with acetate, KAT-l/pEM901 expressed ICL and MSA activities but 
not ICDH kinase/phosphatase. Unlike pEM9, pEM901 did not show any proteins which co­
migrated with ICDH kinase/phosphatase on SDS gels after in vitro transcription/translation, 
but it did direct the synthesis of proteins which co-migrated with ICL and MSA. These results 
were taken to suggest that pEM9 encodes all three structural genes of the ace operon and that 
the HindUl site in pEM901 lies either within or upstream of aceK, within the aceA-aceK 
intercistronic region.
/
Shortly after the start of this project however, LaPorte's group reported both the 
sequence of aceK (Klumpp et al., 1988) and cloning and analysis of the ace operon from 
E. coli K12. Using the derived restriction map, they determined the position of aceK on their 
plasmid, pCLlOOO. They determined the functional map by deleting pCLlOOO from one end in 
conjunction with enzyme assays, SDS gel electrophoresis of products of maxicell labelling and 
complementation. Their conclusions are summarised in figure 3.1. By comparing the 
restriction map of pEM9 with that of pCLlOOO, it is clear that contrary to the assumption that 
the HindlLl site is upstream or within aceK, this gene is within the Clal-HindJR fragment.
Comparison of the restriction maps of pEM9 and pCLlOOO revealed a high degree of 
similarity over the region encoding the operon in pCLlOOO (figure 3.1). Since both plasmids 
were isolated from E. coli and the restriction maps show this high degree of similarity, it 
seemed probable that the functional maps may also be very similar.
The aceA gene lies within a 2.3kb BamUl-Aval region of pCLlOOO. Due to the high
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Figure 3.1: Comparison of restriction maps of clones encoding the complete ace operon
The restriction and functional maps of pCLlOOO and pCL8  were redrawn from 
Chung et al. (1988) and the restriction maps of pEM9 and pEM901 were redrawn from 
El-Mansi et al. (1987).
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degree of similarity between the restriction maps of pEM9 and pCLlOOO, it seemed likely that 
aceA from pEM9 is encoded in the corresponding BamHL-Aval fragment. This fragment 
was therefore subcloned from pEM9.
In order to express ICL from the cloned aceA gene, an expression vector was essential 
since it is the second gene in the operon and as such is transcribed from the promoter upstream 
of aceB. The expression vector chosen was pGLW ll, a derivative of pKK223-3. pGLW ll 
contains the hybrid tac promoter (ptac) (DeBoer et al., 1983), derived from the trp and lac 
promoters and regulated by the lac repressor, upstream of a multiple cloning site. Also 
encoded on pGLW ll is the gene for ampicillin resistance and the lacl gene (Calos, 1978). 
Expression of genes under the control of ptac is achieved by addition of isopropyl p- 
thiogalactopyranoside (IPTG) to the culture medium.
The sequencing strategy which was to be adopted required the generation of a series of 
nested deletions using exonuclease HI (Exo HI). In order to determine the sequence of both 
strands, these deletions had to be generated on both strands.There are two ways by which the 
sequence of both strands of an insert can be determined, i) cloning the insert into both 
M13mp8 and its "sister" vector, M13mp9, which contains the same multiple cloning site but in 
the opposite orientation with respect to the primer or ii) by cloning the insert in both 
orientations in the same vector, M13mp8. Exo in  cannot initiate digestion from DNA which 
has a 3’ overhang of four or more bases. The only restriction enzyme site in the multiple 
cloning site of the sequencing vector, M13mp8, which generates this type of overhang is Pstl. 
The insert therefore had to be cloned in opposite orientations with respect to the Pstl site. This 
could not be achieved by the first method, hence aceA was cloned in both orientations.
pEM9 was digested with BarriHL and Aval. The fragments were then blunt-ended by 
filling in the overhangs using the Klenow fragment of DNA polymerase and a mixture of all 
four dNTPs. The 2.3kb fragment was then purified from an agarose gel and ligated with 
pGLW ll which had been digested with Smal. The ligation mix was then used to transform 
competent E. coli KAT-1 and the cells plated out onto L-agar containing ampicillin. 
Transformants were screened by assaying for ICL activity in sonicated extracts after addition of 
IPTG and glucose to overnight cultures. The restriction map of the plasmid from one of the
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positive transformants, designated, pAR9023 is shown in figure 3.2. Other transformants were 
shown to contain plasmids with 2.3kb inserts but could not express any ICL activity. The 
restriction map of one of these plasmids is shown in figure 3.2. When compared with the 
restriction map of pAR9023, it is clear that this plasmid contains the same insert in the opposite 
direction. Comparison of the restriction map of pAR9023 with a more detailed map of pEM9 
indicates that aceA is transcribed in the direction from BamHl to Aval. This is consistent 
with the functional map of pCLlOOO. Thus aceA is found in the same fragment and 
transcribed in the same direction in both pEM9 and pCLlOOO, and this is a further indication 
that the functional maps of these plasmids may be similar.
3.2.2 Expression Of ICL From  E. coli KAT-1/pAR9023:
One of the project aims was to carry out site directed mutagenesis of ICL and 
characterize the mutant enzymes. In order to do this, the enzymes have to be expressed and 
purified. A long-term aim was to express the wild type and mutant enzymes at different levels 
and study the effect of controlled expression on the partitioning of flux at the branchpoint 
between the TCA cycle and the glyoxylate bypass.
In order to optimize the conditions for expression, the effects of [IPTG] and time after 
addition of IPTG were studied. IPTG was added at different concentrations to cultures of E. 
coli KAT-l/pAR9023 growing on L-broth containing ampicillin in log phase. Samples were 
taken at appropriate time intervals, the absorbance was measured and the cells were harvested. 
Sonicated extracts were assayed for ICL activity. Figure 3.3 shows the effect of time after 
addition of IPTG on ICL activity and Agoo- There is a linear increase in the ICL activity with 
time for a given IPTG concentration. As the IPTG concentration increases, the rate of increase 
of ICL activity also increases. This is due to an increase in the rate of ICL synthesis rather than 
an increase in the growth rate of cultures with higher IPTG concentrations since the growth rate 
decreases with increased IPTG concentration (figure 3.3B). From these results, it appears that 
maximal expression of ICL occurs at an IPTG concentration of ImM.
The rate of increase in specific activity increases with IPTG concentration (figure 3.4), 
therefore the level of ICL activity cannot be regulated precisely by adjusting the IPTG 
concentration since for any given IPTG concentration, the specific activity increases with time.
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Figure 3.2: Restriction maps of pAR9023 and pAR9024
The shaded boxes represent the 2.3kb insert with the arrow indicating the direction 
of transcription. The distances between the restriction sites are indicated. There are 4 PvuII 
sites. The exact position of the middle 2 sites are unknown and the possibilities are 
indicated by the thin lines. The direction of transcription from the tac promoter is indicated 
by a thin arrow.
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Figure 3.3: Effect of IPTG concentration on growth and expression of ICL activity from
E.coli KAT- l/pAR9023.
E.coli KAT-l/pAR9023 was grown in 100ml of L-broth containing lOOjig.mT1. 
ampicillin. At an A ^  of approximately 1.0, IPTG was added to various concentrations as 
indicated. Samples were taken at time intervals and the A ^  was measured (B). The 
samples were then sonicated and assayed for ICL activity (A).
o o mM IPTG 
A 0.25 mM IPTG 
A 0.50 mM IPTG 
o 0.75mM IPTG 
♦ 1.00 mM IPTG
AU/ml 2 H
50
Time (min)
100
B
10-3
0 50 100
Time (min)
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Figure 3.4: Effect of IPTG concentration on the rate of increase in specific activity of
ICL in E.coli KAT-l/pAR9023.
E.coli KAT-l/pAR9023 was grown in 100ml of L-broth containing lOOpg.ml'1. 
ampicillin. At an A6 0 0  of approximately 1.0, IPTG was added to various concentrations. 
Samples were taken at time intervals and the A60 0  was measured. The samples were then 
sonicated and assayed for ICL activity and the specific activity calculated.
(A) shows a plot of increase in specific activity with respect to time at the IPTG 
concentrations indicated:
o o mM IPTG 
A 0.25 mM IPTG 
A 0.50 mM IPTG 
A 0.75mM IPTG 
♦ 1.00 mM IPTG
(B) shows a plot of the rate of increase in specific activity against IPTG 
concentration.
A2.0 n
1.0 -
0.5
0.0
50 1 0 00
Time (min)
B
0 .02  -i
0.00
0 .4 0.60.2 0.8 1.00.0
[IPTG] mM
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KAT-l/pAR9023 was grown on L-broth containing ampicillin and IPTG added to a 
final concentration of ImM. At various time intervals, 1ml samples were taken, the cells were 
harvested and extracts were prepared by boiling the cell pellets in sample buffer, containing 
SDS. Samples were then run on an SDS gel (figure 3.5). There is a relative increase in the 
intensity of a band which co-migrates with pure ICL and accounts for a substantial fraction of 
the total cell protein in tracks loaded with KAT-l/pAR9023. Tracks loaded with KAT-1/ 
pGLW ll, KAT-1/pAR9024 and KAT-1 do not have this band, indicating that this band is a 
result of expression of a gene in the insert under the control of ptac. Since the band co- 
migrates with pure ICL, the insert of pAR9023 probably contains the entire coding region of 
aceA. Because a large proportion of the total cell protein is ICL in KAT-l/pAR9023, it is not 
surprising that there is a decrease in growth rate in the presence of increasing IPTG 
concentrations as there must be a great burden placed on the cell by expressing ICL to this 
level.
With the tracks loaded with KAT-l/pAR9023, as the intensity of the ICL band 
increases, the intensity of a band with a slighter higher Mr decreases relative to other bands. 
This higher Mr band appears in all tracks except that for ML308. Therefore, it is likely that the 
gene encoding this protein is on the KAT-1 chromosome, rather than on pGLWl 1. The 
identity of this protein is not known, although there are several possibilities. E. coli KAT-1 
contains a transposon insertion in the aceA gene, therefore this protein could be encoded by 
the transposon.
3,3 Seqpqnre Qf aceAj 
3,3,1 Sequencing„ Strategy!
Only approximately 200-400 nucleotides can be read from each sequencing reaction by 
the Sanger dideoxynucleotide method (Sanger et al., 1977). Therefore in general, large DNA 
fragments are sequenced by subcloning smaller fragments, each of which are small enough that 
their complete sequence can be read from a single sequencing reaction. By determining the 
sequence of a number of overlapping subclones, the complete sequence of the large DNA
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Figure 3.5; Overexpression of ICL from E.coli KAT-l/pAR9023
IPTG and glucose were added to 10ml overnight cultures to final concentrations of 
ImM and 0.1% (w/v) respectively. 1ml sampes were taken at time intervals and harvested 
in a microfuge. The cell pellets were resuspended in 200|il SDS sample buffer and boiled 
for 5min in the presence of 1% (v/v) 2-mercaptoethanol and loaded onto a 10% SDS- 
polyacrylamide gel.
The mobility of the molecular weight markers are indicated and the lanes are as 
follows:
1) E.coli KAT-1 (120min after addition of IPTG)
2) E.coli ML308 (120min after addition of IPTG)
3) E.coli KAT-l/pGLWl 1 (120min after addition of IPTG)
4) E.coli KAT- l/pEM901 (120min after addition of IPTG)
5) E.coli KAT-l/pAR9024 (no IPTG added)
6 ) E.coli KAT- 1/pAR9024 (120min after addition of IPTG)
7) Purified ICL
8 ) E.coli KAT-l/pAR9023 (Omin after addition of IPTG)
9) E.coli KAT- l/pAR9023 (30min after addition of IPTG)
10) E.coli KAT - 1/p AR9023 (60min after addition of IPTG)
11) E.coli KAT-l/pAR9023 (90min after addition of IPTG)
12) E.coli KAT - 1/p AR9023 (120min after addition of IPTG)
°  1 2 3 4 5 6 7 8 9 10 11 12
O r i g i n
I C L
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6 6 . OK 
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fragment can be determined. It is a prerequisite that the sequence of both strands is determined 
since comparison of the complementary strands can reveal sequencing errors. Many strategies 
have been devised to generate the subclones for sequencing.
A number of strategies involve digesting the large DNA fragment at random. This is 
referred to as shotgun sequencing. Digestion of the DNA with restriction enzymes which 
recognize four base sites followed by ligation into the single-stranded bacteriophage M13 has 
been used with great success. The development of M13 vectors with a variety of unique 
restriction sites in the multiple cloning site has greatly aided this method (Messing, 1981).
Even if the restriction enzymes used to digest the DNA do not generate ends suitable for 
ligation into the sites of the multiple cloning site, oligonucleotide linkers containing the 
appropriate restriction site can be ligated and cleaved prior to ligation with M l3 (Scheller et 
al., 1977; Sanger et al., 1980; Heidecker et al., 1980). One approach is to cleave the large 
DNA fragment by sonication (Messing, 1983) or by digestion with DNase I in the presence of 
Mn2+ (Anderson, 1981), which causes the DNase I to cut double stranded DNA at 
approximately the same position on both strands (Melgar and Goldthwaite, 1968). In both of 
these methods the resulting DNA fragments have to be treated with either nuclease Bal2>\ or 
DNA polymerase I to ensure that the ends are blunt prior to ligation.
If the restriction map of the large fragment is known, then suitable subclones can be 
derived from double digests so that the orientation of the clone is known. Suitable pairs of 
vectors have been engineered which contain the same multiple cloning sites in the opposite 
orientations relative to the primer. This greatly decreases the number of clones that have to be 
sequenced. However, the determination of the restriction map can be very time consuming and 
may well prove to be very difficult as in some cases no convenient restriction sites can be 
found, possibly due to unusual features of the DNA sequence.
For these reasons, several methods have been devised which are less random and 
involve the generation of sets of overlapping deletions. In one method, random cuts are 
introduced into the insert by DNase I in the presence of Mn2+ followed by treatment with DNA 
polymerase I to blunt the ends. Oligonucleotide linkers are then ligated which can be cleaved by 
a restriction enzyme recognizing a unique site in the multiple cloning site, proximal to the
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primer. The recombinant phage DNA is then digested by this enzyme and size fractionated on 
agarose gels. Fragments of an appropriate size can then be recircularised after excision from gel 
slices and used to transform E. coli (Frischauf et al., 1980). A similar method was devised 
by Barnes et al. (1983) and Barnes (1983) except that the DNA was nicked by DNase I in the 
presence of ethidium bromide, which relieves supercoils, followed by extension of the gap by 
digestion with Exo III. The single-stranded region left by Exo m  is then removed by Bal3l to 
leave flush ends. Oligonucleotide linkers are then added and cleaved as above. The DNA is 
then recircularised and then used to transform E. coli. The clones are fractionated by size by 
running intact phage on agarose gels. More progressive deletions can be generated using 
nuclease B aB l, which shortens the insert by digesting both strands. After digestion with an 
enzyme which cuts near the insert, the DNA is then incubated with BaBl and cut with another 
enzyme at the opposite end of the insert. The fragment is then isolated from an agarose gel and 
religated into M13 (Poncz et al., 1982).
The strategy chosen to sequence the aceA gene is based on deletion by Exo III (figure 
3.6) and involves two useful properties of this enzyme; i) Exo ID digests DNA in a 3'-5' 
direction from a 3'-hydroxyl at a very uniform rate, leaving single stranded DNA and ii) Exo 
El cannot however initiate deletion from ends with an 3-overhang of four or more nucleotides 
(Wu et al., 1976; Henikoff, 1984).
Double stranded, replicative form (RF) DNA is digested with two restriction enzymes 
at unique sites between the insert and the primer. The enzyme which cuts nearest the primer 
leaves a four base 5' overhang, thus ensuring unidirectional deletion from the primer. Exo in  
then digests the DNA from the 3-hydroxyl left by the other enzyme resulting in a length of 
single-stranded DNA. Aliquots are removed at time intervals and the reaction stopped by 
incubation at 70°C in the presence of EDTA. SI nuclease is then added to each aliquot to digest 
the single-stranded DNA left by the exonuclease reaction. After the ends have been filled in 
using Klenow polymerase and a mixture of all four dNTPs, the fragment is recircularised using 
T4 DNA ligase and used to transform E. coli. Clones are picked for sequencing by cutting out 
the inserts and determining their size by running the fragments on agarose gels. This method is 
very rapid as it does not involve a gel purification step and the deletion can be carried out in a 
single reaction mixture.
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Figure 3.6: Strategy used to create a series of nested deletions, redrawn from Henikoff 
(1984).
The insert is shown by the shaded box, while the primer sequence is shown by the 
black box.
Bam H1 P stl
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3.3.2 Determination Of Rate Of Digestion Bv Exonuclease III:
The number of nucleotides which can be read from a sequencing reaction is between
/
200-400. Therefore, it is necessary to generate a set of overlapping deletions from which the 
entire sequence of the insert can be determined. For this reason, the determination of the rate of 
digestion of insert DNA by Exo m  is essential.
A pilot experiment was set up in which M13mp8 RF DNA was digested with BamHI 
and Pstl thus generating a 5'-hydroxyl at the overhang left by BamHI and a four base 3'- 
overhang generated by Pstl. The DNA was then digested with Exo III. Aliquots were 
removed at various time intervals and the reaction stopped by incubation at 70°C in the 
presence of 3.75mM EDTA. After digestion with SI nuclease, samples were run on agarose 
gels and the sizes of the resulting fragments calculated in order to examine the extent of 
digestion by Exo HI (figure 3.7).
From the gel, the rate of digestion by Exo HI was 360 nucleotides per minute. 
Therefore, in order to generate a set of overlapping deletions covering the insert encoding 
aceA, it was necessary to take aliquots at 30sec. intervals.
3.3.3_Generation Of A Set Of Nested. Deletions In Both S trands To Sequence 
aceA:
The first step was the recloning of the inserts of pAR9023 and pAR9024 in M13mp8. 
M13mp8, pAR9023 and pAR9024 were digested with BamHI and EcoKL. The 2.3kb inserts 
of pAR9023 and pAR9024, as well as the large fragment of M13mp8 were purified from 
agarose gels and ligated yielding pAR23 and pAR24, from pAR9023 and pAR9024 
respectively. RF DNA was isolated from transformants containing recombinant plasmids and
the orientation of the inserts determined from the restriction map (figure 3.8). The position of
/
the primer in pAR23 and pAR24 is at the opposite side of the insert from the tac promoter in 
pAR9023 and pAR9024, therefore the sequence derived from pAR24 should be the sense 
strand of the aceA gene.
In order to generate the 5'-overhang for initiation of digestion by Exo HI and the four 
base 3'-overhang to block digestion into the insert, pAR23 and pAR24 were digested with
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Figure 3.7: Determination of the rate of digestion by Exonuclease III.
(A) RF M13mp8 was digested with BamHI and Pstl according to methods 2.6.1, 
deleted using Exo IE, according to methods 2.6.2 and aliquots taken at time intervals. The 
aliquots were then incubated with SI nuclease as in methods 2.6.3, and the DNA was then 
run on an 0.8% (w/v) agarose gel. The lanes are as indicated:
1) Lambda /  Hindm. EcoRI
2) RF M13mp8 /ExoIE, SI (Omin)
3) (lmin)
4) (2 min)
5) (3min)
6 ) (4min)
7) (6 min)
8 ) (8 min)
9) (lOmin)
1 0 ) (1 2 min)
1 1 ) (14min)
12) Lambda /  HindHI
(B) The sizes of the fragments were calculated and plotted against time to calculate 
the rate of digestion by ExoIII.
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Fieure 3.8: Restriction maps of pAR23 and pAR24.
(A) pAR23 and pAR24 were digested with various restriction enzymes as follows:
1) Lambda /  HindHI
2) pAR23/BamHI, PvuII
3) " /PvuII
4) " /  EcoRI. PvuII
5) " /BamHI, EcoRI, PvuII
6 ) Lambda / HindHI, EcoRI
7) Lambda / HindHI
8 ) pAR24 /BamHI, PvuII
9) " /PvuII
10) " /  EcoRI, Pvun
11) " /  BamHI, EcoRI. PvuII
12) Lambda/ffindlH, EcoRI
(B) Restriction maps of pAR23 and pAR24. The shaded boxes represent the 2.3kb 
insert with the arrow indicating the direction of transcription. The distances between the 
restriction sites are indicated. The exact position of the PvuII site is unkown and the posible 
sites are indicated by the thin lines. The direction of DNA synthesis from the universal 
primer is shown.
Figure 3.9: Exonuclease m  deletion of pAR23 and pAR24.
The RF DNA from individual clones derived from the digestion of pAR23 and 
pAR24 was isolated and digested by BamHI and EcoRI to liberate the insert The sizes of 
the inserts were estimated from agarose gels.
(A) Distribution of deletion breakpoints for pAR23.
(B) Distribution of deletion breakpoints for pAR24.
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Figure 3.10: Examples Of ExoHI Deletion Of pAR23 and pAR24.
Rf DNA was isolated from individual plaques (methods 2.5.3a), digested with 
HindHI and EcoRI according to methods 2.4.3 and separated on 0.8% (w/v) agarose gels. 
Gel A) shows deletion clones from pAR23; gel B) shows deletions from pAR24.
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should have covered the other gap, of approximately 1 0 0  nucleotides, it was not filled (figure 
3.11). These subclones seemed to have deletions other than from the primer since many of 
them showed identity with sequence 5' of their predicted position at their 5' end and with 3' 
regions at their 3' ends. The possibility that this region contained direct repeats of 5' or 3' 
regions could be ruled out since each subclone showed different regions of identity and the 
sequence was not the same on both strands. One possibility is that this region has the potential 
to form stem-loop structures. If these structures are present during incubation with S1 
nuclease, the single stranded region of the loop will be digested by this enzyme, thus deleting it 
on religation. Consistent with this, two groups (Cortay et al., 1988; Klumpp et al., 1988) 
found that the aceA-aceK intercistronic region had the potential to form several different 
stem-loop structures (section 1.3.6, figure 1.4). When the nucleotide sequence of the insert 
was analysed, the gap in the sequence corresponds to this region. Another possibility is that 
there is an advantage for M13 to delete these regions as they may interfere with packaging of 
the single-stranded DNA. This may explain the 10-fold difference in the number of colonies 
obtained for each time point compared to that obtained by Henikoff (1984). However the 
position of the deletion endpoint was, in general, similar to that predicted from restriction 
digests of each clone. The nucleotide sequence of the coding strand of the insert is shown in 
figure 3.12.
During the course of this work, the sequence of aceA was determined for E. coli K12 
by two independent groups (Rieul et al., 1988; Matsuoka and MacFadden, 1988). When these 
sequences were compared to that of pAR24, there is a very high degree of similarity over the 
full length of the aceA gene from both K12 sequences, although there are differences (section 
3.4.2). This is more evidence that pAR9023 contains the entire coding sequence of aceA.
The nucleotide sequence of aceB (Byrne eta l., 1988) and aceK (Cortay et al., 1988; 
Klumpp et al., 1988) were determined for E. coli K12. Since the BamHI-Aval fragment of 
pCLlOOO containing the aceA gene also contains part of the aceB and aceK genes, the 
sequence of the insert of pAR24 was compared to aceB and aceK. Position 17-333 of pAR24 
showed 100% identity to the 3' end of the aceB sequence (position 17-79 are sequenced on 
only one strand, positions 1-16 are part of M13). The complete sequence of the DNA after the
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Figure 3 J U  The sequencing scheme of aceA.
The 2.3kb insert of pAR9023, containing the gene encoding ICL (dark shaded 
box), MSA (light shaded box) and ICDH kinase/phosphatase (black box) are shown, with 
the untranslated regions shown in the unshaded boxes. The arrows indicate the direction of 
second strand synthesis and length of readable sequence from each clone. The hatched box 
indicates the region which is not covered by any of the deletion clones. The clones above 
the insert were all generated from digestion of pAR24 by Exo in  and the clones below the 
insert were generated from pAR23.
PAR2305-05
101
Eigure 3.12: Nucleotide Sequence Of The Insert Of pAR24.
Nucleotides 1 to 1642 include the 3' end of aceB, the aceB-aceA intercistronic 
region, aceA and part of the aceA-aceK intercistronic region (pAR24-pAR2408-06). 
Nucleotides 1-393' include part of the aceA-aceK intercistronic region and the 5’ end of 
the aceK gene (pAR241 l-10-pAR2411-07).
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gap shows 100% identity to both sequences for aceK. Thus it seems that the BamHL-Aval 
fragment of pEM9 is very similar to the corresponding fragment in pCLlOOO, indicating that 
the functional maps of the two clones are very similar.
3.4 Sequence Analysis:
3.4.1 Translation:
The sequence shown in figure 3.12 was translated from position 80-1642 in the three 
forward reading frames using the CODONPREFERENCE program in the GGG package 
(Gribskov et al., 1984). This program calculates the GC bias in the third position of a codon 
and identifies rare codons by comparing them with codon frequency tables for frequently used 
E. coli codons. This program identified three open reading frames extending a short distance 
into the insert from position 1 (figure 3.13). Two of these reading frames contained many rare 
codons, the other contained very few. When this reading frame was translated using the 
TRANSLATE program of the GCG package, the amino acid sequence showed 100% identity 
to the deduced amino acid sequence at the carboxyl-terminus of aceB (Byrne et al., 1988).
This open reading frame extends to position 232 after which there is a translation termination 
codon, TAA. As well as the stop codon at position 233-235, there is another stop codon in the 
same reading frame at 245-247 (TAA) further downstream and several other stop codons 
upstream of position 233 in the other two reading frames, 187-189 and 196-198 (TGA) in one 
reading frame and at 204-206 (TGA) and 228-230 (TAG) in the other reading frame.
The CODONPREFERENCE program also revealed a large open reading frame 
extending from approximately 250-1550 with very few rare codons (figure 3.13). Downstream 
of the translation termination codon after the aceB gene, there are two ATG translation initiation 
codons in-frame with each other, starting at positions 250 and 265. When translated, they reveal 
an open reading frame which extends to position 1566. However, the only recognisable 
ribosome binding site, Shine-Dalgamo sequence (Shine and Dalgamo, 1974), downstream of 
aceB is at position 252-255,10-13 bases upstream of the second ATG. Therefore, the open 
reading frame which will be translated extends from 265-1566, after which there is a stop
CCDOfSSFB&a of: JtC£-A-2^S8-06-26I^ SEQ Ck: 316, 1 -to 16*2 Krch 11. 1991 18:18 
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Figure 3.13: CODONPREFERENCE Table For Nucleotides 1-1642 Of pAR24.
Each panel represents one reading frame showing the third base GC bias of the 
reading frame. Open reading frames are represented by the open boxes at the bottom of 
each panel and rare codons are represented by vertical bars below the reading frame panels.
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codon, TAA (1567-1569). There are also stop codons in the other reading frames, at positions 
1551-1553 (TGA) and 1538-1540 (TGA). This open reading frame encoded 434 amino acids 
corresponding to a 47,491 dalton protein. This is similar to the value obtained for the subunit 
molecular weight of ICL from E. coli of between 45,000-48,000 (Robertson and Reeves,
1987; MacKintosh and Nimmo, 1988). The N-terminal amino acid sequence of the protein 
translated from this open reading frame is similar to the N-terminal amino acid sequence 
derived from pure ICL (37 residues sequenced) (MacKintosh, 1987) and also contains the 
sequence around the active site cysteine residue reported by Nimmo et aL (1989). Therefore, 
this open reading frame corresponds to the aceA gene.
There are 29 nucleotides between the translation termination codon of aceB and the 
translation initiation codon of aceA and this region contains no sequence with the potential to 
form stable stem-loop structures, which is consistent with the very similar levels of expression 
of ICL and MSA (Cortay et al., 1989).
After the gap in the sequence of the insert, there is a third open reading frame, which 
has its startsite at position 40' and extends to the end of the insert. There is a recognisable 
Shine-Dalgamo sequence at position 29'-32', 8  bases upstream of the ATG. The derived 
amino acid sequence of this open reading frame shows 1 0 0 % identity to the derived amino acid 
sequence of ICDH kinase/phosphatase (Cortay et al., 1988; Klumpp et al., 1988). The 
nucleotide sequence and derived amino acid sequence of the above genes are shown in figure 
3.14.
Downstream of the stop codon at the 3' end of aceA, is a region with 100% identity to 
the first REP (repetitive, extragenic, palindromic) element found within the aceA-aceK 
intercistronic region (Cortay et al., 1988; Klumpp et al., 1988). When compared to the 
aceA-aceK intercistronic region of the K12 sequence, only the first 3 bases at the 5' end of 
REP-2 and the last 12 bases at the 3' end of REP-3 and the first partial element are present. 
Since the second and third REP elements have opposite orientations relative to each other in the 
K12 sequences, they could have formed a stable stem-loop structure, which either could not be 
sequenced, or which was deleted during the Exo ID/SI or cloning in M l3 steps. The second 
partial REP element (Cortay et al., 1988), which includes the Shine-Dalgamo sequence and
105
Figure 3.14: Nucleotide Sequence And Derived Amino Acid Sequence Of The Insert Of 
pAR24.
The nucleotide sequence is shown with the derived amino acid sequence below.
The putitive ribosome binding sites are indicated by the bold print and underlined. The REP 
and the partial REP elements are underlined.
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CTGGGCGAAGAGATGAAAGTCATTGCCAGCGAACTGGGCGAAGAACGTTTCTCCCAGGGGCGTTTTGACGATGCCGCACGCTTGATGGAACAGATCACCACTTCCGATGAGTTAATTGAT 
199
the ATG startsite is present.
3.4.2 Comparison Of The E, coli ICL Sequences With Each Other:
The aceA gene from E. coli K12 was sequenced by two other groups during the 
course of this work (Matsuoka and MacFadden, 1988; Rieul et al., 1988) and by another 
group (Byrne, EMBL library, accession number Pir:S05692) after the ML308 gene was 
sequenced. These sequences will be referred to as the Cozzone, McFadden and Byrne 
sequences respectively. Figure 3.15 shows a LINE UP of the amino acid sequences derived 
from the different aceA sequences.
The derived amino acid sequences from MacFadden's and Cozzone’s groups differ in 
two regions, between amino acid 101 and 117 and between amino acid 419 and the carboxy- 
terminus. The ML308 sequence is the same as the MacFadden sequence between 101 and 117 
and the same as the Cozzone sequence at the carboxy-terminus.The Cozzone sequence also 
differs from the ML308 and MacFadden's sequences at amino acids 215 with a Pro instead of 
an Ala and 338, with a Glu instead of a Gin. The Byrne sequence is identical to that from 
ML308. The nucleotide sequences of the aceA genes are compared in Figure 3.16. The 
Cozzone sequence has no C residue at position 300 in the nucleotide sequence and an extra T at 
position 352. This causes a shift in the reading frame between amino acids 101 and 117. The 
Cozzone nucleotide sequence also differs from the others at bases 643 and 644, with GC 
instead of CG and at 1013, with a G instead of a C. These differences account for the amino 
acid changes at 215 and 338. The MacFadden sequence has an extra G between bases 1255 
and 1256 which results in a change in the reading frame causing early translation termination 
resulting in a protein with a predicted of Mr 47,200.
An important difference between the ICL sequences from E. coli is that the MacFadden 
amino acid sequence places a His at the carboxy-terminus. ICL from several organisms has 
been shown to have a His at the carboxy-terminus (McFadden et al., 1968; Johanson et al., 
1974b; Khan and McFadden, 1982) and removal of this carboxy-terminal His resulted in loss 
of activity in the P. indigofera enzyme (McFadden et a l , 1968). MacFadden used five 
independent deletion clones from both strands to determine the nucleotide sequence of the 3'-
107
Figure 3.15: Comparison of The E. coli ICL Derived Amino Acid Sequences.
The aceA ML308 sequence is the sequence of the aceA gene from pAR24. The 
Cozzone sequence was obtained from Rieul et al. (1988), the McFadden sequence from 
Matsuoka and McFadden (1988) and the Byrne sequence taken from the EMBL database, 
accession number Pir:S05692. The sequences were aligned using the LINEUP programme 
of the UWGCG package. Differences are indicated by an asterisk.
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Figure 3.16: Comparison Of The Nucleotide Sequences Of The aceA Genes From E.
coli.
The aceA ML308 sequence is the sequence of the aceA gene from pAR24. The 
Cozzone sequence was obtained from Rieul et al. (1988), the McFadden sequence from 
Matsuoka and McFadden (1988) and the Byrne sequence taken from the EMBL database, 
accession number Pir:S05692. The sequences were aligned using the LINEUP programme 
of the UWGCG package. Differences are indicated by an asterisk.
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1 
ATGAAAACCC 
GTACACAACA 
AATTGAAGAA 
TTACAGAAAG 
AGTGGACTCA 
ACCGCGTTGG 
GAAGGCATTA 
CTCGCCCATA 
CAGTGCGGAA 
GATGTGGTGA 
AATTACGCGG 
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end of aceA. In support of the ML308 sequence, four independent deletion clones, one from 
the sense strand and three from the antisense strand, were used to identify the sequence of this 
region, as well as several clones on the sense strand which had undergone rearrangement 
elsewhere in the sequence. The other E. coli aceA sequences are identical to the ML308 
sequence over this region (Klumpp et al., 1988; Rieul et al., 1988; Byrne, EMBL library, 
accession number Pir:S05692). Comparing the predicted amino acid sequence of the ML308 
ICL to ICL fromB. napus, R. communis, G. hirsutum and C. tropicalis, indicates that the 
ML308 sequence is probably correct (figure 3.17; section 3.4.3). The plant and yeast ICLs do 
not have a His at the carboxy-terminus, suggesting that a His at the carboxy-terminus is not 
essential for activity.
Each of the differences occurs in only one of the sequences and all the other sequences 
are in agreement over the region where there is a difference, indicating that the differences are 
probably due to sequence errors, strain variation or mutations occurring during cloning. Since 
both the Cozzone and the MacFadden sequences are from E. coli K12, it seems unlikely that 
the differences are due to strain variation. Unfortunately, the strain from which Byrne obtained 
the sequence was not given. No information is given about the sequencing strategy used by 
either Byrne's or Cozzone's groups, however, MacFadden's group sequenced templates from 
several different Exo HI deletion breakpoints covering the region at the carboxy-terminus, 
where there is a difference, on both strands. Therefore, it seems unlikely that MacFadden’s 
group made errors in reading the sequence. If the difference is due to spontaneous mutation, 
then it occurred during the cloning since the same sequence was obtained on several templates 
on both strands.
3,4.3 Comparison Of The Amino Acid Sequences Of E. coli ICL With ICL 
From Other Organisms:
The genes encoding ICL from Brassica napus (Comai et al., 1989), the n-alkane 
assimilating yeast Candida tropicalis (Atomi et al., 1990) castor bean (Riccinus communis) 
(Beeching and Northcote, 1987) and cotton (Gossypium hirsutum) (Turley et al., 1990) have 
all been sequenced. The E. coli enzyme shows 41.7% identity with the R. communis ICL,
110
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42.2% identity with the G. hirsutum enzyme, 42.0% identity with the B.napus enzyme and 
41.6% identity with ICL from C.tropicalis (figure 3.17). This value is above the 25% level 
which is considered to indicate homology between proteins (Doolittle, 1986). There is 
extensive identity between the three plant enzymes, all of which show 86-90% identity to one 
another with the highest identity (90%) between the cotton and castor bean enzymes. The yeast 
ICL shows between 54-55% identity to the plant enzymes.
As well as indicating residues which may be of importance in an enzyme, comparison 
of sequences with a high degree of identity can also indicate possible sequencing errors. The 
C-terminal sequence of the E. coli ML308 enzyme is TEESQF. This sequence is very similar 
to the other sequences, indicating that this sequence is likely to be the correct sequence and not 
the HRRDRLH predicted by MacFadden's group. There is no sequence similar to that 
predicted by MacFadden's group in any of the other C-terminal regions.
Considering the differences between the E. coli ML308 sequence and the Cozzone 
sequence, the similar analysis reveals that there may be sequencing errors in the Cozzone 
sequence. When comparing the E. coli ML308 sequences to all three plant ICLs and the yeast 
ICL, there are several conserved residues; Prol07, Aspl08, Tyrl 12, Prol 13 andVall 17 are all 
conserved. The same region in the Cozzone sequence corresponds to the region where this 
sequence differs from the other E. coli sequences and does not show conservation of any of 
the above residues. Alanine 215 in the ML308 sequence is also conserved in all the other ICL 
sequences whereas at the same position in Cozzone's sequence there is a proline. This is 
further indication that the sequence of the E. coli ML308 aceA gene is correct
There are several regions of considerable identity between the E. coli enzyme and the 
other ICLs. There is a large block of identity between amino acids 141 and 241 in the E. coli 
ML308 sequence and where there are differences, many of them are conservative changes. 
There are also several smaller blocks of identity. There are conserved sequences, YxSGWQ, 
(position 89-94 in the E. coli ML308 sequence), LAYNxSPSFNW (position 314-324) and 
QFITLxGxH (position 349-356) where the gaps are conservative changes, except for a Cys 
instead of a Leu at position 318. An important conserved region is the region around the active 
site cysteine residue, Cys 195 in the E. coli enzyme;
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GAAxxHxEDQxxxxKK£GHMxGKVLVxxxExIxxLVAxR. It is clear from the high degree of 
identity between all of the ICL sequences that ICL has been highly conserved through 
evolution and that the active site is very highly conserved, even though the eukaryotic ICLs 
isolated so far have a much higher subunit Mr than the E. coli enzyme.
The major difference between the E. coli ICL and the other three is the presence of an 
insert, of 103 amino acids in the plant and 98 in the yeast, after Gly 255. There are also 
extensions at the N-terminus and the C-terminus.
Between the three plant enzymes, the region of greatest variation is the insert, although 
there are differences scattered throughout the length of the proteins. This is also reflected in the 
secondary structure predictions using the PEPTIDE STRUCTURE and PLOT STRUCTURE 
programmes of the UWGCG package (data not shown). The N-terminus of all three plant ICL 
enzymes contains the sequence MAASFSxPSMIxEE. The C-terminal extension is also very 
similar. Although the yeast enzyme has a shorter N-terminal extension and also a shorter 
C-terminal extension, although they are similar in sequence to the plant extensions.
Since ICL is found in glyoxysomes in eukaryotic organisms, but there is no 
compartmentation in E. coli, it seems likely that the signal for sequestration of ICL into 
glyoxysomes may be present in the amino-terminus, the carboxy-terminus or the insert 
sequence. Also there seems to be no post-translational processing of ICL during import in to 
the glyoxysome, so the signal for uptake of ICL into these organelles must be encoded in the 
mature peptide (Riezman et al., 1980; Roberts and Lord, 1981; Lazarow and Fujiki, 1985; 
Borst, 1986). The peptide signal for uptake of proteins into peroxisomes was identified to be 
Ser-Lys/His-Leu at the carboxy-terminus (Gould et al., 1988). The carboxy-terminal 
tripeptide of the B.napus ICL is Ser-Arg-Met, which is similar to that for peroxisomal 
proteins. However, the other plant ICLs have Ala-Arg-Met at the carboxy-terminus. It is 
therefore unlikely that this is the signal for uptake of ICL into glyoxysomes. Within the insert, 
the sequence Ala-Thr-Leu in the/?, communis amino acid sequence (position 285-287) is the 
same as a region within the uricase, soybean nodulin 35 polypeptide, which has been indicated 
to be part of the signal for uptake into peroxisomes (Volokita and Somerville, 1987). This 
sequence in the soybean enzyme corresponds to Phe-Leu-Thr-Leu in cucumber malate synthase 
and spinach glycolate oxidase. However, this sequence is similar to Phe-Ile-Thr-Leu which is
113
conserved between all the ICL sequences, including E. coli, which has no glyoxysomes. It 
has been suggested that two clusters of basic residues, each cluster within a five residue 
stretch, could be the signal for uptake of proteins into glyoxysomes (Wierenga et al., 1987). 
Within the insert, there is a cluster of basic residues in the R. communis and G. hirsutum ICL 
of Lys-Arg-Arg-Arg, and in the B. napus ICL, Lys-Ser-Arg-Arg. This or any of the other 
sequences may be the signal for uptake into glycosomes. More information on enzymes present 
in glyoxysomes is required in order to identify the sequence responsible for uptake into these 
organelles.
3.5 A Consensus Isocitrate Binding Site Between ICL And ICDH;
3.5.1 Comparison O f ICL And ICDH From E. coli:
While the reactions catalysed by ICL and ICDH are quite different, and ICDH contains 
an unusual NADP-binding domain, both enzymes bind isocitrate and it seemed interesting to 
investigate whether these competing enzymes could conceivably possess similar isocitrate 
binding sites, structure or sequence motifs although the residues in contact with isocitrate in 
ICDH are dispersed.
The gene encoding ICDH, icd, has now been cloned and sequenced (Thorsness and 
Koshland, 1987). When the amino acid sequences of ICL and ICDH are aligned using the 
BESTFIT program of the UWGCG package, there is 14% identity over the full length of the 
enzymes. Between positions 159-237 in ICL and 158-233 in ICDH there are 14 identities and 
20 conservative changes with only two gaps over the 81 residues. Several of the conserved 
residues are also conserved in all the other ICL enzymes. At position 192-194 in the ICL 
sequence, the tri-peptide Val-Lys-Lys is conserved between the ICL and ICDH from E. coli. 
The plant enzymes all have the sequence Val-Thr-Lys-Lys and the C.tropicalis ICL has the 
sequence Gly-Thr-Lys-Lys at the same position, suggesting that the double Lys could be 
important for isocitrate binding or the structure of the active site since the next residue in ICL is 
the active site Cys. At position 213-214 in the ICL sequence, the di-peptide Leu-Val is 
conserved between all the other ICL sequences and the ICDH. Other residues which are 
conserved between ICDH and all the ICL sequences are Glyl64, Lysl73, Hisl97 and Ala216
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in the E. coli ICL sequence. These residues are close to the active site Cys 195 in E. coli ICL, 
which was identified by two independent groups by chemical modification studies using 
iodoacetate (Nimmo et al., 1989) and 3-bromopyruvate (Ko and McFadden, 1990).
3.5.2 Secondary S tructure Analysis Of ICL And ICDH:
The secondary structure of all the ICL enzymes and ICDH were predicted using the 
PEPTIDE STRUCTURE and PLOT STRUCTURE programs of the GCG package.This 
program makes use of the two methods to predict the secondary structure devised by Gamier 
et al. (1978) and Chou and Fasman (1978).
Between positions 159-237 in the ICL sequence and 158-233 in the ICDH sequence, 
the secondary structures of both enzymes, predicted by both the Chou and Fasman and the 
Gamier methods are similar. The predicted secondary structure for ICDH over this region by 
the Gamier method contains a long a-helix, followed by a short turn and another a-helix. At 
the corresponding region in the ICL sequence, there are two a-helices, a short region of 
random coil, followed by a P-strand, another a-helix and a P-strand. The position and length 
of the a-helices in both enzymes are very similar and the P-strands in the ICL correspond to 
turns in the ICDH. Similarly, by the Chou and Fasman method the ICDH structure over this 
region is a long a-helix, a short p-strand, an a-helix of similar length, two turns a short P- 
strand and an a-helix, while for ICL, this method predicts two a-helices, one turn, and a long 
a-helix. Again, the length of the secondary structures are similar. The main difference between 
the two methods of predicting the structure is the the prediction of turns; where one method 
predicts a turn, the other predicts a p-strand. Since in both methods, the positions of the a -  
helices are similar, the secondary structures could be similar over this region. The secondary 
structure predictions from the PEPTIDE STRUCTURE and PLOTSTRUCTURE programs of 
the UWGCG package are shown in figure 3.18.
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3.5,3 Comparison Of The Predicted ICL Secondary Structure With The Actual 
Structure Of ICPH:
The three dimensional structure of ICDH has now been solved (Hurley et al., 1989) 
and is shown in figure 3.19a. ICDH contains three domains: a large a+p domain, residues 1- 
124 and 318-416 (where the a-helices and p-strands do not alternate), a smaller a /p  domain, 
residues 125-157 (where the a-helices and P-strands alternate), both of which are built around 
a 1 2 -stranded p-sheet and an a/p  clasp-like domain which involves both subunits.
The clasp domain consists of residues 158-202 from both subunits (figure 3.19b). The 
region of greatest sequence similarity between ICDH and ICL covers these residues 158-202 
and also helix-f (figure 3.19a). When the predicted ICL structure is aligned with the actual 
structure of ICDH (figure 3.20), it can be seen that they are similar over the region 159-237 in 
the ICL sequence and 158-233 in the ICDH sequence. There is an a-helix in the ICL 
corresponding to helix-e in ICDH, a p-strand corresponding to strand-N and another a-helix 
corresponding to helix-f. At strand-M, however, the corresponding predicted structure for ICL 
is an a-helix.
Assuming that the two structures are similar, then the active site Cysl95 of ICL, which 
is at the C-terminus of the helix corresponding to helix-e, will point into the front pocket on the 
other subunit, thus allowing it to interact with the isocitrate molecule which was shown to bind 
in this pocket (Hurley et al., 1990a).
The residues which are involved in binding isocitrate and coordinating the Mg2+ in 
ICDH are Seri 13, which is the residue phosphorylated, A snll5, A rgll9, Argl29, Tyrl60, 
Lys230, Argl53, which all coordinate isocitrate and Asp307, Asp283, Asp311, which all 
coordinate the Mg2+. Seri 13 lies at the N-terminus of helix-d and Asnl 15 and Argl 19 also 
form part of this helix. In ICL the predicted structure corresponding to helix-d is a p-strand, 
however, the predicted structure for ICDH is also a p-strand. Of course, where the secondary 
predictions for ICDH are incorrect but similar to the predicted structure for ICL, the secondary 
structure of ICL may in fact be similar to that of ICDH. Seri 13 which forms a hydrogen bond 
with the carboxyl group at C5 of isocitrate is not conserved in ICL, although the corresponding 
residue is an Arg in the E. coli enzyme and a His in all the other ICLs.
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B)
Figure 3.19: Three Dimensional Structure Of ICDH
A) Diagram of the ICDH monomer, taken from Hurley et al. (1989). Helices are 
labelled in alphabetical order as they occur in thechain while the P-strands are labelled as 
they occur in the p-sheet. The front and rear pockets are indicated by I and II respectively. 
The rod represents the crystallographic twofold axis of symmetry relating the two subunits.
/
B) Daigram of the clasp domain, looking down the crystallographic twofold axis of 
symmetry. The shaded part represents the second subunit.
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Therefore there are conservative changes at this position. A snll5 and Argl 19 are conserved in 
the E. coli ICL but not in the other ICLs, Asp corresponding to A snll5 and His 
corresponding to Argl 19. Although an Asp at position 115 would result in charge repulsion, a 
His at position 119 could interact with isocitrate in a similar manner to Arg. Other substitutions 
of isocitrate binding residues are Asp283 in ICDH to Gin in the E. coli ICL and either Glu or 
Asp in the other ICLs and Asp311 to a Lys in E. coli ICL, changing the charge, and either a 
Glu, Asp or Gin in the other ICLs. Tyrl60 in ICDH corresponds to a Phe in all ICLs. 
Therefore, the above residues in the ICLs which are either conserved or are conservative 
changes when compared to ICDH may be important for isocitrate binding and where there are 
differences, these may account for the difference in the Km of ICL and ICDH for isocitrate. 
Site-directed mutagenesis of these residues could confirm whether or not these residues are 
important or not.
Although the secondary structure predictions for ICL from E. coli are similar to the 
actual structure of ICDH, this can only be speculation and whether or not a consensus isocitrate 
binding site exists between ICDH and ICL will not be answered until the three dimensional 
structure of ICL is solved.
3,6 Discussion;
The evidence presented in this chapter shows that the aceA gene of E. coli ML308 is 
indeed in the BamHI-Aval fragment of pEM9. When induced by the addition of IPTG, KAT-1/ 
p AR9023 expresses a protein of the same molecular weight as ICL, concomitant with an 
increase in ICL activity. The nucleotide sequence of the 2.3kb insert has the capacity to encode 
a 434 amino acid protein of molecular weight 47,491, similar to the reported molecular weight 
of ICL, 45,000 - 48,000 (1988; Robertson and Reeves, 1987; MacKintosh and Nimmo). The 
nucleotide sequence and derived amino acid sequence of this reading frame is very similar to 
the other E. coli ICLs and the amino acid sequence is also similar to the amino acid sequences 
of ICL from other organisms. The amino acid sequence at the amino-terminus is very similar to 
the sequence obtained by direct peptide sequencing of the amino-terminus of ICL from E. coli 
ML308 (MacKintosh, 1987). The difference between these sequences is an Asn residue at
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position 8 in the peptide sequence while there is an lie residue at the same postion in the 
derived amino acid sequence. The reason for this difference is not clear. However, for all the 
E. coli ICLs sequences, there is an He residue at this postition. Also, several templates and 
several clones were used to determine the nucleotide sequence of this region on both strands. 
The derived amino acid sequence also contains the sequence around the active site cysteine 
(Nimmo et al., 1989; Ko and McFadden, 1990) and identify this cysteine residue as Cysl95.
Since ICL activity is expressed from pAR9023 with the only open reading frame long 
enough, extending over 1301 bp, encoding a peptide of molecular weight 47,491, these results 
confirm that ICL contains only one type of subunit.
By placing the aceA gene under the control of the tac promoter of pGLWl 1, it was 
hoped that the contribution of ICL to the control of flux through the central metabolic 
pathways, during growth on different carbon sources could be measured. Similar systems have 
been used for this purpose in the past. Walsh and Koshland (1985) placed the gene encoding 
citrate synthase from E. coli under the control of the tac promoter in a vector containing the 
laclq gene. By growing the host cells containing this plasmid in the presence of different 
concentrations of IPTG, they found that citrate synthase was expressed at different specific 
activities. Using this system, they reported that citrate synthase was rate limiting for flux 
through the TCA cycle and the glyoxylate bypass as well as for growth, during growth on 
acetate but not glucose. Using a similar system, LaPorte et al. (1985) showed that the ICDH 
kinase/phosphatase could compensate for high levels of ICDH expressed from the tac 
promoter by phosphorylating ICDH to a higher degree, keeping the level of active ICDH 
constant.
In both of the above examples, the level of the enzyme enzyme expressed by the tac 
promoter was dependent on the concentration of IPTG; in the case of citrate synthase, the 
specific activity could be altered by altering the IPTG concentration. However, expression of 
ICL from E. coli KAT-l/pAR9023 did not give similar results. Different IPTG concentrations 
did not result in different levels of specific activity of ICL. Instead, at any given IPTG 
concentration, the ICL activity increased linearly with time (figure 3.3), hence the rate of 
increase in specific activity of ICL and not the specific activity itself was dependent on the 
concentration of IPTG (figure 3.4).
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As the culture grows, the total number of plasmid molecules increases, increasing the 
number of the aceA genes. This results in increased expression in the presence of IPTG, 
which binds to the lac repressor, preventing it from binding to the lac operator and repressing 
transcription from the tac promoter. However since the constitutive lacl gene is also present 
on the vector, the total number of repressor molecules also increases. The vector pGLWl 1 was 
reported to contain the up-mutation in the promoter of the lacl gene, laclq (Calos, 1978), thus 
expressing higher levels of the repressor (IS. Hunter, personal communication). Therefore, as 
the culture grows, the IPTG, which is present at a constant concentration, should eventually be 
bound to lac repressor so that there is excess lac repressor. This should result in repression of 
transcription from the tac promoter and control the specific activity of ICL. However, it 
appears that the lac repressor is not present at sufficiently high levels in E. coli KAT-1/ 
pAR9023 for controlled expression of ICL. The nucleotide sequence of the promoter upstream 
of the lacl gene in the vector, pGLW ll, was examined (C. Boyd, personal comunication) for 
the presence of the mutation in laclq which causes increased expression of the repressor. It 
was found that pGLWl 1 did not contain the laclq gene, as reported, but the wild type lacl 
gene. This presumably explains why the expression of ICL could not be controlled in a similar 
manner to that reported for citrate synthase (Walsh and Koshland, 1985). However, this 
system allows very high expression of ICL (figure 3.5) and thus aids purification of large 
quantities of the enzyme (section 4.4).
The amino-terminus of ICL from several organisms, Ps. indigofera (McFadden et al., 
1968), L. usitattissimum (Kahn and McFadden, 1982) and E. coli (Matsuoka and McFadden, 
1988; Rieul et al., 1988) has been identified as methionine. The carboxy-terminus from A. 
cras.sa(Johanson et al., 1974b) Ps. indigofera (McFadden et al., 1968) and flax (L. 
usitattissimum) (Kahn and McFadden, 1982) has been shown to be histidine, while from a 
thermophillic Bacillus the carboxy-terminus is a threonine (Chell et al., 1978) and DNA 
sequencing showed the carboxy-terminus to be methionine in R. communis (Beeching and 
Northcote, 1987). The amino acid composition has been calculated for ICL from Ps. 
indigofera (Shiio et al., 1965), thermophillic Bacillus (Chell et al., 1978), N. crassa 
(Johanson et al., 1974b), C. tropicalis (Uchida et al., 1986), P. pinea (Pinzauti et al.,
1986), L. usitattissimum (Khan and McFadden, 1982) and watermelon (Citrullus vulgaris)
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(Jameel et al., 1984). The relative amino acid compositions of the above enzymes and from 
the derived amino acid sequence of the R. communis ICL were used to calculate their 
relatedness to each other using the Marchalonis and Weltman (1971) method (Vanni et al., 
1990). The SAQ values between ICL from all of the above organisms were all less than 50, 
which indicates that the enzymes are related. The inhibition patterns of several of the ICL 
enzymes are similar. Also cysteine has been reported to be at or near the active site in ICL from 
N. crassa, Ps. indigofera, E. coli, L. usitattissimum and Citrullus vulgaris. The amino acid 
sequence around the active site cysteine has been determined (Nimmo et al., 1989) for the 
E. coli ICL and confirmed by Ko and McFadden (1990) to be CGHMGGK and this sequence 
is very highly conserved in ICLs sequenced to date. Because of the similarities between th e . 
ICL from different sources, it seems likely that they are evolutionarily related, even though the 
prokaryotic ICL has a subunit Mr of 45,000-48,000 and the eukaryotic ICL has a subunit Mr of 
65,000-68,000.
Comparison of the ML308 derived amino acid sequence of ICL with those from 
B.napus, R. communis, G.hirsutum and C.tropicalis indicates a high degree of identity, 
confirming the suggestion that all ICL enzymes share a common active site structure despite the 
difference in the molecular weights of the prokaryotic and eukaryotic enzymes. There are two 
regions of high identity, with the E. coli ICL sequence split by a large insert in the plant and 
yeast enzymes (figure 3.17). There are also extensions at the carboxy- and amino-termini. 
Within the regions of high identity, there are several regions which show very high identity 
(figure 3.17), suggesting that these regions are important and could form part of the active site. 
Since the kinetics of both the forward and reverse reactions are similar between the prokaryotic 
and eukaryotic ICLs, as are the kinetics of inhibition and residues at the active site, it appears 
that during evolution, the structural gene encoding ICL has aquired an insert without altering 
the structure of the active site.
The results presented in this chapter show that ICL from a wide range of sources, 
plant, fungi and bacteria, is very highly conserved. Because of the very high degree of identity 
between the various ICLs the sequence data alone does not provide any likely candidates for 
important residues. However in conjunction with chemical modification experiments it will
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provide information on which residues to change using site-directed mutagenesis.
As mentioned above, the sequence around the active site cysteine has been determined 
and comparing this to the E. coli sequence, this residue was identified as Cysl95. This 
residue is conserved between all ICLs sequenced so far (figure 3.17) as is the sequence around 
this residue. Using site directed mutagenesis, the role of Cysl95 in either catalysis or substrate 
binding can be investigated.
His has been implicated as an active site residue in ICL from a number of organisms,
L. usitattissimum (Khan and McFadden, 1982), Citrullus vulgaris (Jameel et al., 1985), and 
E. coli (Ko et al., 1991). The sequence around the modified His is not known as yet for ICL 
from L. usitattissimum and Citrullus vulgaris. In E. coli it has recently been reported that 
there are two His residues which react with DEPC in the E. coli enzyme, His266 and His306 
(Ko et al., 1991). However work done here in Glasgow indicates that only His306 reacts with 
DEPC and that this residue is unlikely to be at or near the active site (Rua, Robertson and 
Nimmo, submitted). His306 is not conserved in any of the other ICL sequences, all of which 
place a Lys at this position, the Ks values for protection against inactivation by DEPC. This 
does not however prove that there are no His residues in the active site, only that DEPC does 
not react with any residues in the active site. There are eight His residues in the E. coli ICL, 
but since only four are conserved, at positions 184,197, 356 and 399, it would not be a 
difficult task to use site directed mutagenesis to change all of these residues and identify which 
is involved in binding of substrate or catalysis.
Itaconate epoxide, which is an analogue of succinate, has been used as a modifying 
agent for ICL from Citrullus vulgaris (Jameel et al., 1985). The inactivation caused by 
itaconate epoxide is protected against by itaconate, a competitive inhibitor with respect to 
succinate and an uncompetitive inhibitor with respect to glyoxylate, succinate and isocitrate. 
Using hydroxylamine to reactivate the modified ICL, it was shown that an ester was formed 
between ICL and itaconate epoxide, indicating that the group modified was a carboxylate of 
either Glu or Asp. Since succinate and itaconate protect against modification by itaconate 
epoxide, the authors suggest that the residue modified is at the succinate sub-site. They also 
suggest that the residue modified could be involved in coordinating the Mg2+. There are nine 
conserved Glu residues, at positions 10, 122, 141, 186, 208, 260, 289, 386 and 431, and
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thirteen conserved Asp residues, at positions 31, 108, 132, 149, 157, 187, 221, 234, 246, 
249,284,294 and 409. Since there are so many Asp and Glu residues, it would be easier to 
identify the modified residue by isolating and sequencing a peptide, labelled by reacting ICL 
with radioactive itaconate epoxide and digested with a protease. Site directed mutagenesis could 
then be used to clarify the role of this residue in catalysis or substrate binding. Since the active 
site Cys residue has been identified as Cysl95, this residue is an obvious candidate for site 
directed mutagenesis and this is the topic of the next chapter.
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Chapter 4 
Site Directed
Mutagenesis Of ICL
4.1 Introduction:
There have been several studies which have identified possible active site residues in 
ICL which may be important in catalysis and/or substrate binding. Inhibition of ICL from L. 
usitatissimum (Khan and McFadden, 1982), Citrullis vulgaris (Jameel etal., 1985) and Zea 
mays (Igamberdiev and Zemlyanukin, 1987) with diethylpyrocarbonate (DEPC) implicated an 
active site histidine, since isocitrate and the products offered protection against inhibition. 
Itaconate epoxide, an analogue of the competitive inhibitor of succinate binding, itaconate, 
implicated the carboxylate group of either aspartate or glutamate at the active site of the 
Citrullis vulgaris enzyme (Jameel et al., 1985). Ko and McFadden (1990) identified two His 
residues in the E. coli enzyme which reacted with DEPC, His266 and His306. It seems 
unlikely that either of these residues is at the active site, since work done here in Glasgow 
indicated that only His306 was modified by DEPC and the Ks values for protection against 
DEPC inactivation by the substrates and products are much higher than the respective Km 
values (Rua, Robertson and Nimmo, submitted).
Through studies with sulphydryl reagents and sulphydryl-modifying reagents, ICL 
from many sources has been shown to have an essential cysteine residue (section 1.3.10). The 
glyoxylate analogue, 3-bromopyruvate (3-BrP) was shown to inhibit ICL from P. indigofera 
(McFadden et al., 1968; Roche and McFadden, 1969; Roche et al., 1971), N. crassa 
(Johanson eta l., 1974b), L. usitatissimum (Khan and McFadden, 1982) and Citrullis 
vulgaris (Jameel et al., 1985) following saturation kinetics with 3-BrP reversibly binding to a 
specific site prior to alkylation of the enzyme. Isocitrate and the products, glyoxylate and 
succinate, offered protection against this inactivation, indicating that the reactive group was at 
or near the active site.
A more detailed study was carried out on the E. coli ML308 enzyme by our group 
(Nimmo et al., 1989) using iodoacetate. Iodoacetate inhibited ICL from this organism in a 
pseudo-first-order process resulting in carboxymethylation of one cysteine residue per subunit. 
Isocitrate, glyoxylate and succinate protected against inhibition by iodoacetate with Kg values 
similar to their respective Km values. Also, the decrease in reactivity of the enzyme with 
iodoacetate over the pH range 8 .1-6.1 was very similar to the decrease in the Km for isocitrate
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over the same pH range. This strongly suggests that the reactive group is in the active site. The 
carboxymethylated peptide was isolated and sequenced after tryptic digestion. The amino acid 
sequence of this peptide was CMCys-Gly-His-Gly-Gly-Lys. Comparison of this sequence 
with the derived amino acid sequence of ICL from E. coli ML308 (figure 3.13) indicated that 
the modified residue was Cysl95. This residue and many of the surrounding residues are 
conserved between E. coli ML308, E. coli K12 (Matsuoka and McFadden, 1988; Rieul et 
al., 1988), Riccinus communis (Beeching and Northcote, 1987), Brassica napus (Comai et 
al., 1989), Candida tropicalis (Atomi et al., 1990) and Gossypium hirsutum (Turley et al., 
1990) (figure 3.17). This suggests that Cysl95 may be an active site residue and as such may 
play an important role in either catalysis, substrate binding or both in all of the above ICLs.
Based on the chemical modification of ICL from P. indigofera by 3-BrP and protection 
by isocitrate and products, glyoxylate and succinate, Roche et al. (1971) tentatively proposed 
a catalytic mechanism indicating a role for an active site Cys in protonating the C3 of isocitrate. 
However, an alternative mechanism has been proposed by Vanni et al. (1990) in which no 
role for an active site Cys has been indicated, instead, these authors prefer a mechanism in 
which a histidine protonates the C3 of isocitrate.
The catalytic mechanism proposed by Roche et al. (1971) indicates that the S-H group 
of the active site cysteine residue in the P. indigofera ICL donates a proton to the C3 of 
isocitrate during the cleavage reaction and accepts a proton from succinate in the condensation 
reaction. Therefore, the ionization of the active site Cys residue is critical for catalysis, if this 
catalytic mechanism is correct. It was for this reason that it was decided to change Cys 195 in 
the E. coli ML308 ICL to a serine, thus replacing the S-H group with a O-H group which 
should have a higher pKa and an alanine, thus replacing the O-H with -H which results in an 
enzyme with no ionizable group at position 195.
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4.2 Site Directed Mutagenesis Of ICL:
4.2.1 Strategy:
The strategy used was based on the method of Eckstein and co-workers (Taylor et al., 
1985a; Taylor et al., 1985b; Nakamaye and Eckstein, 1986; Sayers et al., 1988) and involves 
annealing an oligonucleotide carrying the specific mutation to a single stranded template. 
Klenow polymerase is then used to synthesise double stranded DNA which is then ligated to 
form a closed, circular duplex. Any excess single stranded template DNA is then removed by 
binding to a nitrocellulose filter in conditions which allow free passage of double stranded 
DNA. During the extension step, dCTP is replaced with dCTPaS so that all the newly 
synthesised DNA contains dCMPaS instead of dCMP. The restriction enzyme, Nci I , which 
cannot cut a strand which contains dCMPaS in its recognition site, is then used to digest the 
duplex. Since Nci I cannot cleave the strand with dCMPaS, this results in the duplex being 
nicked in the template strand while the newly synthesised strand, containing the mutation 
remains intact. The nicks in the template strand are then extended using Exo HI which digests 
in a 3'-5' direction. The Nci I restriction site is positioned 3’ of the end of the M13 polylinker 
on the template strand so that the wild type template of the insert in the polylinker is quickly 
deleted. The Exo HI digestion is not carried through to completion so that a double stranded 
region remains, most likely in the M13 sequence, and can be used as a primer for 
repolymerisation. DNA polymerase I is then used to extend the double stranded region using 
the intact strand, carrying the mutation, as the template. This results in the newly synthesised 
double stranded DNA carrying the specific mutation. The double stranded DNA is then ligated 
and used to transform competent host cells. This strategy is outlined in figure 4.1 and 
described in detail in section 2.9.
4.2.2 Design Of Oligonucleotides For The Mutagenesis Reaction:
For the most efficient annealing of the oligonucleotide carrying the mutation to the 
template, the mutation should be towards the middle, at least 3  nucleotides from the 3 ' end and 
several bases from the 5' end. This is to avoid the 3-5' exonuclease activity of the Klenow 
polymerase or any contaminating exonuclease activity from deleting the mismatch within the
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Mutant
oligonucleotide.
Anneal
M13 recombinant 
ssONA template.
Klenow
Ligase
Neil
Exolll
Nicking
Extension + ligation 
with dCTPaS.
Remove unwanted 
remaining ssDNA 
template by 
filtration.
Exonudease III 
digestion
Repolymerization
DNA Ad/I 
T4 DNA ligase
Transformation
Figure 4.1: Site Directed Mutagenesis Scheme
Single stranded template is represented by a single circle while double stranded 
DNA is represented by a double circle. The asterisk indicates the position of the point 
mutation.
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oligonucleotide during the extension step. Figure 4.2 shows the nucleotide sequence and the 
corresponding amino acid sequence around Cys 195. Also shown are the sequences of the two 
oligonucleotides, each 25 nucleotides long with the codon for Cysl95, TGC, changed to TCC, 
Ser, and GCC, Ala in oligonucleotides 654 and 655 respectively. These oligonucleotides 
should anneal to the template, pAR24 at positions 838-862 in the nucleotide sequence of the 
insert.
4.2.3 The Mutagenesis ReactLom
Oligonucleotides 654 and 655 were phosphorylated at their 5' ends using T4 
polynucleotide kinase in order to provide a 5'-phosphate for ligation to form the closed duplex. 
The oligonucleotides were then annealed to the single stranded template, pAR24, and then 
treated as described above (section 4.2.1) and in figure 4.1.
In conjunction with the mutagenesis of aceA by oligonucleotides 654 and 655 on 
pAR24, a control mutagenesis reaction was set up. The control reaction uses a mutated 
M13mp8 which has a stop codon at position 6298, within the lacZ' gene resulting in no (3- 
galactosidase activity, and an oligonucleotide which changes the base at position 6298 back to 
the wild type, restoring (3-galactosidase activity. Thus, the reaction can be evaluated by the 
reversion of white plaques to blue in the control.
Samples were taken at each step of the mutagenesis reaction, after extension and 
ligation, filtration and nicking, Exo m  deletion and after repolymerisation. These samples were 
then run on an agarose gel to asess each step of the reaction (figure 4.3).
For all three reactions, sample 1, taken after extension and ligation, shows the presence 
of single stranded, nicked and covalently closed circular DNA. For the 654 and 655 reactions, 
there appears to be a large proportion of nicked and single stranded DNA. The excess single 
stranded DNA may be due to the annealing conditions, while the large proportion of nicked 
DNA indicates that much of the oligonucleotide is not phosphorylated, however, the control 
oligonucleotide is phosphorylated but also shows a large proportion of nicked DNA at this 
stage. The results of sample 2, taken after filtration through nitrocellulose and nicking with 
Neil, indicates that in all cases, the filtration step removed all of the single stranded template.
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Leu Ala Ser Val Lys Lys Cys Gly His Met Gly Gly Lys Val Leu Val 
CTG GCG TCA GTG AAG AAA TGC GGT CAC ATG GGC GGC AAA GTT TTA GTG
Oliyo-Ala; GTG AAG AAA GCC GGT CAC ATG GGC G
Ala
Oliyo-Ser: GTG AAG AAA TCC GGT CAC ATG GGC G
Ser
Figure 4.2: Oligonucleotide Sequences:
The derived amino acid sequence of ICL is shown between Leu 189 and Val204 with 
the nucleotide sequence underneath. The sequence of the oligonucleotides used in the 
mutagenesis reactions are shown. Where there is a difference in the derived amino acid 
sequence, the amino acid change is indicated.
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Figure 4.3: Analysis Of Mutagenesis
1.0% agarose gel showing samples from each step of the mutagenesis reactions with 
the control reaction, and reactions with mutant oligonucleotides 654 and 655. S1-S4 indicate 
samples taken after extension and ligation; after filtration and nicking with Nci I; after extension 
of the nick with exonuclease m  and after repolymerisation and ligation respectively.
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In all reactions, sample 3 shows a smear, indicating efficient digestion by Exo HI. Sample 4, 
taken after repolymerisation shows a single band corresponding to covalently closed circular 
DNA in all three reactions.
The repolymerised covalently closed circular DNA was then used to transform 
competent TG-1 cells. The results of the transformation are shown in table 4.1. The reason for 
the low number of plaques is not known. A control transformation with lng of RFM13mp8 
resulted in 283 plaques, indicating that the competence of the host cells was high. As can be 
seen from table 4.1,33 of the 39 plaques were blue in the control mutagenesis reaction, 
indicating 84.5% efficiency of mutagenesis.
4,2.4 Nucleotide Sequence Of Mutants:
Single stranded template DNA was prepared from 6  plaques of each of the two 
mutagenesis reactions, 654 and 655. These were then sequenced using an oligonucleotide, 
oligo 700, as the primer which anneals to the insert of pAR24 at positions 701-717 (table 4.2). 
Five of the six templates of the 654 reaction had the Cysl95 codon, TGC, changed to TCC, 
the codon for Ser, at positions 847-849, while all six of the 655 reaction templates had GCC at 
the same positions, changing the Cysl95 to Ala. An example of each sequence is shown in 
figure 4.4.
In order to rule out any possibility that the oligonucleotides had annealed to pAR24 
anywhere other than at the target site in the aceA gene, one template was chosen from each 
mutagenesis reaction, pAR24-654 and pAR24-655, corresponding to reactions with 
oligonucleotides 654 and 655 respectively, and sequenced again. This was done using 
oligonucleotides which allowed the complete sequence of the mutated aceA genes to be 
determined when used as primers in the sequencing reactions (table 4.2, figure 4.5).
Apart from the changes at positions 847-849, the target site for site directed 
mutagenesis, there were no other sequences within the aceA gene to which the mutagenic 
oligonucleotides bound. Also, since when either oligos 654 or 655 were used as primers for 
sequencing, there were no overlapping sequences on the gel, it is clear that these 
oligonucleotides annealed at only the predicted site on pAR24.
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Table 4.1: Results Of Site Directed Mutagenesis Reactions
Plate Number Of Colonies
White Blue
No DNA 0 0
Site Directed Mutagenesis With Oligo-654 1 0 0
Site Directed Mutagenesis With Oligo-655 8 0
RFM13mp8 0 283
RFpAR24 316 0
Control Site Directed Mutagenesis 6 33
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Table 4.2: Oligonucleotide Primers For Sequencing aceA Mutants
Oligonucleotide Sequence Position To Which 
Oligonucleotide 
Anneals On pAR24
Oligo-230 CGTAAACCACCACATAA 231- 247
Oligo-480 ACTGGCGGTCAGGCGCT 481- 497
Oligo-700 GCTATGTCGATTACTTC 701- 717
Oligo-1090 GCCTGGCGTATGCGCCA 1091-1107
Oligo-1330 ACAGCATGTGGTTCAAC 1331-1347
Oligo-1610 CACGCCGCATCCGGCAA 1611-1627
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PAR24-655
A C G T
I I  J
pAR24-654 pAR24 
A C G T
C y s
Figure 4.4: Sequencing Of pAR654 And pAR655
Sequencing reactions were carried out according to section 2.7.2, using oligo700 as 
a primer, and run on a polyacrylamide gel, section 2.7.3. A portion of the sequencing gel is 
shown for pAR24, pAR654 and pAR655 with the corresponding sequence alongside. The 
mutated codon is boxed and the resulting amino acid is indicated.
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Oligo-230 Oligo-700 Oligo-1090 OIigo-1610
 ►  ►  -►  ►
-40 Primer Oligo-480 Oligo-654/655 Oligo-1330
 ►  ►  ►  ■---
Figure 4.5: Sequencing Strategy For Mutant aceA Genes
The 2.3kb insert of pAR24, containing the genes encoding ICL (dark 
shaded box), MSA (light shaded box) and ICDH kinase/phosphatase (black box) 
are shown, with the untranslated regions shown in the unshaded boxes. The 
arrows indicate the direction of second strand synthesis and the length of readable 
sequence from each oligonucleotide primer. The hatched box indicates the region 
which was not sequenced by either this strategy or by Exo ID deletion.
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4.3 Expression Of Mutant aceA Gene Produts. ICLSerl95 And TCLA1al95:
4.3.1 Cloning Of The Inserts Of PAR24-654 And nAR24-655 Into nO LW ll:
In order to characterise the effects of replacing Cysl95 with Ser and Ala, the mutant 
enzymes first had to be expressed and purified. The mutant aceA genes are in the wrong 
orientation with respect to the lac promoter in pAR24-654 and pAR24-655. Also, M13 
inhibits host cell growth and this makes M13 an inefficient expression vector. Therefore, it was 
decided to use pGLWl 1 as the expresson vector. This also had the advantage that the wild type 
aceA gene had been cloned into this vector, pAR9023, and so the activities of ICLSerl95 and 
ICLAlal95 could be compared directly to that of the wild type enzyme.
If the inserts of pAR24-654 and pAR24-655 are digested with BamHl and EcoRl and 
ligated into pGLWl 1 digested with the same enzymes, the aceA gene will be in the wrong 
orientation with respect to the tac promoter for expression. An alternative strategy was to 
digest pAR24-654 and pAR24-655 with BamHl and EcoRL, fill in the sticky ends using 
Klenow polymerase and ligate into pGLWl 1 digested with Smal in the same way that 
pAR9023 was subcloned (section 3.2.1). The correct orientation could then be checked by 
mapping the PvuU sites. When this was tried, the only colonies obtained did not contain any 
insert and corresponded to religated pGLWl 1.
To get round this problem of relatively inefficient ligation of blunt ended insert into 
blunt ended vector compared with sticky end ligation, pAR24-654 and pAR24-655 were 
digested with BamHl and ZscoRI, the ends filled in using Klenow polymerase and the 2.3kb 
fragment ligated into pUC19 digested with Sma I after agarose gel purification (section 2.4.6). 
This strategy had the advantage that recombinant clones could be selected by their white colour 
after growth of transformed TG-1 cells on L-plates containing ampicillin, IPTG and X-gal. The 
PvuU sites were then mapped and two clones, pAR19-654 and pAR19-655 were selected 
which resulted from the ligation of the inserts of pAR24-654 and pAR24-655 into pUC19 
respectively. These clones had l.Okb BamHl-PvuU and 0.6kb EcoRl-PvuU fragments in 
the inserts, so that the aceA genes are transcribed in the EcoRl-BamHl direction (figure 3.2, 
section 3.2.1). pAR19-654 and pAR19-655 were then digested with BamHl and EcoRl and
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ligated into pGLWl 1 digested with the same enzymes after agarose gel purification of the 
appropriate fragments (2.3kb for pAR19-654 and pAR19-655 and 4.85kb for pGLWl 1). This 
strategy is outlined in figure 4.6. The PvuII sites were then mapped in both resulting plasmids, 
pAR654 and pAR655, encoding ICLSerl95 and ICLAlal95 respectively, to check the 
orientation with respect to the tac promoter. These plasmids were then used to transform 
competent E. coli KAT-1 cells.
4.3.2 Expression Of ICLSerl95 And ICLAlal95 From dAR654 And PAR655 
Respgcli.vghn
In order to determine whether or not pAR654 or pAR655 expressed an active ICL 
enzyme, an expression experiment similar to that for KAT-l/pAR9023 was set up (see section 
3.2.2).
IPTG was added to a final concentration of ImM to 100ml cultures of E. coli KAT-1/ 
pAR9023, E. coli KAT-l/pAR654 and E. coli KAT-l/pAR655 growing on L-broth 
containing ampicillin when the A4 2 0  was approximately 0.5. Two 1ml samples were taken 
from each culture at various time intervals. One of the samples was harvested by centrifugation 
and resuspended in SDS sample buffer containing p-mercaptoethanol, boiled and run on an 
SDS gel. Figure 4.7 shows a gel of samples from E. coli KAT-l/pGLWll, E. coli KAT-1/ 
pAR654 and E. coli KAT-l/pAR655 at various times after addition of IPTG. The other 
sample was used for mearurement of A4 2 0 , sonication and assay of ICL activity. Figure 4.8 
shows the effect of time after addition of IPTG on ICL activity relative to A4 2 0  for the various 
cultures.
Figure 4.7 shows a band which co-migrates with purified ICL and increases in 
intensity with time after addition of IPTG for E. coli KAT-l/pAR654 and E. coli KAT-1/ 
pAR655, but not E. coli KAT-l/pGLWll.This suggests that the bands are the result of 
expression of ICLSerl95 and ICLAlal95 respectively. Similarly, a band which co-migrated 
with ICL and increased in intensity with time was observed with E. coli KAT-l/pAR9023 (see 
section 3.2.2 and figure 3.5).
Figure 4.8 shows a graph of ICL activity versus A4 2 0 . E. coli KAT-l/pGLWl 1 
shows little or no ICL activity which remains constant over the time course, while E. coli
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Figure 4.6: Strategy For Constructing Expression Cassettes For Mutant aceA Genes
The mutated inserts of pAR24 are represented by the shaded boxes with the 
arrows indicating the direction of transcription.
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Figure 4.7: Expression Of ICLSerl95 And ICLAlal95 From E. coli KAT-1/ pAR654 And 
KAT-l/pAR655 Respectively
IPTG and glucose were added to cultures to final concentrations of ImM and 0.1% 
(w/v) respectively when the A420 was approximately 0.5. 1ml sampes were taken at the time 
intervals indicated and harvested in a microfuge. The cell pellets were resuspended in 200}il 
SDS sample buffer and boiled for 5min in the presence of 2-mercaptoethanol and loaded onto a 
10% SDS-polyacrylimide gel.
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Figure 4.8: Expression Of Mutant ICL Enzymes
100ml cultures of E. coli KAT- 1/pGLW 11, KAT-l/pAR654 and KAT-l/pAR655 
were grown in the presence of Amp (section 2.3.4) until the A420 was approximately 0.5. 
IPTG was then added to a final concentration of ImM and 1ml samples were taken at 
Omin., 30min., 60min., 90min. and 120min.. The A420 was measured and the samples 
sonicated (section 2.3.8) and assayed for ICL activity (section 2.12b).
• )  £. coli KAT- 1/pGLW 11 
o ) E. coli KAT- l/pAR9023 
*)E.  coli KAT-l/pAR654 
* )£ . coli KAT- 1/pAR655
U/ml
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KAT-l/pAR9023 shows an increase in ICL activity with A4 2 0  suggesting that this activity is 
due to expression from the insert of pAR9023. Although E. coli KAT-l/pAR654 and E. coli 
KAT-l/pAR655 express a protein which co-migrates with wild type ICL, there is very little 
ICL activity. The ICL activity, although very low, does increase with A^o* It therefore 
appears that the mutations Cysl95 to Ser and Ala, have resulted in a dramatic decrease in ICL 
activity in the mutant enzymes.
4.4 Purification Of Mutant Enzvmes. ICLSerl95 And ICLAlal95:
4.4.1 Introduction:
In order to characterise ICLSerl95 and ICLAlal95 in terms of catalytic mechanism and 
thus determine the role of Cysl95 in either catalysis, substrate binding or both, the proteins 
must first be purified. The kinetic properties of ICLSerl95 and ICLAlal95 can then be 
determined and compared to those of the wild type enzyme.
Since ICLSerl95 and ICLAlal95 have very little activity associated with them (figures 
4.7 and 4.8), it would be very difficult to monitor their purification by enzymic assays. It was 
therefore decided to establish a method of purification for the wild type ICL and to use this 
procedure to purify the two mutant enzymes and to monitor their purification on SDS gels. 
Since the mutant enzymes constitute a large proportion of the total cell protein (figure 4.7), it
was thought that monitoring the purification of ICLSerl95 and ICLAlal95 by the presence of
/
an intense band which co-migrates with wild type ICL should be easier than by assaying 
enzyme activity where the activity might be too little to determine.
4.4.2 Purification Of w.t. ICL From E. coli KAT-l/nAR9023:
Initially, the purification procedure developed in this laboratory was employed to purify 
ICL from E. coli KAT-l/pAR9023 after induction with IPTG (Section 2.11.1) (MacKintosh, 
1987; MacKintosh and Nimmo, 1988). This procedure involved treatment of the crude extract 
with protamine sulphate, (NtL^SC^ fractionation, acid treatment, gel filtration through 
Sephacryl S-300, ion exchange on Phenyl Sepharose and finally Mono Q using FPLC. Many
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of the above steps did not give a significant increase in purity, probably due to the fact that a 
significant proportion of the total cellular protein was ICL (figure 4.7). Indeed, much of the 
ICL activity had to be discarded at the gel filtration and ion exchange on Phenyl Sepharose, in 
order to avoid contaminating proteins. For these reasons, it was decided to use a modification 
of the method used by Conder et al. (1988) to purify ICL from an overexpressing strain of E. 
coli K12. This procedure is described in section 2.11.2. Because of the large amount of 
protein after the (NfL^SC^ fractionation, several runs on the Mono Q column had to be done. 
Careful pooling of fractions after ion exchange chromatography on Mono Q using the FPLC 
was essential to avoid contaminants with Mr 80,000 and 41,000, both of which are eluted from 
the column after ICL and correspond to shoulders on the elution profile (figure 4.9). This 
purification procedure produced a high yield and specific activity (table 4.3) and could be 
carried out in less than 24 hours. When dialysed into the 50mM Mops-NaOH pH7.3, ImM 
EDTA, ImM benzamidine, ImM DTT, 1.2mM PMSF, 40% (v/v) glycerol, the enzyme was 
stable for at least 6  months when stored at -20°C.
4,4.3 Purification Of IC L Serl95 and IC LA lal95:
The purification procedure above was used to purify both mutant proteins, ICLSerl95 
and ICLAlal95. In both cases, new Mono Q columns were used in order to rule out completely 
the possibility of cross contamination. Typical elution profiles of ICLSerl95 and ICLAlal95 
from the Mono Q chromatography are shown in figures 4.10 and 4.11 respectively. Again, 
careful pooling of samples was essential to avoid the contaminants, however, this was greatly 
facilitated by the high resolution of the new columns.
Figure 4.12 shows an SDS gel of samples after each stage of the purification of 
ICLSerl95, ICLAlal95 and wild type ICL. This gel reveals the presence of 3 contaminating 
bands with Mr 24,000,16,000 and 11,500, although the intensity of these bands with respect 
to ICL is very low. These bands co-purify with ICL and could not be separated from ICL by 
gel filtration through Sephacryl S-300 superfine,or by chromatography on Phenyl Sepharose 
or Mono Q. The contaminating bands co-eluted with ICL. Non-denaturing gel electrophoresis 
revealed only one band in all three enzymes (figure 4.13). This suggests that there could be a 
sub-population of ICL where one or two peptide bonds in one or more subunits have been
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Figure 4.9: Elution Profile Of Wild Type ICL From Mono Q
Chromotography of ICL was carried out as described in section 2.11.2e.
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Figure 4.10: Elution Profile Of ICLSerl95 From Mono Q
Chromotography of ICLSerl95 was carried out as described in section 2.11.2e.
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Figure 4.11; Elution Profile Of ICLAlal95 From Mono Q
Chromotography of ICLAlal95 was carried out as described in section 2.11 .2e.
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Figure 4.12: Purification Gel Of ICL, ICLSerl95 and IC LA lal95
10% polyacrylamide gel run in the presence of SDS monitors the purification of ICL, 
ICLSerl95 and ICLA lal95 (section 2.11.2).
Lane A) wt ICL, Crude extract; B) wt ICL, Ammonium sulphate 0-30% supernatant;
C) wt ICL, Ammonium sulphate 30-45% pellet; D) wt ICL, Mono Q pool; E) Mr standard 
proteins; F) ICLSerl95, Crude extract; G) ICLSerl95, Ammonium sulphate 0-30% 
supernatant; H) ICLSerl95, Ammonium sulphate 30-45% pellet; I) ICLSerl95, Mono Q pool; 
J) Mr standard proteins; K) ICLAlal95, Crude extract; L) ICLAlal95, Ammonium sulphate 0- 
30% supernatant; M) ICLAlal95, Ammonium sulphate 30-45% pellet; N) ICLAlal95, Mono Q 
pool; O) Mr standard proteins.
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Figure 4,13: Non-Denaturing Polyacrylamide Gel Electrophoresis Of ICL, ICLSerl95 and 
ICLAlal95
Purified ICL, ICLSerl95 and ICLAlal95 run on 1% polyacrylamide tube gels (section 
2 . 10.2).
Lane 1) ICL; 2) ICLSerl95; 3) ICLAlal95; 4) ICL purifued from E. coli KAT-l/pEM 9
cleaved without the resulting peptides dissociating from the enzyme.
The purification results are shown in Table 4.3. The specific activities of the purified 
enzymes, ICLSerl95 and ICLAlal95 were much lower than that of the wild type ICL, only 
1.3% and 2.4%.of the wild type enzyme respectively. This suggested that Cysl95, although 
not essential, does indeed play an important role in the activity of ICL from E. coli ML308. 
This did not however indicate whether Cysl95 is involved in catalysis, substrate binding or 
both. Further characterization of ICLSerl95 and ICLAlal95 was required in order to define the 
role of Cysl95.
4.5 Characterisation Of ICLSerl95 And ICLAlal95;
4.5.1 Conformation Of IC L Serl95. ICLA lal95 And Wild Tvoe ICL:
It is possible that replacing Cysl95 with either Ala or Ser may reduce ICL activity by 
altering the conformation of the enzyme significantly. It was therefore decided to investigate the 
conformations of each of the mutant ICL enzymes and compare them to that of the wild type 
enzyme. The fact that ICLSer 195, ICLAlal95 and the wild type ICL were purified using the 
same procedure suggested that the conformation and physical properties of all three ICL 
enzymes might be very similar. However, a more detailed study of the conformation of these 
enzymes was required.
Using the secondary structure prediction programs of the UWGCG package, 
PEPTIDESTRUCTURE and PLOTSTRUCTURE, the secondary structures of ICLSerl95 and 
ICLAlal95 were predicted and compared to that of the wild type enzyme. There were no 
differences between either ICLSerl95 and ICLAlal95 or between the mutant enzymes and the 
wild type ICL using both the Gamier and Chou-Fasman methods of prediction (results not 
shown).
Examination of the secondary structures of ICLSerl95, ICLAlal95 and the wild type 
using circular dichroism (C.D.) was carried out in collaboration with Dr. N.C. Price at the 
University of Stirling. While C.D. spectra in the far U.V. range (190-250nm) reflect 
transitions of peptide bonds and therefore the secondaiy structure, C.D. spectra in the near
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U.V. range (250-330nm) reflect transitions of the amino acid side chains, since there is no 
overlap with peptide bond transitions above 240-250nm. C.D. spectra in the near U.V. range 
therefore reflect the environment and conformation of amino acid side chains, hence both the 
secondary and tertiary structures contribute to the C.D. spectra in this range.
All C.D. analysis was carried out in lOmM Mops pH7.3, at a protein concentration of 
0.3mg.ml_1 with a slit width of 0.02cm for the far U.V. spectra and 0.5cm for the near U.V. 
spectra (Section 2.15). The results were plotted as ellipticity, 0 (deg.cm2 .d.mol*1) against 
wavelength (nm). Figure 4.14 shows the C.D. spectra of ICLSerl95, ICLAlal95 and wild 
type ICL in the far U.V. range (190-250nm), while figure 4.15 shows the C.D. spectra of all 
three ICL enzymes in the near U.V. range (260-320nm). For both the near and far U.V. 
ranges, there is veiy little difference in the C.D. spectra of the different enzymes, indicating 
that both the secondary and tertiary structures of all three ICL enzymes are very similar.
Using the CONTIN procedure for determining the amount of each type of secondary 
structure from the C.D. spectra, the wild type ICL was shown to have 32 ± 2.6% a-helix, 37 
± 2.7% (3-sheet and 31 ± 4.6% the remainder. These values compare with 32.7% a-helix 
using the Gamier method of secondary structure prediction and 29.5% a-helix by the Chou- 
Fasman method. However, the amount of (3-sheet obtained by either method of secondary 
structure prediction is much different from the experimentally determined value, being 19.1% 
by the Gamier method and 48.4% by the Chou-Fasman method.
In addition to the C.D. spectra, ICLSerl95, ICLAlal95 and wild type ICL were 
analysed by fluorimetry at 20°C. (Section 2.14). This technique principally reflects the 
environment of tryptophan, tyrosine and phenylalanine residues (mainly Trp because of energy 
transfer). The emission spectra in the wavelength range 300-400nm after excitation at 290nm 
are shown in figure 4.16. As with the C.D. spectra, the fluorescence spectra of ICLSerl95, 
ICLAlal95 and the wild type enzyme are veiy similar, indicating that the tertiary structures of 
all three ICL enzymes are very similar.
The evidence presented above indicates that replacing Cysl95 with either Ala or Ser 
does not alter the overall conformation of ICL. In addition, the fact that both ICLSerl95 and 
ICLAlal95 comigrate with the wild type enzyme on non-denaturing gel electrophoresis
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Figure 4.14: Circular Dichriosm Of w.t. ICL, ICLSerl95 And ICLAlal95, Far U.V. 
Spectrum.
Results are plotted as elipticity (units per mean molar ellipticity) against wavelength. 
Data obtained as described in section 2.15.
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Figure 4.15: Circular Dichriosm Of w.t. ICL, ICLSerl95 And ICLAlal95, Near U.V. 
Spectrum.
Results are plotted as for figure 4.14.
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Figure 4.16: Fluorimetric Analysis Of w.t. ICL, ICLSerl95 and ICLAlal95
Results are plotted as intrinsic fluoresence against wavelength (nm). Data obtained 
as described in section 2.14.
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indicates that replacing Cysl95 with either Ser or Ala does not interfere with subunit-subunit 
interactions. This conclusion was supported a preliminary attempt to purify ICLSerl95, in 
which it was found that this enzyme was eluted from a Sephacryl S-300 gel filtration column at 
the same position as wild type ICL.
4.5.2 Sensitivity To Inhibition By Iodoacetate ;
Since pAR24-654 and pAR24-655 were maintained in the host strain TG-1, which 
contains the wild type aceA gene and pAR654 and pAR655 were maintained in the host, 
KAT-1, which is not an aceA deletion mutant but a TnlO :: aceA insertion and therefore also 
contains the complete aceA gene, the possibility of homologous recombination exists between 
the wild type chromosomal aceA gene and the mutant aceA genes on the plasmids in either 
pAR654, pAR655, pAR24-654 and pAR24-655. If this were the case, then any ICL activity in 
the mutant ICLs might be due to the presence of a sub-population of plasmids with the wild 
type aceA gene and not due to the mutated gene.
In order to rule out the possibility that the activity of the mutant ICL enzymes arose 
from a sub-population of wild type enzyme contaminating the purified ICLSerl95 and 
ICLAlal95 mutants, the sulphydryl modifying reagent, iodoacetate, was used to inactivate 
ICLSerl95, ICLAlal95 and the wild type ICL. Iodoacetate reacts with free sulphydryl groups 
and was used to identify the active site Cys residue (Nimmo et al., 1989). If as predicted, 
Cysl95 has been replaced with Ala and Ser in ICLAlal95 and ICLSerl95 respectively, then 
the rate of inactivation of these enzymes by iodoacetate should be different to that of the wild 
type enzyme. Indeed the mutants might be almost completely resistant to iodoacetate since in 
the wild type ICL only Cys 195 was modified by iodoacetate (Nimmo et al., 1989).
Figure 4.17 shows the effect of iodoacetate on ICLSerl95, ICLAlal95 and wild type 
ICL. After 40min, the activity of the wild type ICL is only 4.4% of the activity before addition 
of iodoacetate, while 54.8% and 64.8% of the initial activity remains after incubation of 
ICLAlal95 and ICLSerl95 with iodoacetate for the same time. The half-life of ICLSerl95 and 
ICLAlal95 is therefore very much longer than that of the wild type enzyme, which is 8 min, 
and so the activities of ICLSerl95 and ICLAlal95 are not due to a sub-population of the wild
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Figure 4.17: Inhibition Of w.t. ICL, ICLSerl95 and ICLAlal95 With Iodoacetate
The enzyme (lmg. ml'1) was incubated with iodoacetate (2.0mM) as described i 
section 2.13:
• )  wt ICL
A)ICLAlal95 
a) ICLSerl95
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type ICL present in the purified mutant enzymes either by homologous recombination or 
contamination during purification of the enzymes. Although the half life of the mutant ICL 
enzymes is longer than the wild type ICL, there is a decrease in the activity of the mutant 
enzymes over the time of incubation with iodoacetate. This would suggest that iodoacetate 
reacts slowly with another sulphydryl group or groups on the enzyme.
In order to establish whether or not the reactive group on the enzyme is at or near the 
active site, ICLSerl95, ICLAlal95 and wild type ICL were incubated with 2mM iodoacetate in 
the presence of 5mM Mg2+, 5mM isocitrate and 5mM Mg2+ plus 5mM isocitrate. In the latter 
case the reaction will reach equilibrium and so glyoxylate and succinate will also be present. 
Isocitrate protected against iodoacetate inactivation for the wild type enzyme, increasing the half 
life from 5min to 1 lmin (figure 4.18), while Mg2+ increased the half life to 12min (figure
4.19). With 5mM Mg2+ plus 5mM isocitrate, the half life was greater than 60 min (figure
4.20). With the mutant enzymes, neither Mg2+ (figure 4.19), nor isocitrate (figure 4.18) nor 
Mg2+ plus isocitrate (figure 4.20), had a significant effect on the sensitivity of either enzyme to 
iodoacetate. Therefore, the group on the mutant enzymes which reacts with iodoacetate is 
probably not at or near the active site, since the substrates do not protect against inactivation by 
this reagent.
4.5.3 Kinetic Properties Of ICLSerl95. ICLAlal95 And Wild Type ICL;
It has already been established that the reduction in the specific activity caused by 
replacing Cys 195 of ICL with Ser or Ala does not result from a large change in the 
conformation of the enzyme (section 4.5.1). Therefore, the reduced specific activity of 
ICLSerl95 and ICLAlal95 compared with that of the wild type enzyme must be due to 
differences in either substrate binding, catalysis, or both. In order to discriminate between the 
above possibilities, the Km and kcat of ICLSerl95 and ICLAlal95 were compared to those of 
wild type ICL (table 4.4).
As shown in table 4.4., the values of ICLSerl95 and ICLAlal95 are approximately 
100-fold and 30-fold lower than that of the wild type enzyme respectively. This implies that 
Cys 195 must play some role in the catalytic mechanism, although this residue is obviously not
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E.igure 4,IS; Isocitrate Protection Of w.t. ICL, ICLSerl95 And ICLAlal95 Against 
Inactivation By Iodoacetate
Enzyme (lmg. ml-1) was incubated with iodoacetate (2.0mM) in the presence and 
absence of isocitrate as described in section 2.13:
A)
o) wt ICL.
• )  wt ICL, preincubated with 5mM isocitrate.
A)ICLSerl95.
a ) ICLSerl95, preincubated with 5mM isocitrate.
B)
° ) wt ICL.
• )  wt ICL, preincubated with 5mM isocitrate.
Q)ICLAlal95.
■) ICLAlal95, preincubated with 5mM isocitrate.
A
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Figure 4.19: Mg2+ Protection Of w.t. ICL, ICLSerl95 And ICLAlal95 Against 
Inactivation By Iodoacetate
Enzyme (lmg. ml-1) was incubated with iodoacetate (2.0mM) in the presence and 
absence of isocitrate as described in section 2.13:
A)
° ) wt ICL.
• )  wt ICL, preincubated with 5mM MgC^.
A)ICLSerl95.
a ) ICLSerl95, preincubated with 5mM MgCl^
B)
o) wt ICL.
• )  wt ICL, preincubated with 5mM MgCl2 .
□ )ICLAlal95.
■) ICL Ala 195, preincubated with 5mM MgC^.
A
100 1
% A ct  
Rem.
10 H
7020 30 4010 60500
Time (min)
B
100 -i
A ct
Rem
10 H
30 4 0 701 0 20 600 50
Time (min)
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Figure 4.20: Mg2+-Isocitrate Protection Of w.t. ICL, ICLSerl95 And ICLAlal95 
Against Inactivation By Iodoacetate
Enzyme (lmg. ml-1 ) was incubated with iodoacetate (2.0mM) in the presence and 
absence of isocitrate as described in section 2.13:
A)
° ) wt ICL.
• )  wt ICL, preincubated with 5mM MgCh plus 5mM isocitrate.
A)ICLSerl95.
A) ICLSerl95, preincubated with 5mM MgCh plus 5mM isocitrate.
B)
o) wt ICL.
• )  wt ICL, preincubated with 5mM MgCb plus 5mM isocitrate.
□ )ICLAlal95.
■) ICLAlal95, preincubated with 5mM MgCl2 plus 5mM isocitrate.
A
100
Act
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7 06040 503020100
Time (min)
B
100
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R em .
10 1
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Time (min)
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Table 4.4: Kinetic Properties Of ICLSerl95, ICLAIal95 And Wild Type ICL
Km
OiM)
^cat
(sec*1)
kcat/Km
(sec4 .M '1.)
w.t. ICL 76±6 28.5±2.1 3.75xl05
(n=4) (n=4)
ICL Serl95 272±24 0.296±0.025 1.089xl03
(n=3) (n=3)
ICL Alal95 641±37 0.937+0.072 1.462xl03
(n=3) (n=3)
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essential since there is still some activity associated with the mutant enzymes.
ICLSerl95 and ICLAlal95 also have higher Kms for the substrate, isocitrate, when 
compared to the Km o f the wild type enzyme, by factors o f 3.6-fold and 8.4-fold respectively. 
Assuming that the mutants obey an equilibrium mechanism, as does the wild type (MacKintosh 
and Nimmo, 1988), it can be concluded that the side chain o f Cys 195, CH2 -S-H, affects the 
binding of isocitrate. As expected, replacing the CH2 -S-H o f Cys with the CH2 -O-H group of 
Ser did not reduce the affinity of the enzyme as much as elimination of the CH2 -X-H group by 
replacing it with -CH3  o f Ala. The fact that the values for the Kms o f both mutant ICLs are 
different from the wild type enzyme supports the work with iodoacetate which indicated that 
the activity o f the mutant enzymes was not due to the presence o f a sub-population o f wild type 
ICL. Thus it appears that the side-chain of Cys 195 is important for both substrate binding and 
catalysis, although this residue is not essential since both mutants, ICLSerl95 and ICLAlal95, 
have activity. Interestingly, ICLAlal95 has a higher kcat than ICLSerl95. This was not 
expected since it was thought that the S-H  group of Cys 195 played some part in the reaction 
mechanism. One possibility is that a water molecule is occupying the space created by replacing 
Cys 195 with Ala so providing an O-H group which is likely to be more reactive than that of 
-C H 2 -O -H  in ICLSerl95 (section 4.6).
4.5.4 Effect Of p H  On ICLSerl95. ICLAlal95 And Wild Type ICL;
There has been very little work done on the effect o f pH on catalysis or substrate 
binding for ICL from E. coli. The most comprehensive studies have been done on ICL from 
P. indigofera and N. crassa (Rogers and McFadden, 1976; 1977). These workers found that 
catalysis was dependent on two groups with pKas o f 6.1 and 8 . 6  in the A. crassa enzyme and 
6.9 and 8 . 6  in the P. indigofera enzyme. Also the Km was dependent on a single ionizing 
group on the enzyme-substrate complex with pKa of 8.5 in the N. crassa enzyme, and in the 
P. indigofera enzyme a single group on the free enzyme or free substrate with pKa of 5.8. It 
seems likely, however, that the pKa is that of a group on the free enzyme since the pKas of the 
substrate are 3.29,4.71 and 6.40 (Dawson et al., 1986). The authors suggested that since 
ICL from both these organisms is susceptible to sulphydryl reagents and that catalysis o f both
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enzymes is dependent on a group with pKa of 8 .6 , this group could be the active site cysteine 
since the pKa is within the range for the S-H of cysteine residues (8.3-8.6), although the 
environment of the Cys in the enzyme could alter its pKa quite substantially.
For the E. coli enzyme, there is not such a detailed study of the effect of pH on Km for 
isocitrate or kcat, although it has been shown that the Km for isocitrate decreases with pH over 
the pH range 6.0-8.5 (MacKintosh and Nimmo, 1988; Nimmo et al., 1989). Inactivation of 
ICL from E. coli ML308 by iodoacetate was shown to be dependent on a single ionizing 
group with pKa of 7.1 (Nimmo et al., 1989). A similar result was obtained for the reaction of 
ICL with 3-BrP, which was affected by a single group with a pKa of 7.4 (Ko and McFadden, 
1990). It seems likely that this group is not Cysl95, but another group in the active site whose 
protonation affects the accessibility of Cys 195 to iodoacetate, 3-BrP and isocitrate (section 
1.3.10).
Therefore it was decided to study the effects of pH on Km and kcat for wild type ICL 
and compare them to the effects on ICLSerl95 and ICLAlal95. Above pH8.5 for wild type 
ICL and ICLAlal95, and above pH9.0 for ICLSerl95, the kinetics of substrate binding 
became sigmoidal preventing meaning comparisons of Km and kcat values.
The Km of the wild type ICL for isocitrate declines with pH over the range 6 . 8  to 8.5. 
A plot of log Km against pH is shown in figure 4.21. If the best fit straight line is drawn, this 
line has a gradient of approximately 0.5, indicating that the Km of wild type ICL for isocitrate 
is dependent on more than one ionizing group on the enzyme-substrate complex (Dixon, 1953; 
Fersht, 1977). Similarly, the plot of log VKm against pH (figure 4.22) also indicates that the 
Km is dependent on more than one ionizing group on either the free enzyme or free substrate. 
Thus the ionizing groups affecting Km are likely to be the same in the enzyme-substrate 
complex as those in the free enzyme or the free substrate (Fersht, 1977). A plot of log kcat vs 
pH (figure 4.23) shows that there is very little change in this pH range, while the plot of log 
^ at/Km vs pH (figure 4.24) shows a curve with a straight line portion, gradient -0.5 and 
flattening towards the top. These data are difficult to interpret in terms of simple models. It is 
unfortunate that reliable data for k<.at and Km values at pH9.0 and above could not be obtained.
For ICLSerl95 and ICLAlal95, a plot log Km vs pH (figure 4.21) give straight lines 
with slopes of approximately 1, which tend to flatten at the top. This indicates that Km is
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Figure 4.21: Effect Of pH On log Km Of w.t. ICL, ICLSerl95 And ICLAlal95
The Km was measured at each point by assaying by the method described in section 
2.12a with 50mM Mops-NaOH, 5mM MgCl2 , ImM EDTA (pH6.8-7.8) or 50mM Taps- 
NaOH, 5mM MgCl2 , ImM EDTA (pH7.8-9.0) equilibrated to various pH units.
• )  wt ICL
A)ICLAlal95
*)ICLSerl95
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Figure 4.22: Effect Of pH On log Of w.t. ICL, ICLSerl95 And ICLAlal95 
Assays were carried out as described for figure 4.21.
• )  wtlCL 
A)iCLAlal95 
a) ICLSerl95
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Figure 4.23: Effect Of pH On log Of w .t ICL, ICLSerl95 And ICLAlal95 
Assays were carried out as described for figure 4.21.
• )  wtlCL 
A)ICLAlal95
0 ICLSerl95
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Figure 4.24: Effect Of pH On log ^ / K Of w.t. ICL, ICLSerl95 And ICLAlal95 
Assays were carried out as described for figure 4.21.
• )  wt ICL 
A) ICLAlal95 
A) ICLSerl95
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dependent on a single dissociating group on the enzyme-substrate complex. Similarly, a plot of 
log kcat vs pH for ICLSerl95 gives a curve with a straight line portion which has gradient -1 
and flattens towards the top (figure 4.23). This indicates that kcat is dependent on a single 
dissociating group with a pKa of 7.8 on the enzyme-substrate complex. Unfortunately, the pKa 
of the group(s) affecting kcat of ICLAlal95 could not be determined since no data were 
obtained above pH8.5. However, since the curve for ICLAlal95 is very similar to that of 
ICLSerl95, it seems probable that the same group with pKa 7.8 also affects kcat of 
ICLAlal95. Thus the pKa of the group affecting kcat and Km is the same, 7.8. Similarly, plots 
of log 1/Km vs pH for both ICLSerl95 and ICLAlal95 give straight lines with slopes of 1 and 
tend to flatten towards the bottom (figure 4.22), indicating that the Km of both mutant enzymes 
is dependent on a single dissociating group on the free enzyme or free substrate with pKa 7.8. 
A plot of log k^/Kjn vs pH for both ICLSerl95 and ICLAlal95 (figure 4.24) shows a straight 
line with a slopes of approximately -1, indicating that a single group with a pKa outwith the pH 
range studied affects the catalytic efficiency.
Since the pKa obtained for both ICLSerl95 and ICLAlal95 affecting Km is 7.8, it 
seems probable that the dissociating group is the same for both enzymes. Also, since the 
mutant enzymes have one dissociating group less than wild type ICL which affects Km, it 
seems likely that one dissociating group on the wild type enzyme has a pKa of 7.8
The main feature that emerges from this work is that the response of the mutant ICLs to 
pH is appreciably simpler than that of the wild type enzyme. Thus, it is clear that replacing 
Cys 195 with either Ser or Ala, results in the loss of one dissociating group from the active site 
and allows the determination of the pKa of another dissociating group on which Km and 
^cat/Km is dependent. The data suggest that the pKa of the Cys 195 -S -H  group is within the 
pH range studied, 6.8-8.5. It is therefore concievable that the pKa of 7.1 determined for the 
reaction between iodoacetate and Cys 195 of ICL from E. coli ML308 (Nimmo et al., 1989) 
and 7.4 determined for the reaction of the same residue with 3-BrP from E. coli K12 (Ko and 
McFadden, 1990) is the pKa of this residue and not that of another residue whose protonation 
affects the accessibility of these reagents and the substrates to the active site.
Since the pKa of the group on the enzyme-substrate complex is the same as that of the
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group on the free enzyme or free substrate in both mutant enzymes, it seems likely that this 
group is the same. The pKa of the ionizing groups on the substrate, isocitrate, are 3.29,4.71 
and 6.40 (Dawson et al., 1986). Therefore, the group with pKa 7.8 is likely to be on the free 
enzyme and not the free substrate.
4.6 Discussion:
Site directed mutagenesis can be used to define the role, if any, of proposed active site 
Cys residues and has in some cases indicated whether the residue is essential for substrate 
binding or the reaction mechanism. For 3-hydroxy-3-methylglutaryl-CoA reductase from 
Pseudomonas mevalonii (Jordan-Starck and Rodwell, 1989) either Cysl56, Cys296 or both 
were thought to be in the active site based on evidence from chemical modification studies and 
substrate protection, as were Cys41 of the Pertussis toxin SI subunit (Locht et al., 1990), a 
cysteine residue in human cyclophilin (Liu et a l , 1990), the N-terminal cysteine residue of 
human asparagine synthetase (Van Heeke and Schuster, 1989) and cysteine residues in 
receptor-linked protein tyrosine phosphatases (PTPases) in humans and Drosophila (Streuli et 
a l, 1989). Site directed mutagenesis has shown that although these residues are at or very 
near to the active sites of these enzymes, only for the PTPases and asparagine synthetase were 
the Cys residues essential in that replacement of the Cys residue completely abolished activity 
(Van Heeke and Schuster, 1989; Streuli et al., 1989). For the asparagine synthetase, site 
directed mutagenesis also showed that the N-terminal Cys was essential only for the glutamine 
dependent and not the ammonia dependent activity.
Although Cys 195 is at or near the active site of ICL from E. coli ML308, and is 
conserved between all the ICLs sequenced so far, it was not known whether or not this residue 
was involved in catalysis. It was therefore decided to use site directed mutagenesis to replace 
Cys 195 with othe amino acids, Ala and Ser, in an attempt to discover what role, if any,
Cys 195 played in the reaction mechanism of ICL from E. coli ML308.
It is clear from the evidence in this chapter that Cys 195 does indeed play some role in 
the enzyme's activity, since replacing this residue with either Ser or Ala results in a decrease in 
1^^ and an increase in Km. Both mutants probably have similar conformations to that of the 
wild type enzyme based on evidence from circular dichrioism and fluorimetiy. Therefore, the
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changes in kinetic properties are directly due to replacement o f CH2 -S -H  of Cys 195 with 
CH2 -O -H  and CH3  in ICLSerl95 and ICLAlal95 respectively. Interestingly the results of the 
site directed mutagenesis were not those predicted. It was thought that if  Cys 195 was an active 
site residue, then replacing this residue with a Ser would result in an enzyme which had 
reduced activity and that replacement with Ala would result in an enzyme which had little or no 
activity since there would be no ionization of this group and no potential nucleophile. Contrary 
to this prediction was the finding that although ICLSerl95 had a lower Km than ICLAlal95, 
ICLAlal95 had a higher kcat than ICLSerl95. This can be explained by a water molecule 
occupying the space createdby replacing CH2 -S -H  by CH3 . The O -H  group o f the water 
molecule may interact with the substrate in a less deleterious way than that of Seri 95.
One possible analogy is with chloramphenicol acyltransferase (Lewendon et al.,
1990). It was thought that Serl48 of chloramphenicol acyltransferase was involved in 
transition state stabilisation via a hydrogen bond to the oxyanion of the putative tetrahedral 
intermediate. Substitution of Seri48 with Ala resulted in an enzyme with kcat reduced 53-fold 
and only minor changes in Km, while substitution with Gly at position 148 resulted in an 
enzyme with only a 10-fold reduction in kcat. The authors proposed that a water molecule may 
have partially replaced the hydrogen bonding potential of Seri48. The three dimensional 
structure o f the Alal48 enzyme was isosteric with the wild type enzyme and although the three 
dimensional structure o f the Gly 148 enzyme was not determined, it seems likely that the 
structure o f this enzyme is not much different from that of the wild type enzyme.
The pH studies of the wild type ICL and both mutants throw little light on the 
mechanism of catalysis by ICL because kcat values were fairly constant over the pH range 
studied. However, it can be suggested that the pKa of the S-H  group o f Cys 195 is 7.1 in the 
E. coli ML308 enzyme. This value is approximately one pH unit lower than that expected for 
this residue. A likely explanation is that there is a basic group near to the S-H  and thus causes 
a reduction in the pKa o f Cys 195. The identity o f the basic group interacting with Cys 195 is 
not known although there are several possibilities. Chemical modification using DEPC has 
indicated a His residue at the active site of ICL from several organisms (section 1.4.11). From 
E. coli, it has been shown that neither His266 nor His306, which react with DEPC, are at the 
active site, although the results do not rule out the possibility that another His residue is at or
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near the active site. Indeed there is a His residue at position 197, only two residues from 
Cys 195. In the Cys proteases, e.g. papain, the pKa of the S-H group of the active site Cys is 
lowered by a His residue in close proximity to the reactive Cys (reviewed in Fersht, 1977). 
Also, chemical modification of ICL from Citrullis vulgaris using itaconate epoxide identified a 
carboxyl group of either Asp or Glu at the active site (Jameel et al., 1985). Although the 
authors suggest a role for the carboxyl group in coordinating the Mg2+ it is possible that this 
group acts in the same manner as the His in papain.
This has interesting consequences for the mechanism of ICL. It is clear in the 
condensation reaction that the enzyme deprotonates succinate, creating a succinate carbanion or 
its conjugate base which can then attack the keto group of glyoxylate. The enzyme then acts as 
a proton donor during the condensation reaction (section 1.4.12). Assuming that the S-H of 
Cys 195 is the basic group which deprotonates succinate, this would explain the fact that 
ICLSerl95 has a much lower kcat than the wild type enzyme, since the pKa of the O-H of Ser 
is much higher than that of the S-H of Cys. The data for ICLAlal95 are consistent with this 
proposal, assuming that the presence of a water molecule in the active site is responsible for the 
activity of this enzyme. Thus the mechanism I propose, based on the differences in k ^  
between the wild type ICL and ICLSerl95 and ICLAlal95 and the probable pKa of 7.1 for 
Cysl95 is that the S atom of Cysl95 is made more nucleophilic by the formation of a hydrogen 
bond between the proton on the sulphydryl group and an adjacent base. The S atom then 
extracts a proton from the C2 of succinate, creating a succinate carbanion, which then attacks 
the keto carbon of glyoxylate, concomitant with protonation of the glyoxylate moiety to form 
isocitrate. This mechanism is outlined in figure 4.25.
There is a second possible mechanism in which the sulphydryl group is involved in 
deprotonating the substrate. In this mechanism, Cysl95 and the adjacent base act in the manner 
indicated above but instead of deprotonating succinate in the condensation reaction, the S atom 
deprotonates the hydroxyl group of isocitrate in the cleavage reaction. This results in a 
carbanion at C3 which can then deprotonate the enzyme to give glyoxylate and succinate (figure 
4.25).
Because of the pKas of the groups affecting the Km of ICL for isocitrate are so close,
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Figure 4.25: Postulated Roles Of Cysl95 In The Catalytic Mechanism Of ICL
Two mechanisms are postulated for the role of Cys 195 in catalysis. A) the S atom 
of Cys 195 attacks the hydroxyl proton in the cleavage reaction, B) the S atom attacks a 
proton from the C2 carbon of succinate in the condensation reaction. Solid lines represent 
covalent bonds, while dashed lines represent hydrogen bonds. Both mechanisms are 
disscussed in section 4.6, and HisX may be replaced by a carboxyl group of either a Glu or 
an Asp.
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7.8 and 7.1, their values were not previously determined. Replacement of Cysl95, one of the 
two dissociating groups, with either Ala or Ser allowed determination of the pKa of the second 
dissociating group, 7.8. Both the identity and role of this residue are unknown. It seems 
unlikely that this group is the same as that which forms a hydrogen bond with the S-H group 
of Cysl95, since it has the same pKa in ICLSerl95 as in ICLAlal95. Even if there is an extra 
water molecule in the active site of ICLAlal95, one might expect the ionisation of this water to 
influence the dissociation of this residue to a greater degree than the presence of a hydroxyl 
group at position 195 in ICLSerl95. There are several possibilities for the identity of the group 
with pKa 7.8. The pKa is within the range usually found for the imidazole of His in proteins 
(pKa 5-8) and for the 0 C-NH2  of an N-terminal amino acid. It therefore of note that in ICL from 
P. indigofera, L. usitatissimum, Ricinus communis, B. napus, C. tropicalis, G. hirsutum 
and E. coli, the N-terminal residue is Met (McFadden et aL, 1968; Khan and McFadden,
1982; Beeching and Northcote, 1987; Comai et al., 1989; Atomi et al., 1990; Turley et al., 
1990). The only exception found so far is that the N-terimnal residue in the thermophilic 
Bacillus is Thr (Chell et al., 1978).
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Chapter 5 
General Discussion
5.1 Introduction:
It is now well established that the control of flux at the branchpoint between the 
glyoxylate bypass and the TCA cycle is resolved at least in part by reversible phosphorylation 
and inactivation of ICDH. The phosphorylation and dephosphorylation of ICDH is catalysed 
by a bifunctional ICDH kinase/phosphatase (LaPorte and Koshland, 1982; Nimmo et al., 
1984; LaPorte and Chung, 1985). Holms and Bennett (1971) proposed that ICDH was 
inactivated in order to allow flux through the glyoxylate bypass. Work carried out by 
Koshland's group measuring fluxes through the system and by the Glasgow group studying 
the individual components of the system, both confirmed that the function of phosphorylation 
of ICDH was to render this enzyme rate limiting in the TCA cycle during growth on acetate, 
thus allowing the intracellular concentration of the common substrate of the competing 
pathways, isocitrate, to rise to a level which facilitates flux through ICL and the glyoxylate 
bypass.
The mechanism of inactivation of ICDH has now been determined, the enzyme has 
been crystallized and its three dimensional structure has been determined. The residue which is 
phosphorylated, Seri 13, lies at the entrance of the isocitrate binding pocket and 
phosphorylation of this residue prevents binding of the substrate by electrostatic repulsion 
(Thorsness and Koshland, 1987; Dean et al., 1989; Hurley et al., 1989; 1990a; b; Dean and 
Koshland, 1990).
The system responds to a number of effectors, making it very sensitive to the needs of 
the cell. An essential component of the system is the difference in the kinetic properties of the 
two enzymes which compete for the common substrate, isocitrate. The Km of ICDH for 
isocitrate is at least one order of magnitude lower than that of ICL for the same substrate. This 
results in flux through ICDH at concentrations of isocitrate present during growth on glucose 
or other preferred carbon sources. However, during growth on acetate or fatty acids as the sole 
carbon source, the Vmax of ICDH is decreased four-fold, causing the intracellular isocitrate 
concentration to rise to a level at which ICL can compete effectively for the common substrate, 
but still allowing flux through ICDH in order maintain a balance between synthesis of 
biosynthetic precursors and generation of energy and reducing power.
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Although a lot of work has been carried out on the function and role of ICDH 
phosphorylation, there has been comparatively little done on the competing enzyme, ICL. In 
order to understand more about this branchpoint, it was decided to investigate this enzyme 
further. In conjunction with D. Rice at the University of Sheffield, work was underway to 
determine the three dimensional structure of ICL. In order to facilitate this work, and to provide 
a clone with which to carry out site directed mutagenesis of ICL, the nucleotide sequence of the 
gene encoding ICL, ace A, had to be determined. This provided the start point of the work 
reported in this thesis.
5.2 Comparison Of ICL From Different Sources:
It has been shown that ICL from various organisms are similar in many ways. For 
example, all ICLs studied so far have a requirement for Mg2+ and most are tetramers of 
identical subunits. There appear to be two groups according to subunit Mr, with the bacterial 
enzymes having a subunit Mr of around 45,000 and the eukaryotic enzymes having a subunit 
Mr of around 65,000. The amino acid composition of ICL from a number of organisms have 
been determined and it is clear that they are very similar. The relative amino acid composition 
of these ICL enzymes has been used to determine the relatedness among the various enzymes 
by the method of Marchalonis and Weltman (1971). The results show that the enzymes are 
closely related, with SAQ values of less than 50 in all comparisons (section 1.3.1). In addition 
the amino acid compositions have been used to measure various physico-chemical properties, 
such as the hydrophobicity average (Bigelow, 1967), "non-polar side chains" according to 
Waugh (1954), the polar volume/non-polar volume ratio (Fisher, 1964), the polar/apolar 
residues ratio (Hatch, 1965) the acid/base ratio and the relative specific volume according to 
Cohn and Edsall (1943) (reviewed in Vanni et al., 1990).
At the outset of this project, there were no sequence data for ICL from any source. 
Therefore, one objective of the work was to determine the nucleotide sequence of the gene 
encoding ICL, aceA, from E. coli ML308. During the course of the work, the nucleotide 
sequence of aceA from E. coli K12 was determined. There were, however, two differences 
in the nucleotide sequence reported by different groups. It was therefore necessary to determine 
the nucleotide sequence of the aceA gene from E. coli ML308 before any site directed
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mutagenesis was carried out, since the sequence of the same gene from E. coli K12 produced 
differences. Comparison of the nucleotide sequence of the aceA gene from E. coli ML308 
with that of the two previously sequenced E. coli K12 sequences indicated that these 
differences may be due to sequencing errors and not to strain differences. The most important 
difference is at the C-terminus of ICL. McFadden's group found a His residue at the C- 
terminus from the derived amino acid sequence, while for the ML308 enzyme, the C-terminal 
residue was a Phe, in agreement with Cozzone's and LaPorte's groups. This difference is due 
to a difference in the nucleotide sequence at position 1255, with McFadden's group having an 
extra G resulting in a frame shift and early termination. McFadden's group also carried out 
carboxypeptidase A digestion of ICL and found the C-terminal residue to be His. In support of 
the sequence of the ML308 sequence, the region encoding the C-terminus was sequenced on 
both strands using several templates and both the Amersham sequencing system and Sequenase 
version 2.0. Also, a fourth aceA sequence was determined from E. coli, although the strain 
from which it was obtained was not given, which showed 100% identity with the ML308 
sequence. Attempts by our group to determine the C-terminal residue by carboxypeptidase 
digestion of ICL did not give a clear result. The reason for this is not clear although it is 
thought that the method of detection of amino acids is not suitable for this type of analysis. 
Another possible method for identifying the C-terminal residue was found as a result of the 
determination of the derived amino acid sequence of ICL. Digestion of the enzyme with 
endoproteinase Glu-C and endoproteinase Arg-C should resolve this controversy, assuming 
that the ML308 sequence is correct. If ICL is first digested to completion with endoproteinase 
Arg-C, this will result in 17 peptides, the largest of which is 134 amino acids long, the next 
longest being 71 amino acids long. The largest peptide, which contains the C-terminus, should 
then be easily purified by chromatography on HPLC. If this peptide is then digested to 
completion with endoproteinase Glu-C, there should be seven peptides of length 73,7, 6,16,
28,1 and 3 amino acids long. The peptide which is 3 amino acids long and contains the C- 
terminus should then be easily purified by chromatography on HPLC and sequenced by 
conventional methods. If the McFadden sequence is correct, then digestion of ICL with 
endoproteinase Arg-C should result in 19 peptides, with one peptide two amino acids long 
which contains the C-terminus.
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During the course of this work, the genes encoding ICL from B. napus, G. hirsutum, 
R. communnis and C. tropicalis were also sequenced (Beeching and Northcote, 1987; Comai 
et al., 1989; Turley et al., 1990; Atomi et al., 1990). Comparison of the derived amino acid 
sequences of ICLs revealed a high degree of identity. There was a very high degree of identity 
between the plant enzymes, each showing at least 86% identity to another, and also between 
the plant enzymes and the yeast ICL, with the yeast ICL showing 54-55% identity with the 
plant enzymes. Thus, the eukaryotic enzymes are highly conserved. More surprisingly, the E. 
coli ML308 sequence also shows a high degree of identity with both the yeast enzyme and the 
plant enzymes despite the fact that the E. coli ICL is a member of the lower Mr group 
containing the prokaryotic enzymes while the plant and yeast enzymes are all members of the 
higher Mr group. The areas of identity are interspersed throughout the length of the E. coli 
sequence although there are areas where the amino acid sequences are very highly conserved 
that may form part of the active site (figure 3.17, see below). The major differences between 
the E. coli ICL sequence and the eukaryotic sequences were the extensions at the N-terminus, 
the C-terminus and a large insert within the E. coli sequence, between residues Gly255 and 
Glu256. These extensions probably account for the difference in Mr between the prokaryotic 
and eukaryotic ICLs, although the E. coli sequence is, as yet, the only prokaryotic sequence 
available and may not be typical of the other prokaryotic ICL enzymes. Since there is no 
compartmentation in E. coli, and ICL is found in glyoxysomes in eukaryotes, it is possible 
that any or all of the additional sequences in the plant enzymes are responsible for sequestration 
of ICL into these organelles. This possibility is discussed in section 3.4.3.
The origin of the insert is not known but it is thought that there was an ancestral gene 
encoding an ICL of Mr 16,000. The various ICLs are thought to have arisen by duplication and 
fusion of either three or four copies of this ancestral gene (Matsuoka and McFadden, 1988). 
These authors compared the insert region of the R. communnis ICL with other regions of the 
same enzyme and the bacterial enzyme and found that this region showed weak homology to an 
adjacent region in the R. communnis enzyme between amino acids 380 to 470.
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5.3 The Active Site Of ICL;
Although both ICDH and ICL bind isocitrate, the Km of ICL for this substrate is at least 
one order of magnitude higher than that of ICDH. It is therefore of great interest to find out 
why this is so. The sequence of the gene encoding ICDH has been determined and the three 
dimensional structure is now available for ICDH in the presence of either Mg2+ plus isocitrate, 
NADP+ or in the absence of any substrates. It is a long-term aim to modify ICL in such a way 
that it competes for the common substrate more efficiently so that a mutant organism could 
direct a greater proportion of isocitrate through the glyoxylate bypass in order to produce more 
biomass.
It was hoped that the three dimensional structure of this enzyme would be determined 
by the time I was about to start to generate mutants of the E. coli ML308 ICL. However, this 
was not the case. Crystals of ICL purified from the overexpressing strain KAT-l/pEM9 had 
been made but they were not suitable for X-ray diffraction, apparently because they were not 
sufficiendy ordered.
Chemical modification studies of ICL from a number of organisms had shown that 
there may be a Cys, a His and either a Glu or an Asp at the active site. Cysl95 was identified 
as being at the active site of the E. coli enzyme independently by both our group using 
iodoacetate and McFadden's group using 3-BrP to modify the active site residue. This residue 
is located within a very highly conserved region of the derived amino acid sequence and is 
conserved in all, the ICL sequences to date. The site directed mutagenesis work reported in 
Chapter 4 confirmed that Cys 195 plays an important role in catalysis and allowed me to make 
some speculations as to its precise role that are discussed in section 4.6.
The site directed mutagenesis of Cysl95 was made feasible because the amino acid 
sequence around the modified residue was determined. For the other putative active site
residues, this sort of data were not available. Without the three-dimensional structure, two
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other approaches may identify possible active site residues. Chemical modification can identify 
putative active site residues, which if conserved in other ICLs it can be established whether or 
not these residues are likely to be important. A second approach is comparison of the ICL 
sequences with that of ICDH given that the residues which bind isocitrate have been identified 
for this enzyme from the three-dimensional structure in the presence of Mg2+ and isocitrate.
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Since ICDH also binds NADP+ but ICL does not, it is very unlikely that the two 
enzymes are topologically highly related. Nevertheless ICDH and ICL both bind isocitrate. 
Comparison of the secondary structure predictions of ICL with ICDH indicates that there may 
be some similarity in the structures of the isocitrate binding pockets, and comparison of the 
ICL sequence with that of ICDH may indicate which residues may be at the active site (e.g. the 
His and Asp or Glu residues for which there is chemical modification evidence).
Recently, McFadden’s group reported that His266 and His306 could be at or near the 
active site of the E. coli ICL, based on chemical modification by DEPC and protection of 
inhibition by the substrates. However, work done here in Glasgow has indicated that only His 
306 is modified by DEPC and that it is unlikely that this residue is at the active site (Rua, 
Robertson and Nimmo, submitted). This does not however rule out the possibility that there is 
a His at or near the active site. It is of note that His266 has been proposed as the site of 
phosphorylation of ICL in E. co/f(Matsuoka and McFadden, 1988). There are four conserved 
His residues between all the ICL sequences, at positions 184,197, 356 and 399. Comparison 
of ICL with the ICDH sequence reveals that of the His residues conserved between the ICLs, 
only Hisl97 is also conserved in ICDH. Since Hisl97 is very close to the active site Cysl95, 
it seems likely that this residue is also at or near the active site. Also, the corresponding residue 
in ICDH, His 193 is part of the clasp-like domain and as such is very close to the isocitrate 
binding site in a second subunit. Further indication that a His residue is at the active site came 
from the pH studies with the mutant ICLs. Studies with the wild type ICL suggested that there 
were two ionising groups affecting Km with pKas of very similar values within the pH range 
6.8-8.5 and as such the values for each group could not be determined. However the mutants 
had only one ionising group which affected Km with a pKa of 7.8, which is close to the value 
usually found for His residues in enzymes.
It has been shown that the substrate analogue, itaconate epoxide, inactivates ICL from 
Citrullis vulgaris by modifying either an Asp or a Glu residue. There are 13 conserved Asp 
residues and 9 conserved Glu residues between the ICL sequences. When compared to the 
ICDH sequence, only Asp31, Glu208 and Glu 260, corresponding to Asp35, Glu204 and 
Glu256 in the ICDH sequence are conserved. However, there are two conservative changes in 
the ICDH sequence which has Glu residues at positions 274 and 371 which correspond to
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residues Asp294 and Asp409 in the E. coli ICL sequence. Considering the structure of ICDH, 
Glu208 could be close to the isocitrate binding site of ICL.
Another approach to identify residues in ICL which may bind isocitrate is to look for 
conservation of residues which bind isocitrate in ICDH. The residues which bind isocitrate in 
ICDH have been identified and are shown in figure 5.1. When aligned with the E. coli ML308 
ICL sequence, there are distinct similarities between the two enzymes. Seri 13 in ICDH forms 
a hydrogen bond with the C5 carboxyl group of isocitrate. In E. coli ICL, Seri 13 corresponds 
to Argl23, which may form an electrostatic interaction with the same group on the substrate. In 
the other ICLs, Seri 13 corresponds to a His residue, which if protonated, could form a 
hydrogen bond or an electrostatic interaction with the C5 carboxyl. A snll5 in ICDH 
corresponds to Asnl25 in E. coli ICL, although in the other ICL sequences, the same residue 
corresponds to an Asp. Argl 19 in ICDH forms two hydrogen bonds with two carboxyl groups 
on the substrate. The corresponding residue in E. coli ICL is Argl29 and a His in the other 
enzymes, which if protonated, may form hydrogen bonds in the same manner. Argl29 in 
ICDH does not have a corresponding residue in any of the ICL sequences as there is a gap in 
the ICL sequence spanning p sheet-F (residues 124-132) in the ICDH structure. Asp311 in 
ICDH corresponds to Lys331 in the E. coli ICL sequence although at the same position in G. 
hirsutum and-ff. communnis ICL, there is a Glu, in B. napus, there is an Gin and in C. 
tropicalis, there is an Asp. Therefore, at this position, the possible nucleophile is conserved 
except in the E. coli enzyme. Asp 283 in the ICDH sequence, which coordinates the Mg2+ in 
the active site that is mainly contributed by second subunit, corresponds to Gln303 in the 
E. coli ICL sequence, a Glu in the plant enzymes and an Asp in yeast ICL. Asp307 in the 
ICDH sequence coordinates Mg2+ and corresponds to Asn327 in the E. coli ICL, while in the 
other ICL enzymes, Asp307 corresponds to either an Ala or a Gly. The ICDH Argl53 
corresponds to either a Val or He in the ICL sequences. Lys230 in ICDH forms a hydrogen 
bond with the carboxyl group at the C3 position of isocitrate bound at the second subunit. This 
residue corresponds to Asp234 in the E. coli ICL sequence and the same residue in all the 
other ICL sequences. Tyrl60 in ICDH forms a hydrogen bond to the same carboxyl group as 
Lys230 in the other subunit. In the E. coli ICL, this residue corresponds to Phel62 which is
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Figure 5.1; Binding Of Mg2+ Isocitrate In The Active Site Of ICDH
Taken from Hurley et al. (1990a). Hydrogen bonds and salt bridges between the 
enzyme and substrates are indicated by dashed lines. Residues of the second subunit are 
indicated by a prime. Water molecules are not shown.
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conserved in all other ICL sequences.
Thus it appears that between E. coli ICDH and ICL, the following residues in the ICL 
sequence are conserved or there are conservative changes with the charge remaining the same: 
Argl23, Asnl 15 and Argl 19. In the other ICL sequences, the charge at Argl 19, Asp311 and 
Asp283 in ICDH is conserved but the -NH group of Asnl 15 is substituted by a carboxyl 
group of Asp.
Both of the above approaches have identified several posible active site residues. Until 
the three dimensional structure of ICL has been determined, the actual structure and 
composition of the active site will not be known. However, site directed mutagenesis could be 
used to replace these residues and so determine whether they are at the active site or not.
The second approach also reveals possible reasons as to the difference in dissociation 
constants between ICL and ICDH. For example, the negative charge at Asp283 in ICDH is 
replaced in E. coli ICL by a Gin, Asp311 is replaced by a Lys which has the opposite charge 
and the hydroxyl of Tyrl60 in ICDH which forms a hydrogen bond with the substrate is 
replaced in all the ICL enzymes by a Phe which has no hydroxyl group. Site directed 
mutagenesis of the above residues in ICL replacing them with the corresponding residues in 
ICDH may result in ICL enzymes which have a lower Km for isocitrate than the wild type 
enzyme and so may be able to compete for the common substrate more efficiently.
5.4 Im portance Of Sequence Downstream O f aceK :
Despite the fact that pCL8, a subclone of pCLlOOO, contains the entire coding region of 
aceK, no proteins were found to co-migrate with ICDH kinase/phosphatase on SDS gels after 
maxicell labelling. This was attributed to a sharp downshift in expression of aceK with respect 
to aceA caused by the presence of a stem-loop structure in the aceA-aceK intercistronic 
region, found from the sequence of this region (Klumpp et al., 1988; Cortay et al., 1988). 
However, it seems more likely that the stem-loop prevent degradation of mRNA transcribed 
from aceA since deletion of the aceA-aceK intercistronic region results in a decrease in 
expression of aceA (Klumpp et al., 1988; section 1.3.6). In addition pEM9 does express 
detectable levels of ICDH kinase/phosphatase. The Hindin site at the end of the insert in
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pEM901 corresponds to the HindlH site at the end of pCLlOOO. Assuming that the functional 
maps of pEM901 and pCL8 are similar, the fact that pEM901, like pCL8, cannot express 
ICDH kinase/phosphatase indicates that DNA downstream of the Hindin site is essential for 
expression of ICDH kinase/phosphatase. One possibility is that the Hindm site lies upstream 
of, or is included in a stem-loop which prevents digestion of the mRNA from the 3' end, 
similar to that proposed in the aceA-aceK intercistronic region. Indeed, when the aceB gene 
was used as a probe in a northern blot of E. coli RNA, it was found that the probe hybridised 
to a lOkb transcript, more than 3kb longer than is required to encode all three genes in the ace 
operon. Since the transcription startsite has been located immediately upstream of aceB 
(Chung et al., 1988), this suggests that a large region downstream of aceK is also 
transcribed. This region has recently been sequenced and an open frame was shown to be 
present in the opposite orientation to the ace operon (Galinier et al., 1991; section 1.3.2). 
However, this sequence has not been analysed for the presence of any possible REP or other 
stem-loop structures.
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5.5 Future Work:
The work carried out in this thesis has provided several directions for future work on 
understanding the reaction mechanism of ICL from E. coli ML308. The determination of the 
derived amino acid sequence will greatly aid the determination of the three dimensional 
structure of this enzyme. In conjunction with the three dimensional structure, knowledge of the 
primary structure allows the generation of a number of mutant enzymes which will effect the 
activity of ICL. Therefore, the determination of the three dimensional structure of ICL is a 
major priority.
Attempts have been made to crystallize ICL purified from E. coli KAT-l/pEM9. 
However, it was found that during crystallization, proteolytic degradation had occurred, 
resulting in non-uniform crystals which were not suitable for X-ray diffraction. Using ICL 
purified from E. coli JE10/pICL-l, crystals were formed, but unfortunately, these were not 
suitable for X-ray diffraction either. Another approach was taken in that ICL which had been 
modified using 3-BrP was crystallized giving crystals which were morphologically similar to 
the native crystals although the modified crystals are not disordered. In addition, crystals of
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ICL have been grown in the presence of heavy atoms. These crystals have also been shown to 
be suitable for X-ray diffraction. Work is now underway to determine the three dimensional 
structure of ICL from E. coli (Abeysinghe et al., 1991). However, even without knowledge 
of the three dimensional structure, site directed mutagenesis could still be done, replacing some 
of the residues mentioned in the previous section.
Of particular interest is the suggestion that one of the four His residues conserved in all 
ICLs may be located at the active site and affect the Km for isocitrate, and perhaps the kcat also. 
These residues are obvious targets for further site directed mutagenesis.
The suggestion that ICDH and ICL share an isocitrate binding motif is also of interest. 
It might be possible to obtain further information on the isocitrate binding site of ICL by 
random mutagenesis (Oliphant and Struhl, 1989). Strains containing ICL but no ICDH 
kinase/phosphatase activity are unable to grow, or grow very slowly on acetate as the sole 
carbon source because their intracellular isocitrate concentration is too low. It should therefore 
be possible to select for ICLs with a reduced Km for isocitrate by virtue of an increased growth 
rate on acetate. This would allow identification of residues that affect the binding of isocitrate. 
It would also have another advantage. It would become possible to study the phosphorylation 
of ICDH in a strain in which the isocitrate concentration did not have to be increased by as 
much as in the wild type to allow sufficient flux through the glyoxylate bypass. The behaviour 
of the phosphorylation system in such a strain would be of considerable interest. It seems 
likely that mutagenesis along these lines will prove invaluable in the analysis of regulatory 
systems in the future.
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